Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
T  ||| S:47 E:49 ||| NN
lymphocyte  ||| S:49 E:60 ||| FW
actin  ||| S:60 E:66 ||| FW
cytoskeleton  ||| S:66 E:79 ||| FW
is  ||| S:79 E:82 ||| VBZ
clearly  ||| S:82 E:90 ||| RB
important  ||| S:90 E:108 ||| JJ
in  ||| S:108 E:111 ||| IN
the  ||| S:111 E:115 ||| DT
regulation  ||| S:115 E:126 ||| NN
of  ||| S:126 E:129 ||| IN
cell  ||| S:129 E:134 ||| NN
activity  ||| S:134 E:143 ||| NN
at  ||| S:143 E:146 ||| IN
a  ||| S:146 E:148 ||| DT
variety  ||| S:148 E:156 ||| NN
of  ||| S:156 E:167 ||| IN
different  ||| S:167 E:177 ||| JJ
levels ||| S:177 E:183 ||| NNS
.  ||| S:183 E:185 ||| .
An  ||| S:185 E:188 ||| DT
intact  ||| S:188 E:195 ||| JJ
actin  ||| S:195 E:201 ||| JJ
cytoskeleton  ||| S:201 E:214 ||| NN
is  ||| S:214 E:217 ||| VBZ
required  ||| S:217 E:234 ||| VBN
for  ||| S:234 E:238 ||| IN
sustained  ||| S:238 E:248 ||| JJ
signals  ||| S:248 E:256 ||| NNS
leading  ||| S:256 E:264 ||| VBG
to  ||| S:264 E:267 ||| TO
T  ||| S:267 E:269 ||| NN
cell  ||| S:269 E:274 ||| NN
activation  ||| S:274 E:285 ||| NNS
[  ||| S:285 E:287 ||| -LRB-
1  ||| S:287 E:289 ||| LS
]  ||| S:289 E:291 ||| -RRB-
.  ||| S:291 E:301 ||| .
T  ||| S:301 E:303 ||| NN
helper  ||| S:303 E:310 ||| NNS
and  ||| S:310 E:314 ||| CC
cytolytic  ||| S:314 E:324 ||| JJ
effector  ||| S:324 E:333 ||| JJ
cells  ||| S:333 E:339 ||| NNS
reorient  ||| S:339 E:348 ||| VBD
their  ||| S:348 E:362 ||| PRP$
intracellular  ||| S:362 E:376 ||| JJ
components  ||| S:376 E:387 ||| NNS
for  ||| S:387 E:391 ||| IN
vectorial  ||| S:391 E:401 ||| JJ
secretion  ||| S:401 E:411 ||| NN
of  ||| S:411 E:422 ||| IN
cytokines  ||| S:422 E:432 ||| NNS
[  ||| S:432 E:434 ||| -LRB-
2  ||| S:434 E:436 ||| LS
]  ||| S:436 E:438 ||| -RRB-
or  ||| S:438 E:441 ||| CC
cytolytic  ||| S:441 E:451 ||| JJ
components  ||| S:451 E:462 ||| NNS
[  ||| S:462 E:464 ||| -LRB-
3  ||| S:464 E:466 ||| LS
]  ||| S:466 E:468 ||| -RRB-
via  ||| S:468 E:480 ||| IN
cytoskeletal  ||| S:480 E:493 ||| JJ
dependent  ||| S:493 E:503 ||| JJ
mechanisms ||| S:503 E:513 ||| NNS
.  ||| S:513 E:515 ||| .
Recent  ||| S:515 E:522 ||| JJ
reports  ||| S:522 E:530 ||| NNS
suggest  ||| S:530 E:546 ||| VBP
an  ||| S:546 E:549 ||| DT
active  ||| S:549 E:556 ||| JJ
role  ||| S:556 E:561 ||| NN
played  ||| S:561 E:568 ||| VBD
by  ||| S:568 E:571 ||| IN
the  ||| S:571 E:575 ||| DT
T  ||| S:575 E:577 ||| NN
cell  ||| S:577 E:582 ||| NN
cytoskeleton  ||| S:582 E:595 ||| NN
in  ||| S:595 E:606 ||| IN
maintaining  ||| S:606 E:618 ||| VBG
spatially  ||| S:618 E:628 ||| NNS
defined  ||| S:628 E:636 ||| VBN
molecular  ||| S:636 E:646 ||| JJ
clusters  ||| S:646 E:655 ||| NNS
found  ||| S:655 E:669 ||| VBD
within  ||| S:669 E:676 ||| IN
the  ||| S:676 E:680 ||| DT
immunological  ||| S:680 E:694 ||| JJ
synapse  ||| S:694 E:702 ||| NN
-  ||| S:702 E:704 ||| :
a  ||| S:704 E:706 ||| DT
highly  ||| S:706 E:713 ||| RB
structured  ||| S:713 E:732 ||| VBN
molecular  ||| S:732 E:742 ||| JJ
array  ||| S:742 E:748 ||| NN
defined  ||| S:748 E:756 ||| VBN
by  ||| S:756 E:759 ||| IN
contact  ||| S:759 E:767 ||| NN
regions  ||| S:767 E:775 ||| NNS
between  ||| S:775 E:783 ||| IN
T  ||| S:783 E:785 ||| NN
cells  ||| S:785 E:799 ||| NNS
and  ||| S:799 E:803 ||| CC
antigen  ||| S:803 E:811 ||| JJ
presenting  ||| S:811 E:822 ||| JJ
cells  ||| S:822 E:828 ||| NNS
[  ||| S:828 E:830 ||| -LRB-
4  ||| S:830 E:832 ||| CD
5  ||| S:832 E:834 ||| CD
6  ||| S:834 E:836 ||| CD
7  ||| S:836 E:838 ||| CD
]  ||| S:838 E:840 ||| -RRB-
,  ||| S:840 E:842 ||| ,
and  ||| S:842 E:846 ||| CC
reviewed  ||| S:846 E:855 ||| VBN
in  ||| S:855 E:866 ||| IN
[  ||| S:866 E:868 ||| -LRB-
8  ||| S:868 E:870 ||| CD
9  ||| S:870 E:872 ||| CD
]  ||| S:872 E:874 ||| -RRB-
or  ||| S:874 E:877 ||| CC
NK  ||| S:877 E:880 ||| NNP
cells  ||| S:880 E:886 ||| NNS
and  ||| S:886 E:890 ||| CC
target  ||| S:890 E:897 ||| NN
cells  ||| S:897 E:903 ||| NNS
[  ||| S:903 E:905 ||| -LRB-
10  ||| S:905 E:908 ||| CD
]  ||| S:908 E:910 ||| -RRB-
.  ||| S:910 E:912 ||| .
Although  ||| S:912 E:921 ||| IN
the  ||| S:921 E:933 ||| DT
actin  ||| S:933 E:939 ||| JJ
cytoskeleton  ||| S:939 E:952 ||| NN
has  ||| S:952 E:956 ||| VBZ
been  ||| S:956 E:961 ||| VBN
implicated  ||| S:961 E:972 ||| VBN
in  ||| S:972 E:975 ||| IN
all  ||| S:975 E:979 ||| PDT
these  ||| S:979 E:993 ||| DT
processes ||| S:993 E:1002 ||| NNS
,  ||| S:1002 E:1004 ||| ,
perhaps  ||| S:1004 E:1012 ||| RB
its  ||| S:1012 E:1016 ||| PRP$
greatest  ||| S:1016 E:1025 ||| JJS
role  ||| S:1025 E:1030 ||| NN
is  ||| S:1030 E:1033 ||| VBZ
in  ||| S:1033 E:1036 ||| IN
regulating  ||| S:1036 E:1047 ||| VBG
T  ||| S:1047 E:1057 ||| NN
lymphocyte  ||| S:1057 E:1068 ||| NN
motility  ||| S:1068 E:1077 ||| NNS
and  ||| S:1077 E:1081 ||| CC
morphology ||| S:1081 E:1091 ||| NN
.  ||| S:1091 E:1101 ||| .
The  ||| S:1101 E:1105 ||| DT
first  ||| S:1105 E:1111 ||| JJ
physical  ||| S:1111 E:1120 ||| JJ
step  ||| S:1120 E:1125 ||| NN
in  ||| S:1125 E:1128 ||| IN
directional  ||| S:1128 E:1140 ||| JJ
motility  ||| S:1140 E:1149 ||| NN
is  ||| S:1149 E:1152 ||| VBZ
the  ||| S:1152 E:1164 ||| DT
extension  ||| S:1164 E:1174 ||| NN
of  ||| S:1174 E:1177 ||| IN
cellular  ||| S:1177 E:1186 ||| JJ
processes  ||| S:1186 E:1196 ||| NNS
termed  ||| S:1196 E:1203 ||| VBD
pseudopods  ||| S:1203 E:1214 ||| NNS
[  ||| S:1214 E:1216 ||| -LRB-
11  ||| S:1216 E:1219 ||| CD
]  ||| S:1219 E:1221 ||| -RRB-
.  ||| S:1221 E:1231 ||| .
Pseudopodia  ||| S:1231 E:1243 ||| NNS
are  ||| S:1243 E:1247 ||| VBP
flattened ||| S:1247 E:1256 ||| VBN
,  ||| S:1256 E:1258 ||| ,
fan  ||| S:1258 E:1262 ||| NN
shape  ||| S:1262 E:1268 ||| NN
cellular  ||| S:1268 E:1277 ||| JJ
protrusions  ||| S:1277 E:1297 ||| JJ
enriched  ||| S:1297 E:1306 ||| NN
in  ||| S:1306 E:1309 ||| IN
signaling  ||| S:1309 E:1319 ||| VBG
molecules  ||| S:1319 E:1329 ||| NNS
and  ||| S:1329 E:1333 ||| CC
cytoskeletal  ||| S:1333 E:1346 ||| JJ
elements  ||| S:1346 E:1363 ||| NNS
including  ||| S:1363 E:1373 ||| VBG
filamentous  ||| S:1373 E:1385 ||| JJ
actin ||| S:1385 E:1390 ||| NN
,  ||| S:1390 E:1392 ||| ,
which  ||| S:1392 E:1398 ||| WDT
is  ||| S:1398 E:1401 ||| VBZ
preferentially  ||| S:1401 E:1424 ||| JJ
nucleated  ||| S:1424 E:1434 ||| NN
at  ||| S:1434 E:1437 ||| IN
the  ||| S:1437 E:1441 ||| DT
leading  ||| S:1441 E:1449 ||| JJ
edge  ||| S:1449 E:1454 ||| NN
of  ||| S:1454 E:1457 ||| IN
a  ||| S:1457 E:1459 ||| DT
migrating  ||| S:1459 E:1469 ||| JJ
cell  ||| S:1469 E:1474 ||| NN
[  ||| S:1474 E:1476 ||| -LRB-
12  ||| S:1476 E:1479 ||| CD
]  ||| S:1479 E:1481 ||| -RRB-
.  ||| S:1481 E:1491 ||| .
A  ||| S:1491 E:1493 ||| DT
key  ||| S:1493 E:1497 ||| JJ
candidate  ||| S:1497 E:1507 ||| NN
for  ||| S:1507 E:1511 ||| IN
regulation  ||| S:1511 E:1522 ||| NN
of  ||| S:1522 E:1525 ||| IN
the  ||| S:1525 E:1529 ||| DT
T  ||| S:1529 E:1531 ||| NN
lymphocyte  ||| S:1531 E:1542 ||| FW
actin  ||| S:1542 E:1556 ||| FW
cytoskeleton  ||| S:1556 E:1569 ||| FW
is  ||| S:1569 E:1572 ||| VBZ
the  ||| S:1572 E:1576 ||| DT
GTP-binding  ||| S:1576 E:1588 ||| JJ
protein  ||| S:1588 E:1596 ||| NN
Rho ||| S:1596 E:1599 ||| NNP
.  ||| S:1599 E:1601 ||| .
This  ||| S:1601 E:1606 ||| DT
small  ||| S:1606 E:1620 ||| JJ
member  ||| S:1620 E:1627 ||| NN
of  ||| S:1627 E:1630 ||| IN
the  ||| S:1630 E:1634 ||| DT
Ras  ||| S:1634 E:1638 ||| JJ
GTPase  ||| S:1638 E:1645 ||| JJ
superfamily  ||| S:1645 E:1657 ||| NN
has  ||| S:1657 E:1661 ||| VBZ
been  ||| S:1661 E:1666 ||| VBN
implicated  ||| S:1666 E:1677 ||| VBN
in  ||| S:1677 E:1688 ||| IN
fibroblast  ||| S:1688 E:1699 ||| JJ
models  ||| S:1699 E:1706 ||| NNS
of  ||| S:1706 E:1709 ||| IN
integrin  ||| S:1709 E:1718 ||| JJ
dependent  ||| S:1718 E:1728 ||| JJ
actin  ||| S:1728 E:1734 ||| JJ
stress  ||| S:1734 E:1741 ||| NN
fiber  ||| S:1741 E:1755 ||| NN
formation ||| S:1755 E:1764 ||| NN
,  ||| S:1764 E:1766 ||| ,
focal  ||| S:1766 E:1772 ||| JJ
contact  ||| S:1772 E:1780 ||| NN
assembly  ||| S:1780 E:1789 ||| NN
[  ||| S:1789 E:1791 ||| -LRB-
13  ||| S:1791 E:1794 ||| CD
]  ||| S:1794 E:1796 ||| -RRB-
,  ||| S:1796 E:1798 ||| ,
and  ||| S:1798 E:1802 ||| CC
gene  ||| S:1802 E:1815 ||| NN
induction  ||| S:1815 E:1825 ||| NN
via  ||| S:1825 E:1829 ||| IN
the  ||| S:1829 E:1833 ||| DT
serum  ||| S:1833 E:1839 ||| JJ
response  ||| S:1839 E:1848 ||| NN
element  ||| S:1848 E:1856 ||| NN
[  ||| S:1856 E:1858 ||| -LRB-
14  ||| S:1858 E:1861 ||| CD
]  ||| S:1861 E:1863 ||| -RRB-
.  ||| S:1863 E:1865 ||| .
Studies  ||| S:1865 E:1881 ||| NNS
of  ||| S:1881 E:1884 ||| IN
Rho  ||| S:1884 E:1888 ||| NNP
function  ||| S:1888 E:1897 ||| NN
have  ||| S:1897 E:1902 ||| VBP
been  ||| S:1902 E:1907 ||| VBN
facilitated  ||| S:1907 E:1919 ||| VBN
by  ||| S:1919 E:1922 ||| IN
the  ||| S:1922 E:1926 ||| DT
use  ||| S:1926 E:1930 ||| NN
of  ||| S:1930 E:1941 ||| IN
specific  ||| S:1941 E:1950 ||| JJ
toxins  ||| S:1950 E:1957 ||| JJ
such  ||| S:1957 E:1962 ||| JJ
as  ||| S:1962 E:1974 ||| IN
Clostridium  ||| S:1974 E:1986 ||| NNP
botulinum  ||| S:1986 E:1996 ||| JJ
toxin  ||| S:1996 E:2002 ||| NN
C3  ||| S:2002 E:2005 ||| NN
which  ||| S:2005 E:2019 ||| WDT
catalyses  ||| S:2019 E:2029 ||| VBZ
the  ||| S:2029 E:2033 ||| DT
ADP-ribosylation  ||| S:2033 E:2050 ||| JJ
and  ||| S:2050 E:2054 ||| CC
inactivation  ||| S:2054 E:2067 ||| NN
of  ||| S:2067 E:2070 ||| IN
Rho  ||| S:2070 E:2074 ||| NNP
[  ||| S:2074 E:2076 ||| -LRB-
15  ||| S:2076 E:2087 ||| CD
16  ||| S:2087 E:2090 ||| CD
17  ||| S:2090 E:2093 ||| CD
]  ||| S:2093 E:2095 ||| -RRB-
.  ||| S:2095 E:2097 ||| .
The  ||| S:2097 E:2101 ||| DT
function  ||| S:2101 E:2110 ||| NN
of  ||| S:2110 E:2113 ||| IN
this  ||| S:2113 E:2118 ||| DT
GTPase  ||| S:2118 E:2125 ||| JJ
and  ||| S:2125 E:2129 ||| CC
related  ||| S:2129 E:2137 ||| JJ
family  ||| S:2137 E:2152 ||| NN
members  ||| S:2152 E:2160 ||| NNS
such  ||| S:2160 E:2165 ||| JJ
as  ||| S:2165 E:2168 ||| IN
Rac  ||| S:2168 E:2172 ||| NNP
and  ||| S:2172 E:2176 ||| CC
Cdc42  ||| S:2176 E:2182 ||| NNP
has  ||| S:2182 E:2186 ||| VBZ
been  ||| S:2186 E:2191 ||| VBN
extensively  ||| S:2191 E:2203 ||| RB
studied  ||| S:2203 E:2219 ||| VBN
in  ||| S:2219 E:2222 ||| IN
the  ||| S:2222 E:2226 ||| DT
fibroblast  ||| S:2226 E:2237 ||| JJ
model ||| S:2237 E:2242 ||| NN
.  ||| S:2242 E:2244 ||| .
In  ||| S:2244 E:2247 ||| IN
this  ||| S:2247 E:2252 ||| DT
system  ||| S:2252 E:2259 ||| NN
it  ||| S:2259 E:2262 ||| PRP
has  ||| S:2262 E:2266 ||| VBZ
been  ||| S:2266 E:2271 ||| VBN
shown  ||| S:2271 E:2285 ||| VBN
that  ||| S:2285 E:2290 ||| IN
Rho  ||| S:2290 E:2294 ||| NNP
function  ||| S:2294 E:2303 ||| NN
is  ||| S:2303 E:2306 ||| VBZ
necessary  ||| S:2306 E:2316 ||| JJ
for  ||| S:2316 E:2320 ||| IN
the  ||| S:2320 E:2324 ||| DT
production  ||| S:2324 E:2335 ||| NN
of  ||| S:2335 E:2338 ||| IN
actin  ||| S:2338 E:2352 ||| JJ
stress  ||| S:2352 E:2359 ||| NN
fibers  ||| S:2359 E:2366 ||| NNS
[  ||| S:2366 E:2368 ||| -LRB-
13  ||| S:2368 E:2371 ||| CD
]  ||| S:2371 E:2373 ||| -RRB-
.  ||| S:2373 E:2375 ||| .
However ||| S:2375 E:2382 ||| RB
,  ||| S:2382 E:2384 ||| ,
in  ||| S:2384 E:2387 ||| IN
cells  ||| S:2387 E:2393 ||| NNS
that  ||| S:2393 E:2398 ||| WDT
are  ||| S:2398 E:2410 ||| VBP
considered  ||| S:2410 E:2421 ||| VBN
highly  ||| S:2421 E:2428 ||| RB
motile  ||| S:2428 E:2435 ||| JJ
and  ||| S:2435 E:2439 ||| CC
circulate  ||| S:2439 E:2449 ||| NN
through  ||| S:2449 E:2457 ||| IN
various  ||| S:2457 E:2473 ||| JJ
compartments  ||| S:2473 E:2486 ||| NN
of  ||| S:2486 E:2489 ||| IN
the  ||| S:2489 E:2493 ||| DT
body  ||| S:2493 E:2498 ||| NN
( ||| S:2498 E:2499 ||| -LRB-
such  ||| S:2499 E:2504 ||| JJ
as  ||| S:2504 E:2507 ||| IN
T  ||| S:2507 E:2509 ||| NN
lymphocytes ||| S:2509 E:2520 ||| NN
) ||| S:2520 E:2521 ||| -RRB-
,  ||| S:2521 E:2523 ||| ,
actin  ||| S:2523 E:2537 ||| JJ
stress  ||| S:2537 E:2544 ||| NN
fibers  ||| S:2544 E:2551 ||| NNS
have  ||| S:2551 E:2556 ||| VBP
yet  ||| S:2556 E:2560 ||| RB
to  ||| S:2560 E:2563 ||| TO
be  ||| S:2563 E:2566 ||| VB
identified ||| S:2566 E:2576 ||| VBN
.  ||| S:2576 E:2578 ||| .
By  ||| S:2578 E:2581 ||| IN
comparison  ||| S:2581 E:2592 ||| NN
to  ||| S:2592 E:2603 ||| TO
adherent  ||| S:2603 E:2612 ||| VB
cells  ||| S:2612 E:2618 ||| NNS
such  ||| S:2618 E:2623 ||| JJ
as  ||| S:2623 E:2626 ||| IN
fibroblasts ||| S:2626 E:2637 ||| NN
,  ||| S:2637 E:2639 ||| ,
less  ||| S:2639 E:2644 ||| JJR
work  ||| S:2644 E:2649 ||| NN
has  ||| S:2649 E:2653 ||| VBZ
been  ||| S:2653 E:2658 ||| VBN
done  ||| S:2658 E:2671 ||| VBN
within  ||| S:2671 E:2678 ||| IN
the  ||| S:2678 E:2682 ||| DT
formed  ||| S:2682 E:2689 ||| JJ
elements  ||| S:2689 E:2698 ||| NNS
of  ||| S:2698 E:2701 ||| IN
the  ||| S:2701 E:2705 ||| DT
blood ||| S:2705 E:2710 ||| NN
,  ||| S:2710 E:2712 ||| ,
in  ||| S:2712 E:2715 ||| IN
particular ||| S:2715 E:2725 ||| JJ
,  ||| S:2725 E:2735 ||| ,
studies  ||| S:2735 E:2743 ||| NNS
addressing  ||| S:2743 E:2754 ||| VBG
the  ||| S:2754 E:2758 ||| DT
role  ||| S:2758 E:2763 ||| NN
played  ||| S:2763 E:2770 ||| VBD
by  ||| S:2770 E:2773 ||| IN
Rho  ||| S:2773 E:2777 ||| NNP
in  ||| S:2777 E:2780 ||| IN
the  ||| S:2780 E:2792 ||| DT
maintenance  ||| S:2792 E:2804 ||| NN
of  ||| S:2804 E:2807 ||| IN
T  ||| S:2807 E:2809 ||| NN
lymphocyte  ||| S:2809 E:2820 ||| NN
cytoarchitecture ||| S:2820 E:2836 ||| NN
.  ||| S:2836 E:2846 ||| .
The  ||| S:2846 E:2850 ||| DT
involvement  ||| S:2850 E:2862 ||| NN
of  ||| S:2862 E:2865 ||| IN
Rho  ||| S:2865 E:2869 ||| NNP
GTPases  ||| S:2869 E:2877 ||| NNP
in  ||| S:2877 E:2880 ||| IN
regulating  ||| S:2880 E:2891 ||| VBG
integrin  ||| S:2891 E:2908 ||| JJ
dependent  ||| S:2908 E:2918 ||| JJ
events  ||| S:2918 E:2925 ||| NNS
such  ||| S:2925 E:2930 ||| JJ
as  ||| S:2930 E:2933 ||| IN
leukocyte  ||| S:2933 E:2943 ||| JJ
homotypic  ||| S:2943 E:2953 ||| JJ
aggregation  ||| S:2953 E:2973 ||| NN
and  ||| S:2973 E:2977 ||| CC
in  ||| S:2977 E:2980 ||| IN
chemokine  ||| S:2980 E:2990 ||| JJ
upregulation  ||| S:2990 E:3003 ||| NN
of  ||| S:3003 E:3006 ||| IN
integrin-mediated  ||| S:3006 E:3024 ||| JJ
adhesion  ||| S:3024 E:3041 ||| NN
has  ||| S:3041 E:3045 ||| VBZ
recently  ||| S:3045 E:3054 ||| RB
been  ||| S:3054 E:3059 ||| VBN
identified  ||| S:3059 E:3070 ||| VBN
[  ||| S:3070 E:3072 ||| -LRB-
18  ||| S:3072 E:3075 ||| CD
19  ||| S:3075 E:3078 ||| CD
]  ||| S:3078 E:3080 ||| -RRB-
.  ||| S:3080 E:3082 ||| .
ADP-ribosylation  ||| S:3082 E:3107 ||| JJ
of  ||| S:3107 E:3110 ||| IN
Rho  ||| S:3110 E:3114 ||| NNP
in  ||| S:3114 E:3117 ||| IN
neutrophils  ||| S:3117 E:3129 ||| NN
by  ||| S:3129 E:3132 ||| IN
treatment  ||| S:3132 E:3142 ||| NN
with  ||| S:3142 E:3147 ||| IN
C3  ||| S:3147 E:3150 ||| NNP
not  ||| S:3150 E:3154 ||| RB
only  ||| S:3154 E:3167 ||| RB
inhibits  ||| S:3167 E:3176 ||| JJ
cellular  ||| S:3176 E:3185 ||| JJ
locomotion ||| S:3185 E:3195 ||| NN
,  ||| S:3195 E:3197 ||| ,
but  ||| S:3197 E:3201 ||| CC
augments  ||| S:3201 E:3210 ||| FW
chemoattractant  ||| S:3210 E:3234 ||| FW
induced  ||| S:3234 E:3242 ||| FW
actin  ||| S:3242 E:3248 ||| FW
polymerization  ||| S:3248 E:3263 ||| FW
[  ||| S:3263 E:3265 ||| -LRB-
20  ||| S:3265 E:3268 ||| CD
21  ||| S:3268 E:3271 ||| CD
]  ||| S:3271 E:3273 ||| -RRB-
.  ||| S:3273 E:3275 ||| .
Moreover ||| S:3275 E:3283 ||| RB
,  ||| S:3283 E:3293 ||| ,
inactivation  ||| S:3293 E:3306 ||| NN
of  ||| S:3306 E:3309 ||| IN
Rho  ||| S:3309 E:3313 ||| NNP
in  ||| S:3313 E:3316 ||| IN
monocytic  ||| S:3316 E:3326 ||| JJ
cells  ||| S:3326 E:3332 ||| NNS
leads  ||| S:3332 E:3338 ||| VBZ
to  ||| S:3338 E:3341 ||| TO
accelerated  ||| S:3341 E:3361 ||| JJ
formation  ||| S:3361 E:3371 ||| NN
of  ||| S:3371 E:3374 ||| IN
filopodia ||| S:3374 E:3383 ||| NN
,  ||| S:3383 E:3385 ||| ,
and  ||| S:3385 E:3389 ||| CC
it  ||| S:3389 E:3392 ||| PRP
has  ||| S:3392 E:3396 ||| VBZ
been  ||| S:3396 E:3401 ||| VBN
proposed  ||| S:3401 E:3410 ||| VBN
that  ||| S:3410 E:3415 ||| IN
Rho  ||| S:3415 E:3427 ||| NNP
is  ||| S:3427 E:3430 ||| VBZ
a  ||| S:3430 E:3432 ||| DT
negative  ||| S:3432 E:3441 ||| JJ
regulator  ||| S:3441 E:3451 ||| NN
of  ||| S:3451 E:3454 ||| IN
actin  ||| S:3454 E:3460 ||| JJ
polymerization  ||| S:3460 E:3475 ||| NN
within  ||| S:3475 E:3482 ||| IN
this  ||| S:3482 E:3495 ||| DT
cell  ||| S:3495 E:3500 ||| NN
type  ||| S:3500 E:3505 ||| NN
[  ||| S:3505 E:3507 ||| -LRB-
22  ||| S:3507 E:3510 ||| CD
]  ||| S:3510 E:3512 ||| -RRB-
.  ||| S:3512 E:3514 ||| .
Active  ||| S:3514 E:3521 ||| JJ
Rho  ||| S:3521 E:3525 ||| NNP
is  ||| S:3525 E:3528 ||| VBZ
also  ||| S:3528 E:3533 ||| RB
required  ||| S:3533 E:3542 ||| VBN
for  ||| S:3542 E:3546 ||| IN
normal  ||| S:3546 E:3561 ||| JJ
morphology ||| S:3561 E:3571 ||| NN
,  ||| S:3571 E:3573 ||| ,
motility ||| S:3573 E:3581 ||| NN
,  ||| S:3581 E:3583 ||| ,
and  ||| S:3583 E:3587 ||| CC
cytolytic  ||| S:3587 E:3597 ||| JJ
activity  ||| S:3597 E:3606 ||| NN
of  ||| S:3606 E:3609 ||| IN
IL-2  ||| S:3609 E:3622 ||| FW
activated  ||| S:3622 E:3632 ||| FW
NK  ||| S:3632 E:3635 ||| FW
cells  ||| S:3635 E:3641 ||| FW
[  ||| S:3641 E:3643 ||| -LRB-
23  ||| S:3643 E:3646 ||| CD
24  ||| S:3646 E:3649 ||| CD
]  ||| S:3649 E:3651 ||| -RRB-
.  ||| S:3651 E:3653 ||| .
We  ||| S:3653 E:3656 ||| PRP
and  ||| S:3656 E:3660 ||| CC
others  ||| S:3660 E:3667 ||| NNS
have  ||| S:3667 E:3680 ||| VBP
demonstrated  ||| S:3680 E:3693 ||| VBN
the  ||| S:3693 E:3697 ||| DT
importance  ||| S:3697 E:3708 ||| NN
of  ||| S:3708 E:3711 ||| IN
Rho  ||| S:3711 E:3715 ||| NNP
in  ||| S:3715 E:3718 ||| IN
T  ||| S:3718 E:3720 ||| NN
lymphocyte  ||| S:3720 E:3739 ||| NN
activation  ||| S:3739 E:3750 ||| NNS
[  ||| S:3750 E:3752 ||| -LRB-
25  ||| S:3752 E:3755 ||| CD
26  ||| S:3755 E:3758 ||| CD
]  ||| S:3758 E:3760 ||| -RRB-
.  ||| S:3760 E:3762 ||| .
Given  ||| S:3762 E:3768 ||| VBN
the  ||| S:3768 E:3772 ||| DT
role  ||| S:3772 E:3777 ||| NN
played  ||| S:3777 E:3784 ||| VBD
by  ||| S:3784 E:3787 ||| IN
Rho  ||| S:3787 E:3791 ||| NNP
in  ||| S:3791 E:3794 ||| IN
the  ||| S:3794 E:3806 ||| DT
regulation  ||| S:3806 E:3817 ||| NN
of  ||| S:3817 E:3820 ||| IN
actin  ||| S:3820 E:3826 ||| JJ
microfilaments  ||| S:3826 E:3841 ||| NN
in  ||| S:3841 E:3844 ||| IN
other  ||| S:3844 E:3850 ||| JJ
cell  ||| S:3850 E:3855 ||| NN
types ||| S:3855 E:3860 ||| NNS
,  ||| S:3860 E:3862 ||| ,
and  ||| S:3862 E:3874 ||| CC
the  ||| S:3874 E:3878 ||| DT
indispensability  ||| S:3878 E:3895 ||| NN
of  ||| S:3895 E:3898 ||| IN
a  ||| S:3898 E:3900 ||| DT
functional  ||| S:3900 E:3911 ||| JJ
actin  ||| S:3911 E:3917 ||| JJ
cytoskeleton  ||| S:3917 E:3930 ||| NN
in  ||| S:3930 E:3941 ||| IN
lymphocyte  ||| S:3941 E:3952 ||| JJ
motility  ||| S:3952 E:3961 ||| NN
and  ||| S:3961 E:3965 ||| CC
activation ||| S:3965 E:3975 ||| NN
,  ||| S:3975 E:3977 ||| ,
it  ||| S:3977 E:3980 ||| PRP
is  ||| S:3980 E:3983 ||| VBZ
of  ||| S:3983 E:3986 ||| IN
importance  ||| S:3986 E:3997 ||| NN
to  ||| S:3997 E:4008 ||| TO
study  ||| S:4008 E:4014 ||| VB
Rho ||| S:4014 E:4017 ||| NNP
's  ||| S:4017 E:4020 ||| POS
role  ||| S:4020 E:4025 ||| NN
in  ||| S:4025 E:4028 ||| IN
the  ||| S:4028 E:4032 ||| DT
regulation  ||| S:4032 E:4043 ||| NN
of  ||| S:4043 E:4046 ||| IN
T  ||| S:4046 E:4048 ||| NN
lymphocyte  ||| S:4048 E:4059 ||| VBZ
integrin  ||| S:4059 E:4076 ||| JJ
function  ||| S:4076 E:4085 ||| NN
and  ||| S:4085 E:4089 ||| CC
maintenance  ||| S:4089 E:4101 ||| NN
of  ||| S:4101 E:4104 ||| IN
cytoskeletal  ||| S:4104 E:4117 ||| JJ
organization ||| S:4117 E:4129 ||| NN
.  ||| S:4129 E:4153 ||| .
Results  ||| S:4153 E:4180 ||| NNP
Electroporation  ||| S:4180 E:4196 ||| NNP
of  ||| S:4196 E:4199 ||| IN
C3  ||| S:4199 E:4202 ||| NNP
induces  ||| S:4202 E:4210 ||| VBZ
complete  ||| S:4210 E:4229 ||| JJ
ADP-ribosylation  ||| S:4229 E:4246 ||| NN
of  ||| S:4246 E:4249 ||| IN
Rho  ||| S:4249 E:4253 ||| NNP
in  ||| S:4253 E:4256 ||| IN
HPB-ALL  ||| S:4256 E:4274 ||| JJ
Western  ||| S:4274 E:4282 ||| JJ
blotting  ||| S:4282 E:4291 ||| JJ
analysis  ||| S:4291 E:4300 ||| NN
confirmed  ||| S:4300 E:4310 ||| VBD
the  ||| S:4310 E:4314 ||| DT
presence  ||| S:4314 E:4323 ||| NN
of  ||| S:4323 E:4336 ||| IN
RhoA  ||| S:4336 E:4341 ||| NNP
( ||| S:4341 E:4342 ||| -LRB-
~25  ||| S:4342 E:4346 ||| NNP
kDa ||| S:4346 E:4349 ||| NNP
)  ||| S:4349 E:4351 ||| -RRB-
in  ||| S:4351 E:4354 ||| IN
the  ||| S:4354 E:4358 ||| DT
human  ||| S:4358 E:4364 ||| JJ
T  ||| S:4364 E:4366 ||| NN
cell  ||| S:4366 E:4371 ||| NN
lines  ||| S:4371 E:4377 ||| NNS
HPB-ALL  ||| S:4377 E:4385 ||| JJ
and  ||| S:4385 E:4389 ||| CC
CEM  ||| S:4389 E:4403 ||| NNP
( ||| S:4403 E:4404 ||| -LRB-
Figure  ||| S:4404 E:4411 ||| NNP
1A ||| S:4411 E:4413 ||| NNP
) ||| S:4413 E:4414 ||| -RRB-
.  ||| S:4414 E:4416 ||| .
The  ||| S:4416 E:4420 ||| DT
bacterial  ||| S:4420 E:4430 ||| JJ
toxin  ||| S:4430 E:4436 ||| NN
C3  ||| S:4436 E:4439 ||| NN
from  ||| S:4439 E:4455 ||| IN
Clostridium  ||| S:4455 E:4467 ||| NNP
botulinum  ||| S:4467 E:4477 ||| VBD
ribosylates  ||| S:4477 E:4499 ||| CD
asparagine  ||| S:4499 E:4510 ||| CD
41  ||| S:4510 E:4513 ||| CD
of  ||| S:4513 E:4516 ||| IN
the  ||| S:4516 E:4520 ||| DT
small  ||| S:4520 E:4526 ||| JJ
GTPase  ||| S:4526 E:4533 ||| JJ
Rho  ||| S:4533 E:4537 ||| NNP
[  ||| S:4537 E:4539 ||| -LRB-
15  ||| S:4539 E:4542 ||| CD
16  ||| S:4542 E:4545 ||| CD
]  ||| S:4545 E:4547 ||| -RRB-
,  ||| S:4547 E:4559 ||| ,
resulting  ||| S:4559 E:4569 ||| VBG
in  ||| S:4569 E:4572 ||| IN
its  ||| S:4572 E:4576 ||| PRP$
inactivation ||| S:4576 E:4588 ||| NN
.  ||| S:4588 E:4590 ||| .
C3  ||| S:4590 E:4593 ||| NNP
( ||| S:4593 E:4594 ||| -LRB-
25  ||| S:4594 E:4597 ||| CD
μg ||| S:4597 E:4599 ||| CD
/ ||| S:4599 E:4600 ||| CD
ml ||| S:4600 E:4602 ||| CD
)  ||| S:4602 E:4604 ||| -RRB-
was  ||| S:4604 E:4618 ||| VBD
electroporated  ||| S:4618 E:4633 ||| VBN
into  ||| S:4633 E:4638 ||| IN
the  ||| S:4638 E:4642 ||| DT
T  ||| S:4642 E:4644 ||| NN
cell  ||| S:4644 E:4649 ||| NN
line  ||| S:4649 E:4654 ||| NN
HPB-ALL  ||| S:4654 E:4662 ||| NN
as  ||| S:4662 E:4665 ||| IN
described  ||| S:4665 E:4685 ||| VBN
in  ||| S:4685 E:4688 ||| IN
the  ||| S:4688 E:4692 ||| DT
Materials  ||| S:4692 E:4702 ||| NNPS
and  ||| S:4702 E:4706 ||| CC
Methods ||| S:4706 E:4713 ||| NNP
.  ||| S:4713 E:4715 ||| .
After  ||| S:4715 E:4721 ||| IN
thorough  ||| S:4721 E:4730 ||| JJ
washing ||| S:4730 E:4737 ||| NN
,  ||| S:4737 E:4739 ||| ,
the  ||| S:4739 E:4753 ||| DT
cells  ||| S:4753 E:4759 ||| NNS
were  ||| S:4759 E:4764 ||| VBD
incubated  ||| S:4764 E:4774 ||| VBN
for  ||| S:4774 E:4778 ||| IN
1  ||| S:4778 E:4780 ||| CD
hour  ||| S:4780 E:4785 ||| NN
at  ||| S:4785 E:4788 ||| IN
37°C  ||| S:4788 E:4793 ||| CD
to  ||| S:4793 E:4796 ||| TO
allow  ||| S:4796 E:4813 ||| VB
in  ||| S:4813 E:4816 ||| IN
vivo  ||| S:4816 E:4821 ||| JJ
ribosylation ||| S:4821 E:4833 ||| NN
,  ||| S:4833 E:4835 ||| ,
then  ||| S:4835 E:4850 ||| RB
sonicated  ||| S:4850 E:4860 ||| JJ
and  ||| S:4860 E:4864 ||| CC
lysates  ||| S:4864 E:4872 ||| VB
subjected  ||| S:4872 E:4882 ||| VBN
to  ||| S:4882 E:4885 ||| TO
further  ||| S:4885 E:4893 ||| RBR
C3  ||| S:4893 E:4906 ||| JJ
ribosylation  ||| S:4906 E:4919 ||| NN
by  ||| S:4919 E:4922 ||| IN
the  ||| S:4922 E:4926 ||| DT
addition  ||| S:4926 E:4935 ||| NN
of  ||| S:4935 E:4938 ||| IN
2  ||| S:4938 E:4940 ||| CD
μCi  ||| S:4940 E:4944 ||| NNS
[  ||| S:4944 E:4946 ||| -LRB-
32P ||| S:4946 E:4949 ||| NNP
] ||| S:4949 E:4950 ||| -RRB-
-NAD  ||| S:4950 E:4955 ||| JJ
and  ||| S:4955 E:4959 ||| CC
1  ||| S:4959 E:4961 ||| CD
μg  ||| S:4961 E:4974 ||| NN
of  ||| S:4974 E:4977 ||| IN
C3  ||| S:4977 E:4980 ||| CD
in  ||| S:4980 E:4983 ||| IN
ribosylation  ||| S:4983 E:4996 ||| JJ
buffer ||| S:4996 E:5002 ||| NN
.  ||| S:5002 E:5004 ||| .
By  ||| S:5004 E:5007 ||| IN
this  ||| S:5007 E:5012 ||| DT
method ||| S:5012 E:5018 ||| NN
,  ||| S:5018 E:5020 ||| ,
any  ||| S:5020 E:5024 ||| DT
further  ||| S:5024 E:5042 ||| JJ
ADP  ||| S:5042 E:5046 ||| NNP
ribosylation  ||| S:5046 E:5059 ||| NN
of  ||| S:5059 E:5062 ||| IN
Rho  ||| S:5062 E:5066 ||| NNP
can  ||| S:5066 E:5070 ||| MD
be  ||| S:5070 E:5073 ||| VB
identified  ||| S:5073 E:5095 ||| VBN
in  ||| S:5095 E:5098 ||| IN
vitro  ||| S:5098 E:5104 ||| NN
after  ||| S:5104 E:5121 ||| IN
in  ||| S:5121 E:5124 ||| IN
vivo  ||| S:5124 E:5129 ||| JJ
ribosylation ||| S:5129 E:5141 ||| NN
,  ||| S:5141 E:5143 ||| ,
thus  ||| S:5143 E:5148 ||| RB
serving  ||| S:5148 E:5166 ||| VBG
as  ||| S:5166 E:5169 ||| IN
a  ||| S:5169 E:5171 ||| DT
measure  ||| S:5171 E:5179 ||| NN
of  ||| S:5179 E:5182 ||| IN
the  ||| S:5182 E:5186 ||| DT
efficiency  ||| S:5186 E:5197 ||| NN
of  ||| S:5197 E:5200 ||| IN
the  ||| S:5200 E:5204 ||| DT
electroporation  ||| S:5204 E:5230 ||| JJ
procedure  ||| S:5230 E:5240 ||| NN
for  ||| S:5240 E:5244 ||| IN
introducing  ||| S:5244 E:5256 ||| VBG
C3  ||| S:5256 E:5259 ||| CD
exoenzyme  ||| S:5259 E:5269 ||| NN
into  ||| S:5269 E:5274 ||| IN
HPB-ALL  ||| S:5274 E:5282 ||| JJ
cells  ||| S:5282 E:5298 ||| NNS
[  ||| S:5298 E:5300 ||| -LRB-
31  ||| S:5300 E:5303 ||| CD
]  ||| S:5303 E:5305 ||| -RRB-
.  ||| S:5305 E:5307 ||| .
As  ||| S:5307 E:5310 ||| IN
figure  ||| S:5310 E:5317 ||| NN
1Bdemonstrates ||| S:5317 E:5331 ||| NN
,  ||| S:5331 E:5333 ||| ,
electroporation  ||| S:5333 E:5349 ||| VBG
of  ||| S:5349 E:5352 ||| IN
C3  ||| S:5352 E:5365 ||| CD
transferase  ||| S:5365 E:5377 ||| NNS
( ||| S:5377 E:5378 ||| -LRB-
Figure  ||| S:5378 E:5385 ||| NNP
1B ||| S:5385 E:5387 ||| NNP
,  ||| S:5387 E:5389 ||| ,
lane  ||| S:5389 E:5394 ||| CD
3 ||| S:5394 E:5395 ||| CD
)  ||| S:5395 E:5397 ||| -RRB-
prior  ||| S:5397 E:5403 ||| RB
to  ||| S:5403 E:5406 ||| TO
cell  ||| S:5406 E:5411 ||| NN
disruption  ||| S:5411 E:5432 ||| NN
prevented  ||| S:5432 E:5442 ||| VBD
further  ||| S:5442 E:5450 ||| JJ
ribosylation  ||| S:5450 E:5463 ||| NN
of  ||| S:5463 E:5466 ||| IN
Rho  ||| S:5466 E:5470 ||| NNP
proteins  ||| S:5470 E:5479 ||| NNS
in  ||| S:5479 E:5482 ||| IN
the  ||| S:5482 E:5496 ||| DT
cell  ||| S:5496 E:5501 ||| NN
lysates ||| S:5501 E:5508 ||| NN
.  ||| S:5508 E:5510 ||| .
The  ||| S:5510 E:5514 ||| DT
technique  ||| S:5514 E:5524 ||| NN
of  ||| S:5524 E:5527 ||| IN
electroporation  ||| S:5527 E:5543 ||| NN
of  ||| S:5543 E:5546 ||| IN
C3  ||| S:5546 E:5549 ||| NNP
was  ||| S:5549 E:5563 ||| VBD
very  ||| S:5563 E:5568 ||| RB
efficient ||| S:5568 E:5577 ||| JJ
,  ||| S:5577 E:5579 ||| ,
as  ||| S:5579 E:5582 ||| RB
even  ||| S:5582 E:5587 ||| RB
longer  ||| S:5587 E:5594 ||| RBR
autoradiographic  ||| S:5594 E:5611 ||| JJ
exposures  ||| S:5611 E:5631 ||| NNS
of  ||| S:5631 E:5634 ||| IN
the  ||| S:5634 E:5638 ||| DT
gel  ||| S:5638 E:5642 ||| NN
did  ||| S:5642 E:5646 ||| VBD
not  ||| S:5646 E:5650 ||| RB
demonstrate  ||| S:5650 E:5662 ||| VB
incorporation  ||| S:5662 E:5676 ||| VBN
of  ||| S:5676 E:5679 ||| IN
[  ||| S:5679 E:5691 ||| -LRB-
32P ||| S:5691 E:5694 ||| NNP
] ||| S:5694 E:5695 ||| -RRB-
-NAD  ||| S:5695 E:5700 ||| NNP
( ||| S:5700 E:5701 ||| -LRB-
data  ||| S:5701 E:5706 ||| NNS
not  ||| S:5706 E:5710 ||| RB
shown ||| S:5710 E:5715 ||| VBN
) ||| S:5715 E:5716 ||| -RRB-
.  ||| S:5716 E:5718 ||| .
Thus  ||| S:5718 E:5723 ||| RB
electroporation  ||| S:5723 E:5739 ||| VBN
of  ||| S:5739 E:5742 ||| IN
the  ||| S:5742 E:5756 ||| DT
exoenzyme  ||| S:5756 E:5766 ||| FW
C3  ||| S:5766 E:5769 ||| FW
fully  ||| S:5769 E:5775 ||| FW
ribosylates  ||| S:5775 E:5787 ||| FW
Rho  ||| S:5787 E:5802 ||| FW
in  ||| S:5802 E:5805 ||| FW
vivo  ||| S:5805 E:5810 ||| FW
,  ||| S:5810 E:5812 ||| ,
to  ||| S:5812 E:5815 ||| TO
the  ||| S:5815 E:5819 ||| DT
extent  ||| S:5819 E:5826 ||| NN
that  ||| S:5826 E:5831 ||| IN
no  ||| S:5831 E:5844 ||| DT
further  ||| S:5844 E:5863 ||| JJ
in  ||| S:5863 E:5866 ||| IN
vitro  ||| S:5866 E:5872 ||| JJ
ribosylation  ||| S:5872 E:5885 ||| NN
of  ||| S:5885 E:5888 ||| IN
Rho  ||| S:5888 E:5892 ||| NNP
can  ||| S:5892 E:5896 ||| MD
be  ||| S:5896 E:5909 ||| VB
detected  ||| S:5909 E:5918 ||| VBN
after  ||| S:5918 E:5924 ||| IN
cell  ||| S:5924 E:5929 ||| NN
lysis ||| S:5929 E:5934 ||| NN
.  ||| S:5934 E:5964 ||| .
Alteration  ||| S:5964 E:5975 ||| NNP
of  ||| S:5975 E:5978 ||| IN
HPB-ALL  ||| S:5978 E:5986 ||| JJ
morphology  ||| S:5986 E:5997 ||| NN
by  ||| S:5997 E:6000 ||| IN
C3  ||| S:6000 E:6013 ||| CD
exoenzyme  ||| S:6013 E:6033 ||| CD
Inactivation  ||| S:6033 E:6046 ||| NNS
of  ||| S:6046 E:6049 ||| IN
Rho  ||| S:6049 E:6053 ||| NNP
did  ||| S:6053 E:6057 ||| VBD
not  ||| S:6057 E:6061 ||| RB
affect  ||| S:6061 E:6068 ||| VB
the  ||| S:6068 E:6072 ||| DT
constitutively  ||| S:6072 E:6097 ||| JJ
high  ||| S:6097 E:6102 ||| JJ
adhesion  ||| S:6102 E:6111 ||| NN
of  ||| S:6111 E:6114 ||| IN
HPB-ALL  ||| S:6114 E:6122 ||| JJ
cells  ||| S:6122 E:6128 ||| NNS
to  ||| S:6128 E:6131 ||| TO
the  ||| S:6131 E:6135 ||| DT
extracellular  ||| S:6135 E:6159 ||| FW
matrix  ||| S:6159 E:6166 ||| FW
protein  ||| S:6166 E:6174 ||| FW
fibronectin  ||| S:6174 E:6186 ||| FW
( ||| S:6186 E:6187 ||| -LRB-
Fn ||| S:6187 E:6189 ||| NNP
)  ||| S:6189 E:6191 ||| -RRB-
( ||| S:6191 E:6192 ||| -LRB-
Figure  ||| S:6192 E:6199 ||| NNP
2 ||| S:6199 E:6200 ||| CD
) ||| S:6200 E:6201 ||| -RRB-
.  ||| S:6201 E:6203 ||| .
When  ||| S:6203 E:6208 ||| WRB
HPB-ALL  ||| S:6208 E:6226 ||| JJ
cells  ||| S:6226 E:6232 ||| NNS
are  ||| S:6232 E:6236 ||| VBP
plated  ||| S:6236 E:6243 ||| VBN
onto  ||| S:6243 E:6248 ||| IN
β1  ||| S:6248 E:6251 ||| CD
integrin  ||| S:6251 E:6260 ||| NNS
substrate  ||| S:6260 E:6270 ||| VBP
such  ||| S:6270 E:6275 ||| JJ
as  ||| S:6275 E:6288 ||| IN
fibronectin ||| S:6288 E:6299 ||| NN
,  ||| S:6299 E:6301 ||| ,
vascular  ||| S:6301 E:6310 ||| FW
cell  ||| S:6310 E:6315 ||| FW
adhesion  ||| S:6315 E:6324 ||| FW
molecule-1  ||| S:6324 E:6335 ||| FW
( ||| S:6335 E:6336 ||| -LRB-
VCAM-1 ||| S:6336 E:6342 ||| NNP
) ||| S:6342 E:6343 ||| -RRB-
,  ||| S:6343 E:6355 ||| ,
or  ||| S:6355 E:6358 ||| CC
even  ||| S:6358 E:6363 ||| RB
antibodies  ||| S:6363 E:6374 ||| VBN
to  ||| S:6374 E:6377 ||| TO
α4β1  ||| S:6377 E:6382 ||| CD
integrins ||| S:6382 E:6391 ||| NN
,  ||| S:6391 E:6393 ||| ,
they  ||| S:6393 E:6398 ||| PRP
respond  ||| S:6398 E:6406 ||| VB
by  ||| S:6406 E:6419 ||| IN
extending  ||| S:6419 E:6429 ||| VBG
pseudopodia  ||| S:6429 E:6441 ||| NNS
and  ||| S:6441 E:6445 ||| CC
displaying  ||| S:6445 E:6456 ||| VBG
a  ||| S:6456 E:6458 ||| DT
highly  ||| S:6458 E:6465 ||| RB
flattened ||| S:6465 E:6474 ||| VBN
,  ||| S:6474 E:6486 ||| ,
spread  ||| S:6486 E:6493 ||| NN
morphology  ||| S:6493 E:6504 ||| NNS
( ||| S:6504 E:6505 ||| -LRB-
figure  ||| S:6505 E:6512 ||| NN
3 ||| S:6512 E:6513 ||| CD
,  ||| S:6513 E:6515 ||| ,
panels  ||| S:6515 E:6522 ||| CD
4 ||| S:6522 E:6523 ||| CD
,  ||| S:6523 E:6525 ||| ,
7 ||| S:6525 E:6526 ||| CD
,  ||| S:6526 E:6528 ||| ,
and  ||| S:6528 E:6532 ||| CC
10 ||| S:6532 E:6534 ||| CD
,  ||| S:6534 E:6536 ||| ,
and  ||| S:6536 E:6540 ||| CC
ref  ||| S:6540 E:6554 ||| NNS
[  ||| S:6554 E:6556 ||| -LRB-
32  ||| S:6556 E:6559 ||| CD
]  ||| S:6559 E:6561 ||| CD
) ||| S:6561 E:6562 ||| -RRB-
.  ||| S:6562 E:6564 ||| .
However ||| S:6564 E:6571 ||| RB
,  ||| S:6571 E:6573 ||| ,
electroporation  ||| S:6573 E:6589 ||| VBG
of  ||| S:6589 E:6592 ||| IN
C3  ||| S:6592 E:6595 ||| NNP
appeared  ||| S:6595 E:6604 ||| VBD
to  ||| S:6604 E:6617 ||| TO
alter  ||| S:6617 E:6623 ||| VB
HPB-ALL  ||| S:6623 E:6631 ||| JJ
morphology  ||| S:6631 E:6642 ||| NNS
resulting  ||| S:6642 E:6652 ||| VBG
in  ||| S:6652 E:6655 ||| IN
the  ||| S:6655 E:6659 ||| DT
extension  ||| S:6659 E:6669 ||| NN
of  ||| S:6669 E:6682 ||| IN
very  ||| S:6682 E:6687 ||| RB
fine  ||| S:6687 E:6692 ||| JJ
branched  ||| S:6692 E:6701 ||| JJ
finger-like  ||| S:6701 E:6713 ||| JJ
cellular  ||| S:6713 E:6722 ||| JJ
processes  ||| S:6722 E:6732 ||| NNS
when  ||| S:6732 E:6747 ||| WRB
cells  ||| S:6747 E:6753 ||| NNS
were  ||| S:6753 E:6758 ||| VBD
plated  ||| S:6758 E:6765 ||| VBN
on  ||| S:6765 E:6768 ||| IN
the  ||| S:6768 E:6772 ||| DT
β1  ||| S:6772 E:6775 ||| FW
integrin  ||| S:6775 E:6784 ||| FW
substrates  ||| S:6784 E:6795 ||| FW
Fn  ||| S:6795 E:6808 ||| FW
( ||| S:6808 E:6809 ||| -LRB-
figure  ||| S:6809 E:6816 ||| NN
3 ||| S:6816 E:6817 ||| CD
,  ||| S:6817 E:6819 ||| ,
panel  ||| S:6819 E:6825 ||| NN
6 ||| S:6825 E:6826 ||| CD
) ||| S:6826 E:6827 ||| -RRB-
,  ||| S:6827 E:6829 ||| ,
VCAM-1  ||| S:6829 E:6836 ||| NNP
( ||| S:6836 E:6837 ||| -LRB-
figure  ||| S:6837 E:6844 ||| NN
3 ||| S:6844 E:6845 ||| CD
,  ||| S:6845 E:6847 ||| ,
panel  ||| S:6847 E:6853 ||| NN
9 ||| S:6853 E:6854 ||| CD
) ||| S:6854 E:6855 ||| -RRB-
,  ||| S:6855 E:6857 ||| ,
or  ||| S:6857 E:6860 ||| CC
a  ||| S:6860 E:6862 ||| DT
mAb  ||| S:6862 E:6876 ||| JJ
specific  ||| S:6876 E:6885 ||| JJ
for  ||| S:6885 E:6889 ||| IN
β1  ||| S:6889 E:6892 ||| CD
integrins  ||| S:6892 E:6902 ||| NNS
( ||| S:6902 E:6903 ||| -LRB-
figure  ||| S:6903 E:6910 ||| NN
3 ||| S:6910 E:6911 ||| CD
,  ||| S:6911 E:6913 ||| ,
panel  ||| S:6913 E:6919 ||| NN
12 ||| S:6919 E:6921 ||| CD
) ||| S:6921 E:6922 ||| -RRB-
.  ||| S:6922 E:6924 ||| .
This  ||| S:6924 E:6929 ||| DT
also  ||| S:6929 E:6944 ||| RB
occurred  ||| S:6944 E:6953 ||| VBN
for  ||| S:6953 E:6957 ||| IN
another  ||| S:6957 E:6965 ||| DT
T  ||| S:6965 E:6967 ||| NN
cell  ||| S:6967 E:6972 ||| NN
line ||| S:6972 E:6976 ||| NN
,  ||| S:6976 E:6978 ||| ,
HSB-1  ||| S:6978 E:6984 ||| NNP
( ||| S:6984 E:6985 ||| -LRB-
data  ||| S:6985 E:6990 ||| NNS
not  ||| S:6990 E:6994 ||| RB
shown ||| S:6994 E:6999 ||| VBN
) ||| S:6999 E:7000 ||| -RRB-
,  ||| S:7000 E:7012 ||| ,
and  ||| S:7012 E:7016 ||| CC
in  ||| S:7016 E:7019 ||| IN
activated  ||| S:7019 E:7029 ||| JJ
primary  ||| S:7029 E:7037 ||| JJ
T  ||| S:7037 E:7039 ||| NN
lymphocytes  ||| S:7039 E:7051 ||| NNS
( ||| S:7051 E:7052 ||| -LRB-
Table  ||| S:7052 E:7058 ||| NNP
1 ||| S:7058 E:7059 ||| CD
) ||| S:7059 E:7060 ||| -RRB-
.  ||| S:7060 E:7072 ||| .
Untreated  ||| S:7072 E:7082 ||| NNP
HPB-ALL ||| S:7082 E:7089 ||| NNP
,  ||| S:7089 E:7091 ||| ,
mock  ||| S:7091 E:7096 ||| JJ
electroporated  ||| S:7096 E:7111 ||| JJ
control  ||| S:7111 E:7119 ||| NN
HPB-ALL ||| S:7119 E:7126 ||| NN
,  ||| S:7126 E:7138 ||| ,
or  ||| S:7138 E:7141 ||| CC
C3  ||| S:7141 E:7144 ||| CD
treated  ||| S:7144 E:7152 ||| CD
HPB-ALL  ||| S:7152 E:7160 ||| NNS
do  ||| S:7160 E:7163 ||| VBP
not  ||| S:7163 E:7167 ||| RB
extend  ||| S:7167 E:7174 ||| VB
pseudopodia  ||| S:7174 E:7186 ||| VBN
on  ||| S:7186 E:7189 ||| IN
the  ||| S:7189 E:7203 ||| DT
non-specific  ||| S:7203 E:7216 ||| JJ
cell  ||| S:7216 E:7221 ||| NN
attachment  ||| S:7221 E:7232 ||| FW
substrate  ||| S:7232 E:7242 ||| FW
poly-L-lysine  ||| S:7242 E:7266 ||| FW
( ||| S:7266 E:7267 ||| -LRB-
figure  ||| S:7267 E:7274 ||| NN
3 ||| S:7274 E:7275 ||| CD
,  ||| S:7275 E:7277 ||| ,
panels  ||| S:7277 E:7284 ||| CD
13-15 ||| S:7284 E:7289 ||| CD
) ||| S:7289 E:7290 ||| -RRB-
,  ||| S:7290 E:7292 ||| ,
demonstrating  ||| S:7292 E:7306 ||| VBG
the  ||| S:7306 E:7310 ||| DT
requirement  ||| S:7310 E:7332 ||| NN
for  ||| S:7332 E:7336 ||| IN
integrin  ||| S:7336 E:7345 ||| JJ
dependent  ||| S:7345 E:7355 ||| JJ
signals  ||| S:7355 E:7363 ||| NNS
in  ||| S:7363 E:7366 ||| IN
both  ||| S:7366 E:7371 ||| PDT
the  ||| S:7371 E:7375 ||| DT
normal  ||| S:7375 E:7392 ||| JJ
spreading  ||| S:7392 E:7402 ||| JJ
morphology  ||| S:7402 E:7413 ||| NN
of  ||| S:7413 E:7416 ||| IN
HBP-ALL ||| S:7416 E:7423 ||| NNP
,  ||| S:7423 E:7425 ||| ,
and  ||| S:7425 E:7429 ||| CC
the  ||| S:7429 E:7433 ||| DT
C3  ||| S:7433 E:7436 ||| CD
induced  ||| S:7436 E:7454 ||| CD
morphological  ||| S:7454 E:7468 ||| CD
changes  ||| S:7468 E:7476 ||| NNS
in  ||| S:7476 E:7479 ||| IN
this  ||| S:7479 E:7484 ||| DT
cell  ||| S:7484 E:7489 ||| NN
type ||| S:7489 E:7493 ||| NN
.  ||| S:7493 E:7523 ||| .
RhoA  ||| S:7523 E:7528 ||| JJ
immunolocalization  ||| S:7528 E:7547 ||| NN
in  ||| S:7547 E:7550 ||| IN
normal  ||| S:7550 E:7557 ||| JJ
and  ||| S:7557 E:7561 ||| CC
C3  ||| S:7561 E:7564 ||| NNP
treated  ||| S:7564 E:7582 ||| VBD
HPB-ALL  ||| S:7582 E:7590 ||| JJ
cells  ||| S:7590 E:7596 ||| NNS
spreading  ||| S:7596 E:7606 ||| VBG
on  ||| S:7606 E:7609 ||| IN
fibronectin  ||| S:7609 E:7631 ||| JJ
Immunolocalization  ||| S:7631 E:7650 ||| NNS
of  ||| S:7650 E:7653 ||| IN
the  ||| S:7653 E:7657 ||| DT
GTPase  ||| S:7657 E:7664 ||| JJ
RhoA  ||| S:7664 E:7669 ||| NN
was  ||| S:7669 E:7673 ||| VBD
performed  ||| S:7673 E:7683 ||| VBN
to  ||| S:7683 E:7696 ||| TO
determine  ||| S:7696 E:7706 ||| VB
if  ||| S:7706 E:7709 ||| IN
inactivation  ||| S:7709 E:7722 ||| NN
by  ||| S:7722 E:7725 ||| IN
C3  ||| S:7725 E:7728 ||| CD
exoenzyme  ||| S:7728 E:7738 ||| NNS
caused  ||| S:7738 E:7745 ||| VBD
spatial  ||| S:7745 E:7763 ||| JJ
redistribution  ||| S:7763 E:7778 ||| NN
of  ||| S:7778 E:7781 ||| IN
RhoA  ||| S:7781 E:7786 ||| JJ
in  ||| S:7786 E:7789 ||| IN
HPB-ALL ||| S:7789 E:7796 ||| JJ
.  ||| S:7796 E:7798 ||| .
As  ||| S:7798 E:7801 ||| IN
figure  ||| S:7801 E:7818 ||| NN
4demonstrates ||| S:7818 E:7831 ||| NN
,  ||| S:7831 E:7833 ||| ,
untreated  ||| S:7833 E:7843 ||| JJ
HPB-ALL  ||| S:7843 E:7851 ||| JJ
cells  ||| S:7851 E:7857 ||| NNS
display  ||| S:7857 E:7865 ||| VBP
a  ||| S:7865 E:7867 ||| DT
diffuse  ||| S:7867 E:7885 ||| JJ
staining  ||| S:7885 E:7894 ||| JJ
pattern  ||| S:7894 E:7902 ||| NN
of  ||| S:7902 E:7905 ||| IN
RhoA ||| S:7905 E:7909 ||| NNP
,  ||| S:7909 E:7911 ||| ,
with  ||| S:7911 E:7916 ||| IN
small  ||| S:7916 E:7922 ||| JJ
punctate  ||| S:7922 E:7941 ||| JJ
microclusters  ||| S:7941 E:7955 ||| NN
throughout  ||| S:7955 E:7966 ||| IN
the  ||| S:7966 E:7970 ||| DT
normal  ||| S:7970 E:7977 ||| JJ
pseudopodial  ||| S:7977 E:8000 ||| JJ
extensions  ||| S:8000 E:8011 ||| NNS
( ||| S:8011 E:8012 ||| -LRB-
figure  ||| S:8012 E:8019 ||| NN
4 ||| S:8019 E:8020 ||| CD
,  ||| S:8020 E:8022 ||| ,
left  ||| S:8022 E:8027 ||| VBN
panels ||| S:8027 E:8033 ||| NNS
,  ||| S:8033 E:8035 ||| ,
arrows ||| S:8035 E:8041 ||| CD
) ||| S:8041 E:8042 ||| -RRB-
.  ||| S:8042 E:8044 ||| .
Staining  ||| S:8044 E:8053 ||| NNP
with  ||| S:8053 E:8068 ||| IN
secondary  ||| S:8068 E:8078 ||| JJ
antibody  ||| S:8078 E:8087 ||| NN
alone  ||| S:8087 E:8093 ||| RB
was  ||| S:8093 E:8097 ||| VBD
negative  ||| S:8097 E:8106 ||| JJ
( ||| S:8106 E:8107 ||| -LRB-
data  ||| S:8107 E:8112 ||| NNS
not  ||| S:8112 E:8116 ||| RB
shown ||| S:8116 E:8121 ||| VBN
) ||| S:8121 E:8122 ||| -RRB-
.  ||| S:8122 E:8134 ||| .
Inactivation  ||| S:8134 E:8147 ||| NNP
of  ||| S:8147 E:8150 ||| IN
Rho  ||| S:8150 E:8154 ||| NNP
by  ||| S:8154 E:8157 ||| IN
electroporation  ||| S:8157 E:8173 ||| NN
of  ||| S:8173 E:8176 ||| IN
C3  ||| S:8176 E:8179 ||| CD
exoenzyme  ||| S:8179 E:8199 ||| NNS
did  ||| S:8199 E:8203 ||| VBD
not  ||| S:8203 E:8207 ||| RB
seem  ||| S:8207 E:8212 ||| VB
to  ||| S:8212 E:8215 ||| TO
cause  ||| S:8215 E:8221 ||| VB
a  ||| S:8221 E:8223 ||| DT
large  ||| S:8223 E:8229 ||| JJ
overall  ||| S:8229 E:8237 ||| JJ
redistribution  ||| S:8237 E:8252 ||| NN
of  ||| S:8252 E:8265 ||| IN
RhoA  ||| S:8265 E:8270 ||| JJ
in  ||| S:8270 E:8273 ||| IN
spread  ||| S:8273 E:8280 ||| NN
HPB-ALL ||| S:8280 E:8287 ||| NN
.  ||| S:8287 E:8289 ||| .
However ||| S:8289 E:8296 ||| RB
,  ||| S:8296 E:8298 ||| ,
RhoA  ||| S:8298 E:8303 ||| NNP
appeared  ||| S:8303 E:8312 ||| VBD
to  ||| S:8312 E:8315 ||| TO
be  ||| S:8315 E:8318 ||| VB
in  ||| S:8318 E:8331 ||| IN
relatively  ||| S:8331 E:8342 ||| RB
larger  ||| S:8342 E:8349 ||| JJR
clusters  ||| S:8349 E:8358 ||| NNS
distributed  ||| S:8358 E:8370 ||| VBN
along  ||| S:8370 E:8376 ||| IN
the  ||| S:8376 E:8380 ||| DT
aberrant  ||| S:8380 E:8399 ||| JJ
pseudopodial  ||| S:8399 E:8412 ||| JJ
structures  ||| S:8412 E:8423 ||| NNS
with  ||| S:8423 E:8428 ||| IN
no  ||| S:8428 E:8431 ||| DT
diffuse  ||| S:8431 E:8439 ||| JJ
staining  ||| S:8439 E:8448 ||| NN
observed  ||| S:8448 E:8467 ||| VBD
( ||| S:8467 E:8468 ||| -LRB-
figure  ||| S:8468 E:8475 ||| NN
4 ||| S:8475 E:8476 ||| CD
,  ||| S:8476 E:8478 ||| ,
right  ||| S:8478 E:8484 ||| JJ
panels ||| S:8484 E:8490 ||| NNS
,  ||| S:8490 E:8492 ||| ,
arrows ||| S:8492 E:8498 ||| CD
) ||| S:8498 E:8499 ||| -RRB-
.  ||| S:8499 E:8529 ||| .
Altered  ||| S:8529 E:8537 ||| JJ
pseudopodia  ||| S:8537 E:8549 ||| NNS
are  ||| S:8549 E:8553 ||| VBP
rich  ||| S:8553 E:8558 ||| JJ
in  ||| S:8558 E:8561 ||| IN
filamentous  ||| S:8561 E:8583 ||| NNS
actin  ||| S:8583 E:8599 ||| VBP
The  ||| S:8599 E:8603 ||| DT
Rho  ||| S:8603 E:8607 ||| JJ
family  ||| S:8607 E:8614 ||| NN
of  ||| S:8614 E:8617 ||| IN
GTPases  ||| S:8617 E:8625 ||| NNP
is  ||| S:8625 E:8628 ||| VBZ
largely  ||| S:8628 E:8636 ||| RB
responsible  ||| S:8636 E:8648 ||| JJ
for  ||| S:8648 E:8662 ||| IN
maintenance  ||| S:8662 E:8674 ||| NN
of  ||| S:8674 E:8677 ||| IN
cell  ||| S:8677 E:8682 ||| NN
shape  ||| S:8682 E:8688 ||| NN
in  ||| S:8688 E:8691 ||| IN
a  ||| S:8691 E:8693 ||| DT
variety  ||| S:8693 E:8701 ||| NN
of  ||| S:8701 E:8704 ||| IN
cell  ||| S:8704 E:8709 ||| NN
types ||| S:8709 E:8714 ||| NNS
,  ||| S:8714 E:8716 ||| ,
and  ||| S:8716 E:8730 ||| CC
this  ||| S:8730 E:8735 ||| DT
involves  ||| S:8735 E:8744 ||| JJ
regulation  ||| S:8744 E:8755 ||| NN
of  ||| S:8755 E:8758 ||| IN
the  ||| S:8758 E:8762 ||| DT
actin  ||| S:8762 E:8768 ||| JJ
cytoskeleton ||| S:8768 E:8780 ||| NN
.  ||| S:8780 E:8782 ||| .
To  ||| S:8782 E:8795 ||| TO
localize  ||| S:8795 E:8804 ||| VB
filamentous  ||| S:8804 E:8816 ||| JJ
actin  ||| S:8816 E:8822 ||| NN
within  ||| S:8822 E:8829 ||| IN
HPB-ALL ||| S:8829 E:8836 ||| NNP
,  ||| S:8836 E:8838 ||| ,
cells  ||| S:8838 E:8844 ||| NNS
adherent  ||| S:8844 E:8863 ||| VBP
to  ||| S:8863 E:8866 ||| TO
VCAM-1  ||| S:8866 E:8873 ||| NNP
were  ||| S:8873 E:8878 ||| VBD
fixed  ||| S:8878 E:8884 ||| VBN
and  ||| S:8884 E:8888 ||| CC
stained  ||| S:8888 E:8896 ||| NN
with  ||| S:8896 E:8901 ||| IN
TRITC-phalloidin ||| S:8901 E:8917 ||| JJ
.  ||| S:8917 E:8929 ||| .
Control  ||| S:8929 E:8937 ||| NN
electroporated  ||| S:8937 E:8952 ||| NN
cells  ||| S:8952 E:8958 ||| NNS
display  ||| S:8958 E:8966 ||| VBP
rather  ||| S:8966 E:8973 ||| RB
diffuse  ||| S:8973 E:8991 ||| FW
filamentous  ||| S:8991 E:9003 ||| FW
actin  ||| S:9003 E:9009 ||| FW
staining  ||| S:9009 E:9018 ||| FW
in  ||| S:9018 E:9021 ||| FW
elongated  ||| S:9021 E:9031 ||| FW
pseudopodial  ||| S:9031 E:9054 ||| FW
processes  ||| S:9054 E:9064 ||| VBZ
that  ||| S:9064 E:9069 ||| DT
flatten  ||| S:9069 E:9077 ||| NN
and  ||| S:9077 E:9081 ||| CC
spread  ||| S:9081 E:9088 ||| VB
out  ||| S:9088 E:9092 ||| RP
on  ||| S:9092 E:9095 ||| IN
their  ||| S:9095 E:9101 ||| PRP$
termini ||| S:9101 E:9108 ||| NN
,  ||| S:9108 E:9120 ||| ,
and  ||| S:9120 E:9124 ||| CC
there  ||| S:9124 E:9130 ||| EX
are  ||| S:9130 E:9134 ||| VBP
multiple  ||| S:9134 E:9143 ||| JJ
filopodia  ||| S:9143 E:9153 ||| NNS
extending  ||| S:9153 E:9163 ||| VBG
from  ||| S:9163 E:9168 ||| IN
these  ||| S:9168 E:9184 ||| DT
processes  ||| S:9184 E:9194 ||| NNS
and  ||| S:9194 E:9198 ||| CC
from  ||| S:9198 E:9203 ||| IN
the  ||| S:9203 E:9207 ||| DT
cell  ||| S:9207 E:9212 ||| NN
body  ||| S:9212 E:9217 ||| NN
( ||| S:9217 E:9218 ||| -LRB-
figure  ||| S:9218 E:9225 ||| NN
5A ||| S:9225 E:9227 ||| NN
,  ||| S:9227 E:9229 ||| ,
arrows ||| S:9229 E:9235 ||| CD
) ||| S:9235 E:9236 ||| -RRB-
.  ||| S:9236 E:9248 ||| .
Cells  ||| S:9248 E:9254 ||| NNS
that  ||| S:9254 E:9259 ||| WDT
had  ||| S:9259 E:9263 ||| VBD
been  ||| S:9263 E:9268 ||| VBN
treated  ||| S:9268 E:9276 ||| VBN
with  ||| S:9276 E:9281 ||| IN
C3  ||| S:9281 E:9284 ||| CD
exoenzyme  ||| S:9284 E:9294 ||| NNS
however  ||| S:9294 E:9302 ||| RB
all  ||| S:9302 E:9316 ||| RB
contain  ||| S:9316 E:9324 ||| VB
highly  ||| S:9324 E:9331 ||| RB
enriched  ||| S:9331 E:9340 ||| JJ
filamentous  ||| S:9340 E:9352 ||| JJ
actin  ||| S:9352 E:9358 ||| NN
within  ||| S:9358 E:9365 ||| IN
the  ||| S:9365 E:9379 ||| DT
extended  ||| S:9379 E:9388 ||| JJ
pseudopods ||| S:9388 E:9398 ||| NN
.  ||| S:9398 E:9400 ||| .
This  ||| S:9400 E:9405 ||| DT
is  ||| S:9405 E:9408 ||| VBZ
true  ||| S:9408 E:9413 ||| JJ
on  ||| S:9413 E:9416 ||| IN
the  ||| S:9416 E:9420 ||| DT
substrates  ||| S:9420 E:9431 ||| JJ
FN  ||| S:9431 E:9444 ||| NNP
and  ||| S:9444 E:9448 ||| CC
anti-β1  ||| S:9448 E:9456 ||| FW
integrin  ||| S:9456 E:9465 ||| FW
mAb  ||| S:9465 E:9469 ||| FW
( ||| S:9469 E:9470 ||| -LRB-
data  ||| S:9470 E:9475 ||| NNS
not  ||| S:9475 E:9479 ||| RB
shown ||| S:9479 E:9484 ||| VBN
) ||| S:9484 E:9485 ||| -RRB-
.  ||| S:9485 E:9487 ||| .
In  ||| S:9487 E:9490 ||| IN
the  ||| S:9490 E:9494 ||| DT
C3  ||| S:9494 E:9507 ||| CD
electroporated  ||| S:9507 E:9522 ||| CD
cells ||| S:9522 E:9527 ||| NNS
,  ||| S:9527 E:9529 ||| ,
small  ||| S:9529 E:9535 ||| JJ
filopodia  ||| S:9535 E:9545 ||| NNS
extending  ||| S:9545 E:9555 ||| VBG
from  ||| S:9555 E:9560 ||| IN
the  ||| S:9560 E:9574 ||| DT
cell  ||| S:9574 E:9579 ||| NN
body  ||| S:9579 E:9584 ||| NN
are  ||| S:9584 E:9588 ||| VBP
absent ||| S:9588 E:9594 ||| JJ
,  ||| S:9594 E:9596 ||| ,
and  ||| S:9596 E:9600 ||| CC
multiple  ||| S:9600 E:9609 ||| JJ
branched  ||| S:9609 E:9618 ||| JJ
pseudopodial  ||| S:9618 E:9641 ||| JJ
structures  ||| S:9641 E:9652 ||| NNS
are  ||| S:9652 E:9656 ||| VBP
largely  ||| S:9656 E:9664 ||| RB
enriched  ||| S:9664 E:9673 ||| VBN
in  ||| S:9673 E:9676 ||| IN
filamentous  ||| S:9676 E:9688 ||| JJ
actin  ||| S:9688 E:9704 ||| NNS
( ||| S:9704 E:9705 ||| -LRB-
Figure  ||| S:9705 E:9712 ||| NNP
5B ||| S:9712 E:9714 ||| NNP
,  ||| S:9714 E:9716 ||| ,
arrows ||| S:9716 E:9722 ||| CD
) ||| S:9722 E:9723 ||| -RRB-
.  ||| S:9723 E:9725 ||| .
Of  ||| S:9725 E:9728 ||| IN
interest ||| S:9728 E:9736 ||| NN
,  ||| S:9736 E:9738 ||| ,
electroporation  ||| S:9738 E:9754 ||| VBG
of  ||| S:9754 E:9757 ||| IN
C3  ||| S:9757 E:9770 ||| CD
in  ||| S:9770 E:9773 ||| IN
conjunction  ||| S:9773 E:9785 ||| NN
with  ||| S:9785 E:9790 ||| IN
FITC-labeled  ||| S:9790 E:9803 ||| JJ
monomers  ||| S:9803 E:9812 ||| NN
of  ||| S:9812 E:9815 ||| IN
actin  ||| S:9815 E:9821 ||| NN
did  ||| S:9821 E:9835 ||| VBD
not  ||| S:9835 E:9839 ||| RB
demonstrate  ||| S:9839 E:9851 ||| VB
incorporation  ||| S:9851 E:9865 ||| VBN
of  ||| S:9865 E:9868 ||| IN
FITC-actin  ||| S:9868 E:9879 ||| JJ
in  ||| S:9879 E:9882 ||| IN
the  ||| S:9882 E:9896 ||| DT
altered  ||| S:9896 E:9904 ||| JJ
pseudopods  ||| S:9904 E:9915 ||| NN
at  ||| S:9915 E:9918 ||| IN
early  ||| S:9918 E:9924 ||| JJ
time  ||| S:9924 E:9929 ||| NN
points  ||| S:9929 E:9936 ||| NNS
( ||| S:9936 E:9937 ||| -LRB-
data  ||| S:9937 E:9942 ||| NNS
not  ||| S:9942 E:9946 ||| RB
shown ||| S:9946 E:9951 ||| VBN
) ||| S:9951 E:9952 ||| -RRB-
,  ||| S:9952 E:9964 ||| ,
suggesting  ||| S:9964 E:9975 ||| VBG
that  ||| S:9975 E:9980 ||| IN
the  ||| S:9980 E:9984 ||| DT
filamentous  ||| S:9984 E:9996 ||| JJ
actin  ||| S:9996 E:10002 ||| NN
in  ||| S:10002 E:10005 ||| IN
the  ||| S:10005 E:10009 ||| DT
altered  ||| S:10009 E:10027 ||| JJ
pseudopods  ||| S:10027 E:10038 ||| NNS
initially  ||| S:10038 E:10048 ||| RB
results  ||| S:10048 E:10056 ||| NNS
from  ||| S:10056 E:10061 ||| IN
rearrangement  ||| S:10061 E:10075 ||| NN
of  ||| S:10075 E:10088 ||| IN
pre-formed  ||| S:10088 E:10099 ||| JJ
actin  ||| S:10099 E:10105 ||| JJ
filaments ||| S:10105 E:10114 ||| NN
.  ||| S:10114 E:10144 ||| .
Time  ||| S:10144 E:10149 ||| NN
lapse  ||| S:10149 E:10155 ||| NN
microscopy  ||| S:10155 E:10166 ||| NN
of  ||| S:10166 E:10169 ||| IN
C3  ||| S:10169 E:10172 ||| CD
treated  ||| S:10172 E:10180 ||| CD
cells  ||| S:10180 E:10196 ||| NNS
In  ||| S:10196 E:10199 ||| IN
fibroblast  ||| S:10199 E:10210 ||| JJ
models ||| S:10210 E:10216 ||| NNS
,  ||| S:10216 E:10218 ||| ,
inactivation  ||| S:10218 E:10231 ||| NN
of  ||| S:10231 E:10234 ||| IN
Rho  ||| S:10234 E:10238 ||| NNP
causes  ||| S:10238 E:10255 ||| VBZ
retraction  ||| S:10255 E:10266 ||| VBN
of  ||| S:10266 E:10269 ||| IN
pre-formed  ||| S:10269 E:10280 ||| JJ
pseudopods  ||| S:10280 E:10291 ||| NN
with  ||| S:10291 E:10296 ||| IN
a  ||| S:10296 E:10298 ||| DT
resultant  ||| S:10298 E:10318 ||| JJ
deposition  ||| S:10318 E:10329 ||| NN
of  ||| S:10329 E:10332 ||| IN
parallel  ||| S:10332 E:10341 ||| JJ
tracks  ||| S:10341 E:10348 ||| NNS
of  ||| S:10348 E:10351 ||| IN
thin  ||| S:10351 E:10356 ||| JJ
dendritic  ||| S:10356 E:10366 ||| JJ
processes  ||| S:10366 E:10386 ||| NNS
[  ||| S:10386 E:10388 ||| -LRB-
17  ||| S:10388 E:10391 ||| CD
]  ||| S:10391 E:10393 ||| -RRB-
,  ||| S:10393 E:10395 ||| ,
a  ||| S:10395 E:10397 ||| DT
phenotype  ||| S:10397 E:10407 ||| NN
ultimately  ||| S:10407 E:10418 ||| RB
resembling  ||| S:10418 E:10429 ||| VBG
that  ||| S:10429 E:10434 ||| IN
seen  ||| S:10434 E:10439 ||| VBN
in  ||| S:10439 E:10452 ||| IN
C3  ||| S:10452 E:10455 ||| NNP
treated  ||| S:10455 E:10463 ||| VBD
HPB-ALL ||| S:10463 E:10470 ||| JJ
.  ||| S:10470 E:10472 ||| .
The  ||| S:10472 E:10476 ||| DT
phenotype  ||| S:10476 E:10486 ||| JJ
induced  ||| S:10486 E:10494 ||| NN
by  ||| S:10494 E:10497 ||| IN
C3  ||| S:10497 E:10500 ||| CD
mediated  ||| S:10500 E:10519 ||| JJ
ribosylation  ||| S:10519 E:10532 ||| NN
of  ||| S:10532 E:10535 ||| IN
Rho  ||| S:10535 E:10539 ||| NNP
in  ||| S:10539 E:10542 ||| IN
HPB-ALL  ||| S:10542 E:10550 ||| NNP
could  ||| S:10550 E:10556 ||| MD
result  ||| S:10556 E:10563 ||| VB
from  ||| S:10563 E:10568 ||| IN
either  ||| S:10568 E:10585 ||| DT
aberrant  ||| S:10585 E:10594 ||| JJ
retraction  ||| S:10594 E:10605 ||| NN
of  ||| S:10605 E:10608 ||| IN
recently  ||| S:10608 E:10617 ||| RB
formed  ||| S:10617 E:10624 ||| VBN
pseudopods ||| S:10624 E:10634 ||| NN
,  ||| S:10634 E:10636 ||| ,
or  ||| S:10636 E:10649 ||| CC
altered  ||| S:10649 E:10657 ||| JJ
pseudopodial  ||| S:10657 E:10670 ||| JJ
extension ||| S:10670 E:10679 ||| NN
.  ||| S:10679 E:10681 ||| .
These  ||| S:10681 E:10687 ||| DT
possibilities  ||| S:10687 E:10701 ||| NNS
were  ||| S:10701 E:10716 ||| VBD
explored  ||| S:10716 E:10725 ||| VBN
using  ||| S:10725 E:10731 ||| VBG
video  ||| S:10731 E:10737 ||| JJ
time-lapse  ||| S:10737 E:10748 ||| JJ
microscopy ||| S:10748 E:10758 ||| NN
.  ||| S:10758 E:10760 ||| .
Figure  ||| S:10760 E:10777 ||| NNP
6demonstrates  ||| S:10777 E:10791 ||| NNP
HPB-ALL  ||| S:10791 E:10799 ||| NNP
spreading  ||| S:10799 E:10809 ||| VBG
on  ||| S:10809 E:10812 ||| IN
VCAM-1  ||| S:10812 E:10819 ||| CD
over  ||| S:10819 E:10824 ||| IN
a  ||| S:10824 E:10826 ||| DT
period  ||| S:10826 E:10843 ||| NN
of  ||| S:10843 E:10846 ||| IN
1  ||| S:10846 E:10848 ||| CD
hour ||| S:10848 E:10852 ||| NN
,  ||| S:10852 E:10854 ||| ,
where  ||| S:10854 E:10860 ||| WRB
images  ||| S:10860 E:10867 ||| NNS
from  ||| S:10867 E:10872 ||| IN
the  ||| S:10872 E:10876 ||| DT
first  ||| S:10876 E:10882 ||| JJ
10  ||| S:10882 E:10885 ||| CD
minutes  ||| S:10885 E:10893 ||| NNS
were  ||| S:10893 E:10908 ||| VBD
obtained  ||| S:10908 E:10917 ||| VBN
from  ||| S:10917 E:10922 ||| IN
recorded  ||| S:10922 E:10931 ||| JJ
videotape ||| S:10931 E:10940 ||| NN
,  ||| S:10940 E:10942 ||| ,
followed  ||| S:10942 E:10951 ||| VBN
by  ||| S:10951 E:10954 ||| IN
a  ||| S:10954 E:10956 ||| DT
60  ||| S:10956 E:10959 ||| CD
minute  ||| S:10959 E:10976 ||| NN
time  ||| S:10976 E:10981 ||| NN
point ||| S:10981 E:10986 ||| NN
.  ||| S:10986 E:10988 ||| .
Untreated  ||| S:10988 E:10998 ||| JJ
cells  ||| S:10998 E:11004 ||| NNS
and  ||| S:11004 E:11008 ||| CC
mock  ||| S:11008 E:11013 ||| JJ
electroporated  ||| S:11013 E:11028 ||| JJ
cells  ||| S:11028 E:11044 ||| NNS
demonstrate  ||| S:11044 E:11056 ||| VBP
normal  ||| S:11056 E:11063 ||| JJ
HPB-ALL  ||| S:11063 E:11071 ||| JJ
cell  ||| S:11071 E:11076 ||| NN
spreading  ||| S:11076 E:11086 ||| VBG
( ||| S:11086 E:11087 ||| -LRB-
figure  ||| S:11087 E:11094 ||| NN
6 ||| S:11094 E:11095 ||| CD
,  ||| S:11095 E:11097 ||| ,
see  ||| S:11097 E:11111 ||| VBP
arrows ||| S:11111 E:11117 ||| VBN
) ||| S:11117 E:11118 ||| -RRB-
.  ||| S:11118 E:11120 ||| .
They  ||| S:11120 E:11125 ||| PRP
extend  ||| S:11125 E:11132 ||| VBP
thick  ||| S:11132 E:11138 ||| JJ
pseudopodia  ||| S:11138 E:11150 ||| NN
with  ||| S:11150 E:11155 ||| IN
fanned  ||| S:11155 E:11172 ||| JJ
termini ||| S:11172 E:11179 ||| NN
,  ||| S:11179 E:11181 ||| ,
and  ||| S:11181 E:11185 ||| CC
their  ||| S:11185 E:11191 ||| PRP$
cell  ||| S:11191 E:11196 ||| NN
bodies  ||| S:11196 E:11203 ||| NNS
are  ||| S:11203 E:11207 ||| VBP
flattened  ||| S:11207 E:11217 ||| VBN
and  ||| S:11217 E:11221 ||| CC
oval  ||| S:11221 E:11226 ||| NN
in  ||| S:11226 E:11239 ||| IN
shape ||| S:11239 E:11244 ||| NN
.  ||| S:11244 E:11246 ||| .
The  ||| S:11246 E:11250 ||| DT
C3  ||| S:11250 E:11253 ||| CD
induced  ||| S:11253 E:11261 ||| CD
phenotype  ||| S:11261 E:11271 ||| CD
forms  ||| S:11271 E:11277 ||| NNS
at  ||| S:11277 E:11280 ||| IN
the  ||| S:11280 E:11284 ||| DT
onset  ||| S:11284 E:11290 ||| NN
of  ||| S:11290 E:11303 ||| IN
cell  ||| S:11303 E:11308 ||| NN
spreading  ||| S:11308 E:11318 ||| VBG
( ||| S:11318 E:11319 ||| -LRB-
figure  ||| S:11319 E:11326 ||| NN
6 ||| S:11326 E:11327 ||| CD
,  ||| S:11327 E:11329 ||| ,
see  ||| S:11329 E:11333 ||| VBP
arrows ||| S:11333 E:11339 ||| VBN
) ||| S:11339 E:11340 ||| -RRB-
.  ||| S:11340 E:11342 ||| .
The  ||| S:11342 E:11346 ||| DT
finger-like  ||| S:11346 E:11368 ||| JJ
extensions  ||| S:11368 E:11379 ||| NNS
initially  ||| S:11379 E:11389 ||| RB
form  ||| S:11389 E:11394 ||| VB
from  ||| S:11394 E:11399 ||| IN
a  ||| S:11399 E:11401 ||| DT
rounded  ||| S:11401 E:11409 ||| JJ
cell  ||| S:11409 E:11414 ||| NN
body  ||| S:11414 E:11419 ||| NN
and  ||| S:11419 E:11433 ||| CC
elongate  ||| S:11433 E:11442 ||| NN
throughout  ||| S:11442 E:11453 ||| IN
the  ||| S:11453 E:11457 ||| DT
duration  ||| S:11457 E:11466 ||| NN
of  ||| S:11466 E:11469 ||| IN
the  ||| S:11469 E:11473 ||| DT
assay ||| S:11473 E:11478 ||| NN
.  ||| S:11478 E:11480 ||| .
The  ||| S:11480 E:11494 ||| DT
stellate  ||| S:11494 E:11503 ||| JJ
projections  ||| S:11503 E:11515 ||| NNS
are  ||| S:11515 E:11519 ||| VBP
clearly  ||| S:11519 E:11527 ||| RB
delineated  ||| S:11527 E:11538 ||| VBN
even  ||| S:11538 E:11543 ||| RB
at  ||| S:11543 E:11546 ||| IN
their  ||| S:11546 E:11562 ||| PRP$
termini ||| S:11562 E:11569 ||| NN
,  ||| S:11569 E:11571 ||| ,
and  ||| S:11571 E:11575 ||| CC
the  ||| S:11575 E:11579 ||| DT
cell  ||| S:11579 E:11584 ||| NN
bodies  ||| S:11584 E:11591 ||| NNS
do  ||| S:11591 E:11594 ||| VBP
not  ||| S:11594 E:11598 ||| RB
demonstrate  ||| S:11598 E:11610 ||| VB
a  ||| S:11610 E:11622 ||| DT
flattened ||| S:11622 E:11631 ||| NN
,  ||| S:11631 E:11633 ||| ,
oval ||| S:11633 E:11637 ||| NN
,  ||| S:11637 E:11639 ||| ,
or  ||| S:11639 E:11642 ||| CC
spindle  ||| S:11642 E:11650 ||| JJ
phenotype ||| S:11650 E:11659 ||| NN
.  ||| S:11659 E:11661 ||| .
Thus ||| S:11661 E:11665 ||| RB
,  ||| S:11665 E:11667 ||| ,
the  ||| S:11667 E:11671 ||| DT
C3  ||| S:11671 E:11684 ||| FW
induced  ||| S:11684 E:11692 ||| FW
stellate  ||| S:11692 E:11701 ||| FW
phenotype  ||| S:11701 E:11711 ||| FW
is  ||| S:11711 E:11714 ||| VBZ
not  ||| S:11714 E:11718 ||| RB
primarily  ||| S:11718 E:11728 ||| RB
due  ||| S:11728 E:11732 ||| JJ
to  ||| S:11732 E:11745 ||| TO
aberrant  ||| S:11745 E:11754 ||| VB
pseudopodial  ||| S:11754 E:11767 ||| JJ
retraction ||| S:11767 E:11777 ||| NN
,  ||| S:11777 E:11779 ||| ,
but  ||| S:11779 E:11783 ||| CC
an  ||| S:11783 E:11786 ||| DT
altered  ||| S:11786 E:11804 ||| JJ
pseudopodial  ||| S:11804 E:11817 ||| JJ
extension ||| S:11817 E:11826 ||| NN
.  ||| S:11826 E:11828 ||| .
Also  ||| S:11828 E:11833 ||| RB
of  ||| S:11833 E:11836 ||| IN
note  ||| S:11836 E:11841 ||| NN
was  ||| S:11841 E:11845 ||| VBD
the  ||| S:11845 E:11849 ||| DT
effect  ||| S:11849 E:11856 ||| NN
of  ||| S:11856 E:11859 ||| IN
C3  ||| S:11859 E:11872 ||| CD
on  ||| S:11872 E:11875 ||| IN
the  ||| S:11875 E:11879 ||| DT
dynamic  ||| S:11879 E:11887 ||| JJ
maintenance  ||| S:11887 E:11899 ||| NN
of  ||| S:11899 E:11902 ||| IN
pseudopodia ||| S:11902 E:11913 ||| NN
.  ||| S:11913 E:11915 ||| .
Under  ||| S:11915 E:11921 ||| IN
normal  ||| S:11921 E:11938 ||| JJ
or  ||| S:11938 E:11941 ||| CC
control  ||| S:11941 E:11949 ||| NN
electroporation  ||| S:11949 E:11965 ||| NN
conditions ||| S:11965 E:11975 ||| NNS
,  ||| S:11975 E:11977 ||| ,
some  ||| S:11977 E:11982 ||| DT
of  ||| S:11982 E:11985 ||| IN
the  ||| S:11985 E:11989 ||| DT
VCAM-1  ||| S:11989 E:12006 ||| CD
adherent  ||| S:12006 E:12015 ||| CD
cells  ||| S:12015 E:12021 ||| NNS
would  ||| S:12021 E:12027 ||| MD
retract  ||| S:12027 E:12035 ||| VB
pseudopodia ||| S:12035 E:12046 ||| NNS
,  ||| S:12046 E:12048 ||| ,
then  ||| S:12048 E:12053 ||| RB
form  ||| S:12053 E:12058 ||| VB
new  ||| S:12058 E:12072 ||| JJ
extensions  ||| S:12072 E:12083 ||| NNS
in  ||| S:12083 E:12086 ||| IN
different  ||| S:12086 E:12096 ||| JJ
directions ||| S:12096 E:12106 ||| NNS
.  ||| S:12106 E:12108 ||| .
This  ||| S:12108 E:12113 ||| DT
activity  ||| S:12113 E:12122 ||| NN
was  ||| S:12122 E:12136 ||| VBD
clearly  ||| S:12136 E:12144 ||| RB
inhibited  ||| S:12144 E:12154 ||| VBN
in  ||| S:12154 E:12157 ||| IN
the  ||| S:12157 E:12161 ||| DT
C3  ||| S:12161 E:12164 ||| NN
treated  ||| S:12164 E:12172 ||| VBN
cells ||| S:12172 E:12177 ||| NNS
.  ||| S:12177 E:12179 ||| .
Once  ||| S:12179 E:12184 ||| IN
the  ||| S:12184 E:12198 ||| DT
aberrant  ||| S:12198 E:12207 ||| JJ
finger-like  ||| S:12207 E:12219 ||| JJ
projections  ||| S:12219 E:12231 ||| NNS
were  ||| S:12231 E:12236 ||| VBD
formed ||| S:12236 E:12242 ||| VBN
,  ||| S:12242 E:12244 ||| ,
no  ||| S:12244 E:12257 ||| DT
pseudopodial  ||| S:12257 E:12270 ||| JJ
retraction  ||| S:12270 E:12281 ||| NN
was  ||| S:12281 E:12285 ||| VBD
noted  ||| S:12285 E:12291 ||| VBN
during  ||| S:12291 E:12298 ||| IN
this  ||| S:12298 E:12303 ||| DT
time  ||| S:12303 E:12318 ||| NN
period ||| S:12318 E:12324 ||| NN
,  ||| S:12324 E:12326 ||| ,
and  ||| S:12326 E:12330 ||| CC
the  ||| S:12330 E:12334 ||| DT
cells  ||| S:12334 E:12340 ||| NNS
became  ||| S:12340 E:12347 ||| VBD
completely  ||| S:12347 E:12358 ||| RB
immobile ||| S:12358 E:12366 ||| VBN
.  ||| S:12366 E:12378 ||| .
Quantification  ||| S:12378 E:12393 ||| NNP
of  ||| S:12393 E:12396 ||| IN
the  ||| S:12396 E:12400 ||| DT
original  ||| S:12400 E:12409 ||| JJ
movies  ||| S:12409 E:12416 ||| NNS
indicate  ||| S:12416 E:12425 ||| VBP
that  ||| S:12425 E:12430 ||| IN
only  ||| S:12430 E:12445 ||| RB
1.7 ||| S:12445 E:12448 ||| CD
%  ||| S:12448 E:12450 ||| NN
( ||| S:12450 E:12451 ||| -LRB-
1 ||| S:12451 E:12452 ||| CD
/ ||| S:12452 E:12453 ||| CD
60 ||| S:12453 E:12455 ||| CD
)  ||| S:12455 E:12457 ||| -RRB-
of  ||| S:12457 E:12460 ||| IN
the  ||| S:12460 E:12464 ||| DT
C3-treated  ||| S:12464 E:12475 ||| CD
cells  ||| S:12475 E:12481 ||| NNS
were  ||| S:12481 E:12486 ||| VBD
motile  ||| S:12486 E:12493 ||| VBN
whereas  ||| S:12493 E:12511 ||| IN
34.9 ||| S:12511 E:12515 ||| CD
%  ||| S:12515 E:12517 ||| NN
( ||| S:12517 E:12518 ||| -LRB-
45 ||| S:12518 E:12520 ||| CD
/ ||| S:12520 E:12521 ||| CD
129 ||| S:12521 E:12524 ||| CD
)  ||| S:12524 E:12526 ||| -RRB-
of  ||| S:12526 E:12529 ||| IN
mock-electroporated  ||| S:12529 E:12549 ||| JJ
cells  ||| S:12549 E:12555 ||| NNS
displayed  ||| S:12555 E:12575 ||| VBD
motility ||| S:12575 E:12583 ||| VBN
.  ||| S:12583 E:12585 ||| .
See  ||| S:12585 E:12589 ||| VB
additional  ||| S:12589 E:12600 ||| JJ
file1 ||| S:12600 E:12605 ||| NN
: ||| S:12605 E:12606 ||| :
C3.movand  ||| S:12606 E:12626 ||| CD
file2 ||| S:12626 E:12631 ||| CD
: ||| S:12631 E:12632 ||| :
mock.movfor  ||| S:12632 E:12644 ||| CD
the  ||| S:12644 E:12648 ||| DT
original  ||| S:12648 E:12657 ||| JJ
movies ||| S:12657 E:12663 ||| NNS
.  ||| S:12663 E:12675 ||| .
Additional  ||| S:12675 E:12686 ||| JJ
File  ||| S:12686 E:12691 ||| NNP
1  ||| S:12691 E:12703 ||| CD
C3  ||| S:12703 E:12706 ||| CD
transfection  ||| S:12706 E:12719 ||| NN
on  ||| S:12719 E:12722 ||| IN
VCAM  ||| S:12722 E:12727 ||| NNP
C3  ||| S:12727 E:12730 ||| NNP
exoenzyme  ||| S:12730 E:12740 ||| VBD
transfected  ||| S:12740 E:12752 ||| VBN
into  ||| S:12752 E:12767 ||| IN
HPB-ALL  ||| S:12767 E:12775 ||| JJ
cells  ||| S:12775 E:12781 ||| NNS
inhibits  ||| S:12781 E:12790 ||| VBP
motility  ||| S:12790 E:12799 ||| VBN
on  ||| S:12799 E:12802 ||| IN
immobilized  ||| S:12802 E:12814 ||| CD
VCAM-1  ||| S:12814 E:12831 ||| CD
substrate ||| S:12831 E:12840 ||| NNS
.  ||| S:12840 E:12852 ||| .
Click  ||| S:12852 E:12858 ||| NNP
here  ||| S:12858 E:12863 ||| RB
for  ||| S:12863 E:12867 ||| IN
file  ||| S:12867 E:12882 ||| NN
Additional  ||| S:12882 E:12893 ||| NNP
File  ||| S:12893 E:12898 ||| NNP
2  ||| S:12898 E:12910 ||| CD
Mock  ||| S:12910 E:12915 ||| JJ
transfection  ||| S:12915 E:12928 ||| NN
on  ||| S:12928 E:12931 ||| IN
VCAM  ||| S:12931 E:12936 ||| NNP
Mock  ||| S:12936 E:12941 ||| NNP
transfected  ||| S:12941 E:12953 ||| VBD
HPB-ALL  ||| S:12953 E:12971 ||| JJ
cells  ||| S:12971 E:12977 ||| NNS
have  ||| S:12977 E:12982 ||| VBP
normal  ||| S:12982 E:12989 ||| JJ
motility  ||| S:12989 E:12998 ||| NN
on  ||| S:12998 E:13001 ||| IN
immobilized  ||| S:13001 E:13013 ||| CD
VCAM-1  ||| S:13013 E:13030 ||| CD
substrate ||| S:13030 E:13039 ||| NNS
.  ||| S:13039 E:13051 ||| .
Click  ||| S:13051 E:13057 ||| NNP
here  ||| S:13057 E:13062 ||| RB
for  ||| S:13062 E:13066 ||| IN
file  ||| S:13066 E:13102 ||| NN
Discussion  ||| S:13102 E:13121 ||| NNS
In  ||| S:13121 E:13124 ||| IN
the  ||| S:13124 E:13128 ||| DT
present  ||| S:13128 E:13136 ||| JJ
study ||| S:13136 E:13141 ||| NN
,  ||| S:13141 E:13143 ||| ,
we  ||| S:13143 E:13146 ||| PRP
demonstrate  ||| S:13146 E:13158 ||| VBP
that  ||| S:13158 E:13171 ||| IN
ADP-ribosylation  ||| S:13171 E:13188 ||| JJ
of  ||| S:13188 E:13191 ||| IN
the  ||| S:13191 E:13195 ||| DT
GTPase  ||| S:13195 E:13202 ||| JJ
Rho  ||| S:13202 E:13206 ||| NNS
in  ||| S:13206 E:13209 ||| IN
HPB-ALL  ||| S:13209 E:13217 ||| JJ
cells  ||| S:13217 E:13223 ||| NNS
does  ||| S:13223 E:13236 ||| VBZ
not  ||| S:13236 E:13240 ||| RB
result  ||| S:13240 E:13247 ||| VB
in  ||| S:13247 E:13250 ||| IN
a  ||| S:13250 E:13252 ||| DT
decrease  ||| S:13252 E:13261 ||| NN
in  ||| S:13261 E:13264 ||| IN
constitutively  ||| S:13264 E:13279 ||| JJ
high  ||| S:13279 E:13284 ||| JJ
adhesion  ||| S:13284 E:13293 ||| NN
to  ||| S:13293 E:13304 ||| TO
the  ||| S:13304 E:13308 ||| DT
extracellular  ||| S:13308 E:13322 ||| JJ
matrix  ||| S:13322 E:13329 ||| JJ
component  ||| S:13329 E:13339 ||| NN
fibronectin ||| S:13339 E:13350 ||| NN
.  ||| S:13350 E:13352 ||| .
However ||| S:13352 E:13359 ||| RB
,  ||| S:13359 E:13369 ||| ,
inactivation  ||| S:13369 E:13382 ||| NN
of  ||| S:13382 E:13385 ||| IN
Rho  ||| S:13385 E:13389 ||| NNP
protein  ||| S:13389 E:13397 ||| NN
does  ||| S:13397 E:13402 ||| VBZ
result  ||| S:13402 E:13409 ||| NN
in  ||| S:13409 E:13412 ||| IN
the  ||| S:13412 E:13416 ||| DT
aberrant  ||| S:13416 E:13433 ||| JJ
extension  ||| S:13433 E:13443 ||| NN
of  ||| S:13443 E:13446 ||| IN
finger-like ||| S:13446 E:13457 ||| NNP
,  ||| S:13457 E:13459 ||| ,
branched  ||| S:13459 E:13468 ||| VBN
dendritic  ||| S:13468 E:13478 ||| JJ
projections  ||| S:13478 E:13490 ||| NNS
in  ||| S:13490 E:13501 ||| IN
HBP-ALL  ||| S:13501 E:13509 ||| JJ
cells  ||| S:13509 E:13515 ||| NNS
when  ||| S:13515 E:13520 ||| WRB
plated  ||| S:13520 E:13527 ||| NNS
on  ||| S:13527 E:13530 ||| IN
the  ||| S:13530 E:13534 ||| DT
substrates  ||| S:13534 E:13545 ||| JJ
VCAM-1 ||| S:13545 E:13551 ||| NN
,  ||| S:13551 E:13561 ||| ,
fibronectin ||| S:13561 E:13572 ||| NN
,  ||| S:13572 E:13574 ||| ,
and  ||| S:13574 E:13578 ||| CC
mAb  ||| S:13578 E:13582 ||| JJ
specific  ||| S:13582 E:13591 ||| JJ
for  ||| S:13591 E:13595 ||| IN
β1  ||| S:13595 E:13598 ||| CD
integrins ||| S:13598 E:13607 ||| NNS
.  ||| S:13607 E:13609 ||| .
Altered  ||| S:13609 E:13625 ||| FW
pseudopodial  ||| S:13625 E:13638 ||| FW
extension  ||| S:13638 E:13648 ||| FW
required  ||| S:13648 E:13657 ||| FW
β1  ||| S:13657 E:13660 ||| FW
integrin  ||| S:13660 E:13669 ||| FW
signaling ||| S:13669 E:13678 ||| FW
,  ||| S:13678 E:13680 ||| ,
as  ||| S:13680 E:13691 ||| IN
C3  ||| S:13691 E:13694 ||| CD
treated  ||| S:13694 E:13702 ||| CD
cells  ||| S:13702 E:13708 ||| NNS
plated  ||| S:13708 E:13715 ||| VBN
on  ||| S:13715 E:13718 ||| IN
the  ||| S:13718 E:13722 ||| DT
non-specific  ||| S:13722 E:13735 ||| JJ
cell  ||| S:13735 E:13740 ||| NN
attachment  ||| S:13740 E:13759 ||| NN
factor  ||| S:13759 E:13766 ||| NN
poly-L-lysine  ||| S:13766 E:13780 ||| NN
did  ||| S:13780 E:13784 ||| VBD
not  ||| S:13784 E:13788 ||| RB
extend  ||| S:13788 E:13795 ||| VB
dendritic  ||| S:13795 E:13805 ||| VBN
like  ||| S:13805 E:13818 ||| IN
processes ||| S:13818 E:13827 ||| NNS
.  ||| S:13827 E:13829 ||| .
Electroporation  ||| S:13829 E:13845 ||| NNP
of  ||| S:13845 E:13848 ||| IN
polyclonal  ||| S:13848 E:13859 ||| JJ
antibodies  ||| S:13859 E:13878 ||| NNS
specific  ||| S:13878 E:13887 ||| JJ
for  ||| S:13887 E:13891 ||| IN
RhoA  ||| S:13891 E:13896 ||| JJ
mimicked  ||| S:13896 E:13905 ||| NNS
the  ||| S:13905 E:13909 ||| DT
C3  ||| S:13909 E:13912 ||| FW
induced  ||| S:13912 E:13920 ||| FW
phenotype  ||| S:13920 E:13930 ||| FW
( ||| S:13930 E:13931 ||| -LRB-
data  ||| S:13931 E:13944 ||| NNS
not  ||| S:13944 E:13948 ||| RB
shown ||| S:13948 E:13953 ||| VBN
) ||| S:13953 E:13954 ||| -RRB-
.  ||| S:13954 E:13956 ||| .
The  ||| S:13956 E:13960 ||| DT
C3  ||| S:13960 E:13963 ||| CD
induced  ||| S:13963 E:13971 ||| CD
extensions  ||| S:13971 E:13982 ||| NNS
were  ||| S:13982 E:13987 ||| VBD
rich  ||| S:13987 E:13992 ||| JJ
in  ||| S:13992 E:14003 ||| IN
filamentous  ||| S:14003 E:14015 ||| JJ
actin ||| S:14015 E:14020 ||| NN
,  ||| S:14020 E:14022 ||| ,
and  ||| S:14022 E:14026 ||| CC
C3  ||| S:14026 E:14029 ||| NNP
treated  ||| S:14029 E:14037 ||| VBD
HPB-ALL  ||| S:14037 E:14045 ||| JJ
cell  ||| S:14045 E:14050 ||| NN
bodies  ||| S:14050 E:14065 ||| NNS
apparently  ||| S:14065 E:14076 ||| RB
lacked  ||| S:14076 E:14083 ||| VBD
filopodial  ||| S:14083 E:14094 ||| JJ
actin  ||| S:14094 E:14100 ||| JJ
microspikes ||| S:14100 E:14111 ||| NN
,  ||| S:14111 E:14113 ||| ,
present  ||| S:14113 E:14121 ||| JJ
in  ||| S:14121 E:14132 ||| IN
normal  ||| S:14132 E:14139 ||| JJ
spreading  ||| S:14139 E:14149 ||| VBG
cells ||| S:14149 E:14154 ||| NNS
.  ||| S:14154 E:14156 ||| .
Immunolocalization  ||| S:14156 E:14175 ||| JJ
studies  ||| S:14175 E:14183 ||| NNS
of  ||| S:14183 E:14186 ||| IN
RhoA  ||| S:14186 E:14199 ||| JJ
in  ||| S:14199 E:14202 ||| IN
C3  ||| S:14202 E:14205 ||| NNP
treated  ||| S:14205 E:14213 ||| VBD
HBP-ALL  ||| S:14213 E:14221 ||| JJ
cells  ||| S:14221 E:14227 ||| NNS
spreading  ||| S:14227 E:14237 ||| VBG
on  ||| S:14237 E:14240 ||| IN
fibronectin  ||| S:14240 E:14252 ||| NN
showed  ||| S:14252 E:14267 ||| VBD
no  ||| S:14267 E:14270 ||| DT
gross  ||| S:14270 E:14276 ||| JJ
differences  ||| S:14276 E:14288 ||| NNS
in  ||| S:14288 E:14291 ||| IN
RhoA  ||| S:14291 E:14296 ||| JJ
distribution ||| S:14296 E:14308 ||| NN
,  ||| S:14308 E:14310 ||| ,
however  ||| S:14310 E:14318 ||| RB
clusters  ||| S:14318 E:14335 ||| VBN
of  ||| S:14335 E:14338 ||| IN
RhoA  ||| S:14338 E:14343 ||| NNP
were  ||| S:14343 E:14348 ||| VBD
more  ||| S:14348 E:14353 ||| JJR
delineated  ||| S:14353 E:14364 ||| NN
along  ||| S:14364 E:14370 ||| IN
the  ||| S:14370 E:14374 ||| DT
finger-like  ||| S:14374 E:14394 ||| JJ
dendritic  ||| S:14394 E:14404 ||| JJ
processes  ||| S:14404 E:14414 ||| NNS
of  ||| S:14414 E:14417 ||| IN
the  ||| S:14417 E:14421 ||| DT
C3  ||| S:14421 E:14424 ||| NN
treated  ||| S:14424 E:14432 ||| VBN
cells ||| S:14432 E:14437 ||| NNS
.  ||| S:14437 E:14439 ||| .
Thus ||| S:14439 E:14443 ||| RB
,  ||| S:14443 E:14453 ||| ,
functional  ||| S:14453 E:14464 ||| JJ
Rho  ||| S:14464 E:14468 ||| NNP
is  ||| S:14468 E:14471 ||| VBZ
required  ||| S:14471 E:14480 ||| VBN
for  ||| S:14480 E:14484 ||| IN
the  ||| S:14484 E:14488 ||| DT
proper  ||| S:14488 E:14495 ||| JJ
extension  ||| S:14495 E:14505 ||| NN
and  ||| S:14505 E:14517 ||| CC
retraction  ||| S:14517 E:14528 ||| NN
of  ||| S:14528 E:14531 ||| IN
pseudopods  ||| S:14531 E:14542 ||| NN
in  ||| S:14542 E:14545 ||| IN
T  ||| S:14545 E:14547 ||| NN
lymphocytes  ||| S:14547 E:14559 ||| NN
on  ||| S:14559 E:14562 ||| IN
β1  ||| S:14562 E:14565 ||| CD
integrin  ||| S:14565 E:14582 ||| CD
substrates ||| S:14582 E:14592 ||| NNS
.  ||| S:14592 E:14602 ||| .
A  ||| S:14602 E:14604 ||| DT
large  ||| S:14604 E:14610 ||| JJ
body  ||| S:14610 E:14615 ||| NN
of  ||| S:14615 E:14618 ||| IN
work  ||| S:14618 E:14623 ||| NN
has  ||| S:14623 E:14627 ||| VBZ
described  ||| S:14627 E:14637 ||| VBN
the  ||| S:14637 E:14641 ||| DT
morphological  ||| S:14641 E:14663 ||| JJ
functions  ||| S:14663 E:14673 ||| NNS
regulated  ||| S:14673 E:14683 ||| VBN
by  ||| S:14683 E:14686 ||| IN
small  ||| S:14686 E:14692 ||| JJ
GTPases  ||| S:14692 E:14700 ||| NN
of  ||| S:14700 E:14703 ||| IN
the  ||| S:14703 E:14707 ||| DT
Rho  ||| S:14707 E:14711 ||| JJ
subfamily ||| S:14711 E:14720 ||| NN
.  ||| S:14720 E:14730 ||| .
Members  ||| S:14730 E:14738 ||| NNS
of  ||| S:14738 E:14741 ||| IN
this  ||| S:14741 E:14746 ||| DT
family  ||| S:14746 E:14753 ||| NN
include  ||| S:14753 E:14761 ||| VBP
RhoA ||| S:14761 E:14765 ||| JJ
,  ||| S:14765 E:14767 ||| ,
RhoB ||| S:14767 E:14771 ||| NNP
,  ||| S:14771 E:14773 ||| ,
RhoC  ||| S:14773 E:14778 ||| NNP
( ||| S:14778 E:14779 ||| -LRB-
which  ||| S:14779 E:14785 ||| WDT
are  ||| S:14785 E:14797 ||| VBP
isoforms ||| S:14797 E:14805 ||| VBN
) ||| S:14805 E:14806 ||| -RRB-
,  ||| S:14806 E:14808 ||| ,
Cdc42 ||| S:14808 E:14813 ||| NNP
,  ||| S:14813 E:14815 ||| ,
G25K ||| S:14815 E:14819 ||| NNP
,  ||| S:14819 E:14821 ||| ,
RhoG ||| S:14821 E:14825 ||| NNP
,  ||| S:14825 E:14827 ||| ,
Rac1 ||| S:14827 E:14831 ||| NNP
,  ||| S:14831 E:14833 ||| ,
Rac2 ||| S:14833 E:14837 ||| NNP
,  ||| S:14837 E:14839 ||| ,
and  ||| S:14839 E:14843 ||| CC
TC10  ||| S:14843 E:14856 ||| NNP
( ||| S:14856 E:14857 ||| -LRB-
reviewed  ||| S:14857 E:14866 ||| VBN
in  ||| S:14866 E:14869 ||| IN
[  ||| S:14869 E:14871 ||| -LRB-
34  ||| S:14871 E:14874 ||| CD
]  ||| S:14874 E:14876 ||| CD
) ||| S:14876 E:14877 ||| -RRB-
.  ||| S:14877 E:14879 ||| .
In  ||| S:14879 E:14882 ||| IN
fibroblast  ||| S:14882 E:14893 ||| JJ
models ||| S:14893 E:14899 ||| NNS
,  ||| S:14899 E:14901 ||| ,
these  ||| S:14901 E:14907 ||| DT
GTPases  ||| S:14907 E:14923 ||| NNS
have  ||| S:14923 E:14928 ||| VBP
been  ||| S:14928 E:14933 ||| VBN
proposed  ||| S:14933 E:14942 ||| VBN
to  ||| S:14942 E:14945 ||| TO
act  ||| S:14945 E:14949 ||| VB
in  ||| S:14949 E:14952 ||| IN
a  ||| S:14952 E:14954 ||| DT
concerted  ||| S:14954 E:14964 ||| JJ
hierarchy  ||| S:14964 E:14974 ||| NN
to  ||| S:14974 E:14985 ||| TO
coordinately  ||| S:14985 E:14998 ||| VB
regulate  ||| S:14998 E:15007 ||| VB
distinct  ||| S:15007 E:15016 ||| JJ
morphological  ||| S:15016 E:15030 ||| JJ
features ||| S:15030 E:15038 ||| NNS
.  ||| S:15038 E:15048 ||| .
Filopodia  ||| S:15048 E:15058 ||| JJ
formation  ||| S:15058 E:15068 ||| NN
of  ||| S:15068 E:15071 ||| IN
short  ||| S:15071 E:15077 ||| JJ
filamentous  ||| S:15077 E:15089 ||| JJ
actin  ||| S:15089 E:15095 ||| JJ
microspikes  ||| S:15095 E:15115 ||| NN
gives  ||| S:15115 E:15121 ||| VBZ
way  ||| S:15121 E:15125 ||| NN
to  ||| S:15125 E:15128 ||| TO
membrane  ||| S:15128 E:15137 ||| VB
ruffling  ||| S:15137 E:15146 ||| NNS
and  ||| S:15146 E:15150 ||| CC
lamellipodia  ||| S:15150 E:15163 ||| JJ
formation ||| S:15163 E:15172 ||| NN
,  ||| S:15172 E:15182 ||| ,
culminating  ||| S:15182 E:15194 ||| VBG
in  ||| S:15194 E:15197 ||| IN
the  ||| S:15197 E:15201 ||| DT
organized  ||| S:15201 E:15211 ||| JJ
production  ||| S:15211 E:15222 ||| NN
of  ||| S:15222 E:15225 ||| IN
actin  ||| S:15225 E:15231 ||| JJ
stress  ||| S:15231 E:15246 ||| NN
fibers ||| S:15246 E:15252 ||| NNS
.  ||| S:15252 E:15254 ||| .
This  ||| S:15254 E:15259 ||| DT
has  ||| S:15259 E:15263 ||| VBZ
lead  ||| S:15263 E:15268 ||| JJ
to  ||| S:15268 E:15271 ||| TO
the  ||| S:15271 E:15275 ||| DT
hypothesis  ||| S:15275 E:15286 ||| NN
that  ||| S:15286 E:15291 ||| IN
small  ||| S:15291 E:15297 ||| JJ
GTP  ||| S:15297 E:15309 ||| FW
binding  ||| S:15309 E:15317 ||| FW
proteins  ||| S:15317 E:15326 ||| FW
act  ||| S:15326 E:15330 ||| FW
sequentially ||| S:15330 E:15342 ||| FW
,  ||| S:15342 E:15344 ||| ,
in  ||| S:15344 E:15347 ||| IN
the  ||| S:15347 E:15351 ||| DT
GTPase  ||| S:15351 E:15358 ||| JJ
cascade  ||| S:15358 E:15374 ||| NN
Cdc42→Rac→Rho  ||| S:15374 E:15388 ||| NNP
[  ||| S:15388 E:15390 ||| -LRB-
35  ||| S:15390 E:15393 ||| CD
]  ||| S:15393 E:15395 ||| -RRB-
.  ||| S:15395 E:15397 ||| .
Facilitating  ||| S:15397 E:15410 ||| VBG
the  ||| S:15410 E:15414 ||| DT
study  ||| S:15414 E:15420 ||| NN
of  ||| S:15420 E:15423 ||| IN
Rho  ||| S:15423 E:15427 ||| NNP
in  ||| S:15427 E:15438 ||| IN
regulation  ||| S:15438 E:15449 ||| NN
of  ||| S:15449 E:15452 ||| IN
cell  ||| S:15452 E:15457 ||| NN
activity  ||| S:15457 E:15466 ||| NN
has  ||| S:15466 E:15470 ||| VBZ
been  ||| S:15470 E:15475 ||| VBN
the  ||| S:15475 E:15479 ||| DT
use  ||| S:15479 E:15483 ||| NN
of  ||| S:15483 E:15486 ||| IN
C3  ||| S:15486 E:15497 ||| CD
exoenzyme ||| S:15497 E:15506 ||| NN
,  ||| S:15506 E:15508 ||| ,
a  ||| S:15508 E:15510 ||| DT
toxin  ||| S:15510 E:15516 ||| NN
from  ||| S:15516 E:15530 ||| IN
Clostridium  ||| S:15530 E:15542 ||| NNP
botulinum  ||| S:15542 E:15552 ||| NN
that  ||| S:15552 E:15565 ||| IN
ADP-ribosylates  ||| S:15565 E:15581 ||| NNP
[  ||| S:15581 E:15583 ||| -LRB-
15  ||| S:15583 E:15586 ||| CD
16  ||| S:15586 E:15589 ||| CD
]  ||| S:15589 E:15591 ||| -RRB-
and  ||| S:15591 E:15595 ||| CC
inactivates  ||| S:15595 E:15607 ||| JJ
Rho  ||| S:15607 E:15611 ||| JJ
proteins ||| S:15611 E:15619 ||| NNS
.  ||| S:15619 E:15629 ||| .
Although  ||| S:15629 E:15638 ||| IN
ribosylation  ||| S:15638 E:15651 ||| NN
of  ||| S:15651 E:15654 ||| IN
other  ||| S:15654 E:15660 ||| JJ
Rho  ||| S:15660 E:15664 ||| JJ
family  ||| S:15664 E:15671 ||| NN
proteins  ||| S:15671 E:15680 ||| NNS
such  ||| S:15680 E:15685 ||| JJ
as  ||| S:15685 E:15696 ||| IN
Rac1  ||| S:15696 E:15701 ||| NNP
can  ||| S:15701 E:15705 ||| MD
occur  ||| S:15705 E:15711 ||| VB
with  ||| S:15711 E:15716 ||| IN
C3  ||| S:15716 E:15719 ||| NNP
[  ||| S:15719 E:15721 ||| -LRB-
33  ||| S:15721 E:15724 ||| CD
]  ||| S:15724 E:15726 ||| -RRB-
,  ||| S:15726 E:15728 ||| ,
this  ||| S:15728 E:15733 ||| DT
seemed  ||| S:15733 E:15740 ||| VBN
to  ||| S:15740 E:15743 ||| TO
be  ||| S:15743 E:15746 ||| VB
very  ||| S:15746 E:15751 ||| RB
weak  ||| S:15751 E:15764 ||| JJ
[  ||| S:15764 E:15766 ||| -LRB-
13  ||| S:15766 E:15769 ||| CD
]  ||| S:15769 E:15771 ||| -RRB-
.  ||| S:15771 E:15773 ||| .
In  ||| S:15773 E:15776 ||| IN
our  ||| S:15776 E:15780 ||| PRP$
work ||| S:15780 E:15784 ||| NN
,  ||| S:15784 E:15786 ||| ,
C3  ||| S:15786 E:15789 ||| CD
electroporated  ||| S:15789 E:15804 ||| NN
into  ||| S:15804 E:15809 ||| IN
the  ||| S:15809 E:15813 ||| DT
T  ||| S:15813 E:15815 ||| NN
cell  ||| S:15815 E:15828 ||| NN
line  ||| S:15828 E:15833 ||| NN
HPB-ALL  ||| S:15833 E:15841 ||| NN
caused  ||| S:15841 E:15848 ||| VBD
complete  ||| S:15848 E:15857 ||| JJ
ADP-ribosylation  ||| S:15857 E:15874 ||| NN
of  ||| S:15874 E:15877 ||| IN
Rho  ||| S:15877 E:15889 ||| NNP
proteins  ||| S:15889 E:15898 ||| NNS
( ||| S:15898 E:15899 ||| -LRB-
~25  ||| S:15899 E:15903 ||| NNP
kDa ||| S:15903 E:15906 ||| NNP
) ||| S:15906 E:15907 ||| -RRB-
.  ||| S:15907 E:15909 ||| .
Although  ||| S:15909 E:15918 ||| IN
Rac1  ||| S:15918 E:15923 ||| NNP
and  ||| S:15923 E:15927 ||| CC
Cdc42  ||| S:15927 E:15933 ||| NNP
were  ||| S:15933 E:15938 ||| VBD
identified  ||| S:15938 E:15957 ||| VBN
in  ||| S:15957 E:15960 ||| IN
western  ||| S:15960 E:15968 ||| JJ
blots  ||| S:15968 E:15974 ||| NN
of  ||| S:15974 E:15977 ||| IN
whole  ||| S:15977 E:15983 ||| JJ
cell  ||| S:15983 E:15988 ||| NN
lysates  ||| S:15988 E:15996 ||| VBZ
prepared  ||| S:15996 E:16005 ||| VBN
from  ||| S:16005 E:16010 ||| IN
the  ||| S:16010 E:16014 ||| DT
T  ||| S:16014 E:16024 ||| NN
cell  ||| S:16024 E:16029 ||| NN
lines  ||| S:16029 E:16035 ||| NNS
HPB-ALL ||| S:16035 E:16042 ||| JJ
,  ||| S:16042 E:16044 ||| ,
CEM ||| S:16044 E:16047 ||| NNP
,  ||| S:16047 E:16049 ||| ,
HSB  ||| S:16049 E:16053 ||| NNP
( ||| S:16053 E:16054 ||| -LRB-
data  ||| S:16054 E:16059 ||| NNS
not  ||| S:16059 E:16063 ||| RB
shown ||| S:16063 E:16068 ||| VBN
) ||| S:16068 E:16069 ||| -RRB-
,  ||| S:16069 E:16071 ||| ,
and  ||| S:16071 E:16075 ||| CC
PB  ||| S:16075 E:16078 ||| NNP
human  ||| S:16078 E:16092 ||| JJ
T  ||| S:16092 E:16094 ||| NN
lymphocytes  ||| S:16094 E:16106 ||| NNS
( ||| S:16106 E:16107 ||| -LRB-
data  ||| S:16107 E:16112 ||| NNS
not  ||| S:16112 E:16116 ||| RB
shown ||| S:16116 E:16121 ||| VBN
) ||| S:16121 E:16122 ||| -RRB-
,  ||| S:16122 E:16124 ||| ,
there  ||| S:16124 E:16130 ||| EX
was  ||| S:16130 E:16134 ||| VBD
no  ||| S:16134 E:16137 ||| DT
detection  ||| S:16137 E:16147 ||| NN
of  ||| S:16147 E:16158 ||| IN
ribosylation  ||| S:16158 E:16171 ||| NN
in  ||| S:16171 E:16174 ||| IN
the  ||| S:16174 E:16178 ||| DT
lower  ||| S:16178 E:16184 ||| JJR
molecular  ||| S:16184 E:16194 ||| JJ
weight  ||| S:16194 E:16201 ||| NN
Rac  ||| S:16201 E:16205 ||| NNP
and  ||| S:16205 E:16209 ||| CC
Cdc42  ||| S:16209 E:16223 ||| CD
related  ||| S:16223 E:16231 ||| JJ
GTPases  ||| S:16231 E:16239 ||| NN
in  ||| S:16239 E:16242 ||| IN
HPB-ALL  ||| S:16242 E:16250 ||| JJ
cells ||| S:16250 E:16255 ||| NNS
,  ||| S:16255 E:16257 ||| ,
indicating  ||| S:16257 E:16268 ||| VBG
the  ||| S:16268 E:16280 ||| DT
specificity  ||| S:16280 E:16292 ||| NN
of  ||| S:16292 E:16295 ||| IN
C3 ||| S:16295 E:16297 ||| CD
.  ||| S:16297 E:16307 ||| .
Previous  ||| S:16307 E:16316 ||| JJ
reports  ||| S:16316 E:16324 ||| NNS
have  ||| S:16324 E:16329 ||| VBP
demonstrated  ||| S:16329 E:16342 ||| VBN
that  ||| S:16342 E:16347 ||| IN
ADP-ribosylation  ||| S:16347 E:16372 ||| JJ
of  ||| S:16372 E:16375 ||| IN
B-lymphoid  ||| S:16375 E:16386 ||| JJ
cell  ||| S:16386 E:16391 ||| NN
lines  ||| S:16391 E:16397 ||| NNS
by  ||| S:16397 E:16400 ||| IN
C3  ||| S:16400 E:16403 ||| FW
treatment  ||| S:16403 E:16413 ||| FW
inhibits  ||| S:16413 E:16422 ||| FW
phorbol  ||| S:16422 E:16438 ||| FW
ester  ||| S:16438 E:16444 ||| FW
induced  ||| S:16444 E:16452 ||| FW
cellular  ||| S:16452 E:16461 ||| FW
homotypic  ||| S:16461 E:16471 ||| FW
aggregation  ||| S:16471 E:16483 ||| FW
[  ||| S:16483 E:16485 ||| -LRB-
18  ||| S:16485 E:16488 ||| CD
]  ||| S:16488 E:16490 ||| -RRB-
.  ||| S:16490 E:16492 ||| .
Also ||| S:16492 E:16496 ||| RB
,  ||| S:16496 E:16506 ||| ,
phorbol  ||| S:16506 E:16514 ||| JJ
ester  ||| S:16514 E:16520 ||| NN
and  ||| S:16520 E:16524 ||| CC
chemoattractant  ||| S:16524 E:16540 ||| NNS
( ||| S:16540 E:16541 ||| -LRB-
IL-8  ||| S:16541 E:16546 ||| NNP
and  ||| S:16546 E:16550 ||| CC
fMLP ||| S:16550 E:16554 ||| NNP
)  ||| S:16554 E:16556 ||| -RRB-
induced  ||| S:16556 E:16572 ||| FW
pre-B  ||| S:16572 E:16578 ||| FW
lymphoblastoid  ||| S:16578 E:16593 ||| FW
adhesion  ||| S:16593 E:16602 ||| FW
to  ||| S:16602 E:16605 ||| TO
VCAM-1  ||| S:16605 E:16612 ||| CD
and  ||| S:16612 E:16616 ||| CC
neutrophil  ||| S:16616 E:16635 ||| JJ
adhesion  ||| S:16635 E:16644 ||| NN
to  ||| S:16644 E:16647 ||| TO
fibrinogen  ||| S:16647 E:16658 ||| NNS
was  ||| S:16658 E:16662 ||| VBD
abrogated  ||| S:16662 E:16672 ||| VBN
in  ||| S:16672 E:16675 ||| IN
a  ||| S:16675 E:16677 ||| DT
dose-dependent  ||| S:16677 E:16700 ||| JJ
manner  ||| S:16700 E:16707 ||| NN
by  ||| S:16707 E:16710 ||| IN
C3  ||| S:16710 E:16713 ||| CD
exoenzyme  ||| S:16713 E:16723 ||| NNS
[  ||| S:16723 E:16725 ||| -LRB-
36  ||| S:16725 E:16728 ||| CD
]  ||| S:16728 E:16730 ||| -RRB-
.  ||| S:16730 E:16732 ||| .
This  ||| S:16732 E:16737 ||| DT
may  ||| S:16737 E:16741 ||| MD
indicate  ||| S:16741 E:16750 ||| VB
that  ||| S:16750 E:16755 ||| IN
in  ||| S:16755 E:16766 ||| IN
cells  ||| S:16766 E:16772 ||| NNS
of  ||| S:16772 E:16775 ||| IN
hematopoietic  ||| S:16775 E:16789 ||| JJ
lineages ||| S:16789 E:16797 ||| NN
,  ||| S:16797 E:16799 ||| ,
the  ||| S:16799 E:16803 ||| DT
induction  ||| S:16803 E:16813 ||| NN
of  ||| S:16813 E:16816 ||| IN
an  ||| S:16816 E:16827 ||| DT
increased  ||| S:16827 E:16837 ||| JJ
adhesive  ||| S:16837 E:16846 ||| NN
state  ||| S:16846 E:16852 ||| NN
may  ||| S:16852 E:16856 ||| MD
be  ||| S:16856 E:16859 ||| VB
susceptible  ||| S:16859 E:16871 ||| JJ
to  ||| S:16871 E:16874 ||| TO
regulation  ||| S:16874 E:16893 ||| NN
by  ||| S:16893 E:16896 ||| IN
Rho  ||| S:16896 E:16900 ||| NNP
proteins ||| S:16900 E:16908 ||| NNS
.  ||| S:16908 E:16910 ||| .
However ||| S:16910 E:16917 ||| RB
,  ||| S:16917 E:16919 ||| ,
we  ||| S:16919 E:16922 ||| PRP
have  ||| S:16922 E:16927 ||| VBP
recently  ||| S:16927 E:16936 ||| RB
demonstrated  ||| S:16936 E:16957 ||| VBN
that  ||| S:16957 E:16962 ||| IN
induced  ||| S:16962 E:16970 ||| JJ
adhesion  ||| S:16970 E:16979 ||| NN
of  ||| S:16979 E:16982 ||| IN
primary  ||| S:16982 E:16990 ||| JJ
T  ||| S:16990 E:16992 ||| NN
lymphocytes  ||| S:16992 E:17004 ||| NN
to  ||| S:17004 E:17015 ||| TO
fibronectin  ||| S:17015 E:17027 ||| NN
is  ||| S:17027 E:17030 ||| VBZ
unaffected  ||| S:17030 E:17041 ||| VBN
by  ||| S:17041 E:17044 ||| IN
Rho  ||| S:17044 E:17048 ||| NNP
inactivation  ||| S:17048 E:17061 ||| NNS
[  ||| S:17061 E:17063 ||| -LRB-
25  ||| S:17063 E:17066 ||| CD
]  ||| S:17066 E:17068 ||| -RRB-
,  ||| S:17068 E:17070 ||| ,
and  ||| S:17070 E:17082 ||| CC
data  ||| S:17082 E:17087 ||| NNS
presented  ||| S:17087 E:17097 ||| VBD
here  ||| S:17097 E:17102 ||| RB
suggests  ||| S:17102 E:17111 ||| VBZ
that  ||| S:17111 E:17116 ||| DT
constitutively  ||| S:17116 E:17131 ||| JJ
high  ||| S:17131 E:17144 ||| JJ
adhesion  ||| S:17144 E:17153 ||| NN
of  ||| S:17153 E:17156 ||| IN
HPB-ALL  ||| S:17156 E:17164 ||| JJ
cells  ||| S:17164 E:17170 ||| NNS
to  ||| S:17170 E:17173 ||| TO
β1  ||| S:17173 E:17176 ||| CD
integrin  ||| S:17176 E:17185 ||| JJ
substrate  ||| S:17185 E:17195 ||| NN
is  ||| S:17195 E:17206 ||| VBZ
unaffected  ||| S:17206 E:17217 ||| VBN
by  ||| S:17217 E:17220 ||| IN
C3  ||| S:17220 E:17223 ||| CD
treatment ||| S:17223 E:17232 ||| NN
.  ||| S:17232 E:17234 ||| .
Others  ||| S:17234 E:17241 ||| NNS
have  ||| S:17241 E:17246 ||| VBP
demonstrated  ||| S:17246 E:17259 ||| VBN
that  ||| S:17259 E:17272 ||| IN
inactivation  ||| S:17272 E:17285 ||| NN
of  ||| S:17285 E:17288 ||| IN
Rho  ||| S:17288 E:17292 ||| NNP
in  ||| S:17292 E:17295 ||| IN
monocytes  ||| S:17295 E:17305 ||| NN
promotes  ||| S:17305 E:17314 ||| VBZ
cellular  ||| S:17314 E:17323 ||| JJ
adhesion  ||| S:17323 E:17340 ||| NN
to  ||| S:17340 E:17343 ||| TO
β1  ||| S:17343 E:17346 ||| CD
integrin  ||| S:17346 E:17355 ||| CD
substrates  ||| S:17355 E:17366 ||| NNS
[  ||| S:17366 E:17368 ||| -LRB-
37  ||| S:17368 E:17371 ||| CD
]  ||| S:17371 E:17373 ||| -RRB-
.  ||| S:17373 E:17375 ||| .
Static  ||| S:17375 E:17382 ||| JJ
cell  ||| S:17382 E:17387 ||| NN
adhesion  ||| S:17387 E:17404 ||| NN
studies  ||| S:17404 E:17412 ||| NNS
rely  ||| S:17412 E:17417 ||| VBP
on  ||| S:17417 E:17420 ||| IN
a  ||| S:17420 E:17422 ||| DT
number  ||| S:17422 E:17429 ||| NN
of  ||| S:17429 E:17432 ||| IN
factors  ||| S:17432 E:17440 ||| NNS
including  ||| S:17440 E:17450 ||| VBG
integrin  ||| S:17450 E:17467 ||| JJ
affinity  ||| S:17467 E:17476 ||| JJ
regulation ||| S:17476 E:17486 ||| NN
,  ||| S:17486 E:17488 ||| ,
integrin  ||| S:17488 E:17497 ||| FW
avidity ||| S:17497 E:17504 ||| FW
/ ||| S:17504 E:17505 ||| FW
clustering ||| S:17505 E:17515 ||| FW
,  ||| S:17515 E:17517 ||| ,
and  ||| S:17517 E:17521 ||| CC
shear  ||| S:17521 E:17535 ||| JJ
resistant  ||| S:17535 E:17545 ||| JJ
cell  ||| S:17545 E:17550 ||| NN
shape  ||| S:17550 E:17556 ||| NN
changes ||| S:17556 E:17563 ||| NNS
.  ||| S:17563 E:17565 ||| .
Factors  ||| S:17565 E:17573 ||| NNS
affecting  ||| S:17573 E:17583 ||| VBG
adhesion  ||| S:17583 E:17600 ||| NNS
can  ||| S:17600 E:17604 ||| MD
do  ||| S:17604 E:17607 ||| VB
so  ||| S:17607 E:17610 ||| RB
by  ||| S:17610 E:17613 ||| IN
regulating  ||| S:17613 E:17624 ||| VBG
any  ||| S:17624 E:17628 ||| DT
number  ||| S:17628 E:17635 ||| NN
of  ||| S:17635 E:17638 ||| IN
these  ||| S:17638 E:17644 ||| DT
parameters ||| S:17644 E:17654 ||| NN
.  ||| S:17654 E:17664 ||| .
Thus  ||| S:17664 E:17669 ||| RB
the  ||| S:17669 E:17673 ||| DT
effects  ||| S:17673 E:17681 ||| NNS
due  ||| S:17681 E:17685 ||| JJ
to  ||| S:17685 E:17688 ||| TO
Rho  ||| S:17688 E:17692 ||| NNP
inactivation  ||| S:17692 E:17705 ||| NN
on  ||| S:17705 E:17708 ||| IN
cell  ||| S:17708 E:17713 ||| NN
adhesion  ||| S:17713 E:17730 ||| NNS
may  ||| S:17730 E:17734 ||| MD
not  ||| S:17734 E:17738 ||| RB
only  ||| S:17738 E:17743 ||| RB
influence  ||| S:17743 E:17753 ||| VB
one  ||| S:17753 E:17757 ||| CD
or  ||| S:17757 E:17760 ||| CC
more  ||| S:17760 E:17765 ||| JJR
of  ||| S:17765 E:17768 ||| IN
these  ||| S:17768 E:17774 ||| DT
parameters ||| S:17774 E:17784 ||| NN
,  ||| S:17784 E:17786 ||| ,
but  ||| S:17786 E:17798 ||| CC
also  ||| S:17798 E:17803 ||| RB
be  ||| S:17803 E:17806 ||| VB
cell  ||| S:17806 E:17811 ||| NN
type  ||| S:17811 E:17816 ||| NN
specific  ||| S:17816 E:17825 ||| NN
even  ||| S:17825 E:17830 ||| RB
amongst  ||| S:17830 E:17838 ||| IN
the  ||| S:17838 E:17842 ||| DT
cells  ||| S:17842 E:17848 ||| NNS
of  ||| S:17848 E:17851 ||| IN
the  ||| S:17851 E:17863 ||| DT
hematopoeitic  ||| S:17863 E:17877 ||| JJ
lineage ||| S:17877 E:17884 ||| NN
.  ||| S:17884 E:17894 ||| .
The  ||| S:17894 E:17898 ||| DT
phenotype  ||| S:17898 E:17908 ||| JJ
induced  ||| S:17908 E:17916 ||| NN
by  ||| S:17916 E:17919 ||| IN
ADP-ribosylation  ||| S:17919 E:17936 ||| JJ
of  ||| S:17936 E:17939 ||| IN
Rho  ||| S:17939 E:17943 ||| NNP
in  ||| S:17943 E:17946 ||| IN
T  ||| S:17946 E:17956 ||| NN
lymphocytes  ||| S:17956 E:17968 ||| NNS
appeared  ||| S:17968 E:17977 ||| VBD
different  ||| S:17977 E:17987 ||| JJ
than  ||| S:17987 E:17992 ||| IN
that  ||| S:17992 E:17997 ||| DT
induced  ||| S:17997 E:18005 ||| NN
in  ||| S:18005 E:18016 ||| IN
fibroblast  ||| S:18016 E:18027 ||| JJ
models ||| S:18027 E:18033 ||| NNS
,  ||| S:18033 E:18035 ||| ,
where  ||| S:18035 E:18041 ||| WRB
microinjection  ||| S:18041 E:18056 ||| NNS
of  ||| S:18056 E:18059 ||| IN
C3  ||| S:18059 E:18062 ||| CD
results  ||| S:18062 E:18070 ||| NNS
in  ||| S:18070 E:18081 ||| IN
fibroblast  ||| S:18081 E:18092 ||| JJ
retraction  ||| S:18092 E:18103 ||| NN
of  ||| S:18103 E:18106 ||| IN
pseudopodia ||| S:18106 E:18117 ||| NN
,  ||| S:18117 E:18119 ||| ,
with  ||| S:18119 E:18124 ||| IN
the  ||| S:18124 E:18128 ||| DT
cell  ||| S:18128 E:18133 ||| NN
body  ||| S:18133 E:18146 ||| NN
rounding  ||| S:18146 E:18155 ||| VBD
up  ||| S:18155 E:18158 ||| RP
eventually  ||| S:18158 E:18169 ||| RB
to  ||| S:18169 E:18172 ||| TO
become  ||| S:18172 E:18179 ||| VB
non-adherent  ||| S:18179 E:18192 ||| JJ
[  ||| S:18192 E:18194 ||| -LRB-
17  ||| S:18194 E:18197 ||| CD
]  ||| S:18197 E:18199 ||| -RRB-
.  ||| S:18199 E:18209 ||| .
Video  ||| S:18209 E:18215 ||| JJ
time-lapse  ||| S:18215 E:18226 ||| JJ
microscopy  ||| S:18226 E:18237 ||| NN
demonstrated  ||| S:18237 E:18250 ||| VBD
the  ||| S:18250 E:18254 ||| DT
elongation  ||| S:18254 E:18265 ||| NN
of  ||| S:18265 E:18276 ||| IN
aberrant  ||| S:18276 E:18285 ||| JJ
pseudopods  ||| S:18285 E:18296 ||| NN
in  ||| S:18296 E:18299 ||| IN
HPB-ALL  ||| S:18299 E:18307 ||| JJ
cells  ||| S:18307 E:18313 ||| NNS
plated  ||| S:18313 E:18320 ||| VBN
on  ||| S:18320 E:18323 ||| IN
the  ||| S:18323 E:18327 ||| DT
β1  ||| S:18327 E:18338 ||| CD
substrate  ||| S:18338 E:18348 ||| CD
VCAM-1 ||| S:18348 E:18354 ||| CD
,  ||| S:18354 E:18356 ||| ,
rather  ||| S:18356 E:18363 ||| RB
than  ||| S:18363 E:18368 ||| IN
an  ||| S:18368 E:18371 ||| DT
altered  ||| S:18371 E:18379 ||| JJ
retraction  ||| S:18379 E:18390 ||| NN
of  ||| S:18390 E:18401 ||| IN
already  ||| S:18401 E:18409 ||| RB
formed  ||| S:18409 E:18416 ||| VBN
pseudopods ||| S:18416 E:18426 ||| NN
.  ||| S:18426 E:18428 ||| .
These  ||| S:18428 E:18434 ||| DT
results  ||| S:18434 E:18442 ||| NNS
suggest  ||| S:18442 E:18450 ||| VBP
an  ||| S:18450 E:18453 ||| DT
altered  ||| S:18453 E:18469 ||| JJ
pseudopodial  ||| S:18469 E:18482 ||| JJ
extension  ||| S:18482 E:18492 ||| NN
although  ||| S:18492 E:18501 ||| IN
a  ||| S:18501 E:18503 ||| DT
defect  ||| S:18503 E:18510 ||| NN
in  ||| S:18510 E:18513 ||| IN
contractibility  ||| S:18513 E:18537 ||| NNS
could  ||| S:18537 E:18543 ||| MD
be  ||| S:18543 E:18546 ||| VB
involved  ||| S:18546 E:18555 ||| VBN
as  ||| S:18555 E:18558 ||| IN
a  ||| S:18558 E:18560 ||| DT
secondary  ||| S:18560 E:18570 ||| JJ
mechanism  ||| S:18570 E:18580 ||| NN
for  ||| S:18580 E:18584 ||| IN
formation  ||| S:18584 E:18594 ||| NN
of  ||| S:18594 E:18605 ||| IN
aberrant  ||| S:18605 E:18614 ||| JJ
processes ||| S:18614 E:18623 ||| NNS
.  ||| S:18623 E:18625 ||| .
This  ||| S:18625 E:18630 ||| DT
phenotype  ||| S:18630 E:18640 ||| NN
also  ||| S:18640 E:18645 ||| RB
coincided  ||| S:18645 E:18655 ||| VBN
with  ||| S:18655 E:18660 ||| IN
the  ||| S:18660 E:18672 ||| DT
complete  ||| S:18672 E:18681 ||| JJ
loss  ||| S:18681 E:18686 ||| NN
of  ||| S:18686 E:18689 ||| IN
cellular  ||| S:18689 E:18698 ||| JJ
motility  ||| S:18698 E:18707 ||| NN
in  ||| S:18707 E:18710 ||| IN
HPB-ALL ||| S:18710 E:18717 ||| NNP
,  ||| S:18717 E:18719 ||| ,
even  ||| S:18719 E:18724 ||| RB
though  ||| S:18724 E:18739 ||| RB
adhesion  ||| S:18739 E:18748 ||| VBN
to  ||| S:18748 E:18751 ||| TO
substrate  ||| S:18751 E:18761 ||| NNS
was  ||| S:18761 E:18765 ||| VBD
not  ||| S:18765 E:18769 ||| RB
noticeably  ||| S:18769 E:18780 ||| RB
altered ||| S:18780 E:18787 ||| VBN
.  ||| S:18787 E:18789 ||| .
It  ||| S:18789 E:18792 ||| PRP
is  ||| S:18792 E:18803 ||| VBZ
also  ||| S:18803 E:18808 ||| RB
important  ||| S:18808 E:18818 ||| JJ
to  ||| S:18818 E:18821 ||| TO
note  ||| S:18821 E:18826 ||| VB
that  ||| S:18826 E:18831 ||| DT
normal  ||| S:18831 E:18838 ||| JJ
and  ||| S:18838 E:18842 ||| CC
C3  ||| S:18842 E:18845 ||| CD
induced  ||| S:18845 E:18853 ||| NNS
aberrant  ||| S:18853 E:18870 ||| VBP
HPB-ALL  ||| S:18870 E:18878 ||| JJ
spreading  ||| S:18878 E:18888 ||| NN
on  ||| S:18888 E:18891 ||| IN
Fn  ||| S:18891 E:18894 ||| NNP
or  ||| S:18894 E:18897 ||| CC
VCAM-1  ||| S:18897 E:18904 ||| NNP
is  ||| S:18904 E:18907 ||| VBZ
dependent  ||| S:18907 E:18917 ||| JJ
on  ||| S:18917 E:18920 ||| IN
signals  ||| S:18920 E:18936 ||| NNS
generated  ||| S:18936 E:18946 ||| VBN
through  ||| S:18946 E:18954 ||| IN
β1  ||| S:18954 E:18957 ||| CD
integrins ||| S:18957 E:18966 ||| NN
,  ||| S:18966 E:18968 ||| ,
as  ||| S:18968 E:18971 ||| IN
both  ||| S:18971 E:18976 ||| DT
morphologies  ||| S:18976 E:18989 ||| NN
could  ||| S:18989 E:19003 ||| MD
be  ||| S:19003 E:19006 ||| VB
seen  ||| S:19006 E:19011 ||| VBN
when  ||| S:19011 E:19016 ||| WRB
untreated  ||| S:19016 E:19026 ||| NNS
or  ||| S:19026 E:19029 ||| CC
C3  ||| S:19029 E:19032 ||| NNP
treated  ||| S:19032 E:19040 ||| VBD
HPB-ALL  ||| S:19040 E:19048 ||| NNP
were  ||| S:19048 E:19053 ||| VBD
plated  ||| S:19053 E:19060 ||| VBN
on  ||| S:19060 E:19071 ||| IN
the  ||| S:19071 E:19075 ||| DT
β1  ||| S:19075 E:19078 ||| JJ
specific  ||| S:19078 E:19087 ||| JJ
mAb  ||| S:19087 E:19091 ||| JJ
33B6 ||| S:19091 E:19095 ||| NN
.  ||| S:19095 E:19097 ||| .
When  ||| S:19097 E:19102 ||| WRB
these  ||| S:19102 E:19108 ||| DT
same  ||| S:19108 E:19113 ||| JJ
cells  ||| S:19113 E:19119 ||| NNS
are  ||| S:19119 E:19123 ||| VBP
plated  ||| S:19123 E:19138 ||| VBN
on  ||| S:19138 E:19141 ||| IN
the  ||| S:19141 E:19145 ||| DT
non-specific  ||| S:19145 E:19158 ||| JJ
cell  ||| S:19158 E:19163 ||| NN
attachment  ||| S:19163 E:19174 ||| NN
factor  ||| S:19174 E:19181 ||| NN
poly-L-lysine ||| S:19181 E:19194 ||| NN
,  ||| S:19194 E:19204 ||| ,
cells  ||| S:19204 E:19210 ||| NNS
remain  ||| S:19210 E:19217 ||| VBP
round  ||| S:19217 E:19223 ||| NN
and  ||| S:19223 E:19227 ||| CC
no  ||| S:19227 E:19230 ||| DT
spreading  ||| S:19230 E:19240 ||| NN
occurs ||| S:19240 E:19246 ||| VBZ
.  ||| S:19246 E:19248 ||| .
The  ||| S:19248 E:19252 ||| DT
elongated  ||| S:19252 E:19270 ||| JJ
dendritic-like  ||| S:19270 E:19285 ||| JJ
processes  ||| S:19285 E:19295 ||| NNS
in  ||| S:19295 E:19298 ||| IN
C3  ||| S:19298 E:19301 ||| NNP
treated  ||| S:19301 E:19309 ||| VBD
HPB-ALL  ||| S:19309 E:19317 ||| JJ
cells  ||| S:19317 E:19323 ||| NNS
were  ||| S:19323 E:19336 ||| VBD
F-actin  ||| S:19336 E:19344 ||| JJ
rich ||| S:19344 E:19348 ||| JJ
.  ||| S:19348 E:19350 ||| .
This  ||| S:19350 E:19355 ||| DT
phenotype  ||| S:19355 E:19365 ||| NN
caused  ||| S:19365 E:19372 ||| VBN
by  ||| S:19372 E:19375 ||| IN
inactivation  ||| S:19375 E:19388 ||| NN
of  ||| S:19388 E:19391 ||| IN
Rho  ||| S:19391 E:19403 ||| NNP
is  ||| S:19403 E:19406 ||| VBZ
the  ||| S:19406 E:19410 ||| DT
first  ||| S:19410 E:19416 ||| JJ
to  ||| S:19416 E:19419 ||| TO
be  ||| S:19419 E:19422 ||| VB
described  ||| S:19422 E:19432 ||| VBN
in  ||| S:19432 E:19435 ||| IN
T  ||| S:19435 E:19437 ||| NN
lymphocytes ||| S:19437 E:19448 ||| NN
,  ||| S:19448 E:19450 ||| ,
however ||| S:19450 E:19457 ||| RB
,  ||| S:19457 E:19459 ||| ,
Rho  ||| S:19459 E:19471 ||| NNP
regulation  ||| S:19471 E:19482 ||| NN
of  ||| S:19482 E:19485 ||| IN
the  ||| S:19485 E:19489 ||| DT
actin  ||| S:19489 E:19495 ||| JJ
cytoskeleton  ||| S:19495 E:19508 ||| NN
is  ||| S:19508 E:19511 ||| VBZ
not  ||| S:19511 E:19515 ||| RB
novel  ||| S:19515 E:19521 ||| NN
among  ||| S:19521 E:19535 ||| IN
cells  ||| S:19535 E:19541 ||| NNS
of  ||| S:19541 E:19544 ||| IN
the  ||| S:19544 E:19548 ||| DT
hematopoietic  ||| S:19548 E:19562 ||| JJ
lineage ||| S:19562 E:19569 ||| NN
.  ||| S:19569 E:19571 ||| .
ADP-ribosylation  ||| S:19571 E:19588 ||| JJ
of  ||| S:19588 E:19591 ||| IN
Rho  ||| S:19591 E:19603 ||| NNP
proteins  ||| S:19603 E:19612 ||| NNS
in  ||| S:19612 E:19615 ||| IN
chemoattractant  ||| S:19615 E:19631 ||| FW
stimulated  ||| S:19631 E:19642 ||| FW
neutrophils  ||| S:19642 E:19654 ||| FW
[  ||| S:19654 E:19656 ||| -LRB-
20  ||| S:19656 E:19659 ||| CD
21  ||| S:19659 E:19670 ||| CD
]  ||| S:19670 E:19672 ||| -RRB-
and  ||| S:19672 E:19676 ||| CC
in  ||| S:19676 E:19679 ||| IN
both  ||| S:19679 E:19684 ||| DT
monocytic  ||| S:19684 E:19694 ||| JJ
lines  ||| S:19694 E:19700 ||| NNS
and  ||| S:19700 E:19704 ||| CC
fresh  ||| S:19704 E:19710 ||| JJ
blood  ||| S:19710 E:19716 ||| NN
monocytes  ||| S:19716 E:19726 ||| NNS
[  ||| S:19726 E:19736 ||| -LRB-
22  ||| S:19736 E:19739 ||| CD
38  ||| S:19739 E:19742 ||| CD
]  ||| S:19742 E:19744 ||| -RRB-
results  ||| S:19744 E:19752 ||| NNS
in  ||| S:19752 E:19755 ||| IN
actin  ||| S:19755 E:19761 ||| JJ
filament  ||| S:19761 E:19770 ||| JJ
polymerization ||| S:19770 E:19784 ||| NN
.  ||| S:19784 E:19786 ||| .
Although  ||| S:19786 E:19803 ||| IN
this  ||| S:19803 E:19808 ||| DT
once  ||| S:19808 E:19813 ||| RB
again  ||| S:19813 E:19819 ||| RB
highlights  ||| S:19819 E:19830 ||| JJ
differences  ||| S:19830 E:19842 ||| NNS
between  ||| S:19842 E:19850 ||| IN
the  ||| S:19850 E:19854 ||| DT
affects  ||| S:19854 E:19870 ||| NN
of  ||| S:19870 E:19873 ||| IN
C3  ||| S:19873 E:19876 ||| CD
in  ||| S:19876 E:19879 ||| IN
fibroblasts  ||| S:19879 E:19891 ||| NN
and  ||| S:19891 E:19895 ||| CC
leukocytes ||| S:19895 E:19905 ||| NN
,  ||| S:19905 E:19907 ||| ,
there  ||| S:19907 E:19913 ||| EX
may  ||| S:19913 E:19917 ||| MD
be  ||| S:19917 E:19928 ||| VB
commonalties  ||| S:19928 E:19941 ||| JJ
amongst  ||| S:19941 E:19949 ||| JJ
cells  ||| S:19949 E:19955 ||| NNS
that  ||| S:19955 E:19960 ||| WDT
do  ||| S:19960 E:19963 ||| VBP
not  ||| S:19963 E:19967 ||| RB
form  ||| S:19967 E:19972 ||| VB
distinct  ||| S:19972 E:19981 ||| JJ
actin  ||| S:19981 E:19995 ||| JJ
stress  ||| S:19995 E:20002 ||| NN
fibers ||| S:20002 E:20008 ||| NNS
,  ||| S:20008 E:20010 ||| ,
such  ||| S:20010 E:20015 ||| JJ
as  ||| S:20015 E:20018 ||| IN
leukocytes  ||| S:20018 E:20029 ||| NN
and  ||| S:20029 E:20033 ||| CC
neuronal  ||| S:20033 E:20042 ||| JJ
cells ||| S:20042 E:20047 ||| NNS
.  ||| S:20047 E:20057 ||| .
ADP-ribosylation  ||| S:20057 E:20074 ||| JJ
of  ||| S:20074 E:20077 ||| IN
Rho  ||| S:20077 E:20081 ||| NNP
proteins  ||| S:20081 E:20090 ||| NNS
by  ||| S:20090 E:20093 ||| IN
C3  ||| S:20093 E:20096 ||| CD
exoenzyme  ||| S:20096 E:20106 ||| NN
prevents  ||| S:20106 E:20123 ||| VBZ
neurite  ||| S:20123 E:20131 ||| JJ
retraction  ||| S:20131 E:20142 ||| NN
in  ||| S:20142 E:20145 ||| IN
the  ||| S:20145 E:20149 ||| DT
specialized  ||| S:20149 E:20161 ||| JJ
growth  ||| S:20161 E:20168 ||| NN
cone  ||| S:20168 E:20173 ||| NN
of  ||| S:20173 E:20184 ||| IN
developing  ||| S:20184 E:20195 ||| VBG
neurons ||| S:20195 E:20202 ||| NN
,  ||| S:20202 E:20204 ||| ,
and  ||| S:20204 E:20208 ||| CC
in  ||| S:20208 E:20211 ||| IN
fact  ||| S:20211 E:20216 ||| NN
promotes  ||| S:20216 E:20225 ||| VBZ
neurite  ||| S:20225 E:20233 ||| JJ
outgrowth  ||| S:20233 E:20251 ||| NN
in  ||| S:20251 E:20254 ||| IN
the  ||| S:20254 E:20258 ||| DT
same  ||| S:20258 E:20263 ||| JJ
fashion  ||| S:20263 E:20271 ||| NN
as  ||| S:20271 E:20274 ||| IN
microinjection  ||| S:20274 E:20289 ||| NN
of  ||| S:20289 E:20292 ||| IN
purified  ||| S:20292 E:20301 ||| JJ
dominant  ||| S:20301 E:20318 ||| JJ
negative  ||| S:20318 E:20327 ||| JJ
RhoA  ||| S:20327 E:20332 ||| JJ
T19N  ||| S:20332 E:20337 ||| NNP
[  ||| S:20337 E:20339 ||| -LRB-
39  ||| S:20339 E:20342 ||| CD
]  ||| S:20342 E:20344 ||| -RRB-
.  ||| S:20344 E:20346 ||| .
In  ||| S:20346 E:20349 ||| IN
these  ||| S:20349 E:20355 ||| DT
instances ||| S:20355 E:20364 ||| NNS
,  ||| S:20364 E:20366 ||| ,
neuronal  ||| S:20366 E:20383 ||| FW
N1E-115  ||| S:20383 E:20391 ||| FW
cell  ||| S:20391 E:20396 ||| FW
outgrowth  ||| S:20396 E:20406 ||| FW
induced  ||| S:20406 E:20414 ||| FW
by  ||| S:20414 E:20417 ||| IN
inactivation  ||| S:20417 E:20430 ||| NN
of  ||| S:20430 E:20433 ||| IN
RhoA  ||| S:20433 E:20438 ||| NNP
was  ||| S:20438 E:20450 ||| VBD
mimicked  ||| S:20450 E:20459 ||| VBN
by  ||| S:20459 E:20462 ||| IN
microinjection  ||| S:20462 E:20477 ||| NN
of  ||| S:20477 E:20480 ||| IN
Rac1-  ||| S:20480 E:20486 ||| NNP
or  ||| S:20486 E:20489 ||| CC
Cdc42-GST  ||| S:20489 E:20499 ||| CD
fusion  ||| S:20499 E:20514 ||| NN
proteins ||| S:20514 E:20522 ||| NNS
,  ||| S:20522 E:20524 ||| ,
and  ||| S:20524 E:20528 ||| CC
could  ||| S:20528 E:20534 ||| MD
be  ||| S:20534 E:20537 ||| VB
abolished  ||| S:20537 E:20547 ||| VBN
by  ||| S:20547 E:20550 ||| IN
coinjection  ||| S:20550 E:20562 ||| NN
of  ||| S:20562 E:20565 ||| IN
dominant  ||| S:20565 E:20582 ||| JJ
negative  ||| S:20582 E:20591 ||| JJ
Cdc42  ||| S:20591 E:20597 ||| CD
T17Nor  ||| S:20597 E:20604 ||| CD
Rac1  ||| S:20604 E:20609 ||| CD
T17N  ||| S:20609 E:20614 ||| CD
[  ||| S:20614 E:20616 ||| -LRB-
39  ||| S:20616 E:20619 ||| CD
]  ||| S:20619 E:20621 ||| -RRB-
.  ||| S:20621 E:20623 ||| .
From  ||| S:20623 E:20628 ||| IN
these  ||| S:20628 E:20642 ||| DT
results ||| S:20642 E:20649 ||| NNS
,  ||| S:20649 E:20651 ||| ,
the  ||| S:20651 E:20655 ||| DT
authors  ||| S:20655 E:20663 ||| NNS
concluded  ||| S:20663 E:20673 ||| VBD
that  ||| S:20673 E:20678 ||| DT
inactivation  ||| S:20678 E:20691 ||| NN
of  ||| S:20691 E:20694 ||| IN
RhoA  ||| S:20694 E:20699 ||| JJ
by  ||| S:20699 E:20710 ||| IN
C3  ||| S:20710 E:20713 ||| CD
exoenzyme  ||| S:20713 E:20723 ||| JJ
treatment  ||| S:20723 E:20733 ||| NN
resulted  ||| S:20733 E:20742 ||| VBD
in  ||| S:20742 E:20745 ||| IN
the  ||| S:20745 E:20749 ||| DT
activation  ||| S:20749 E:20760 ||| NN
of  ||| S:20760 E:20763 ||| IN
Rac1  ||| S:20763 E:20776 ||| NNP
and  ||| S:20776 E:20780 ||| CC
Cdc42  ||| S:20780 E:20786 ||| NNP
GTPases ||| S:20786 E:20793 ||| NNP
,  ||| S:20793 E:20795 ||| ,
suggesting  ||| S:20795 E:20806 ||| VBG
the  ||| S:20806 E:20810 ||| DT
mutually  ||| S:20810 E:20819 ||| JJ
exclusive  ||| S:20819 E:20837 ||| JJ
function  ||| S:20837 E:20846 ||| NN
of  ||| S:20846 E:20849 ||| IN
RhoA  ||| S:20849 E:20854 ||| JJ
and  ||| S:20854 E:20858 ||| CC
Rac1 ||| S:20858 E:20862 ||| CD
/ ||| S:20862 E:20863 ||| CD
Cdc42 ||| S:20863 E:20868 ||| CD
.  ||| S:20868 E:20870 ||| .
Cdc42  ||| S:20870 E:20876 ||| NNP
has  ||| S:20876 E:20880 ||| VBZ
been  ||| S:20880 E:20885 ||| VBN
implicated  ||| S:20885 E:20904 ||| VBN
in  ||| S:20904 E:20907 ||| IN
the  ||| S:20907 E:20911 ||| DT
formation  ||| S:20911 E:20921 ||| NN
of  ||| S:20921 E:20924 ||| IN
small ||| S:20924 E:20929 ||| JJ
,  ||| S:20929 E:20931 ||| ,
actin-rich  ||| S:20931 E:20942 ||| JJ
filopodia  ||| S:20942 E:20952 ||| NNS
[  ||| S:20952 E:20954 ||| -LRB-
34  ||| S:20954 E:20957 ||| CD
]  ||| S:20957 E:20959 ||| -RRB-
,  ||| S:20959 E:20969 ||| ,
which  ||| S:20969 E:20975 ||| WDT
are  ||| S:20975 E:20979 ||| VBP
similar  ||| S:20979 E:20987 ||| JJ
to  ||| S:20987 E:20990 ||| TO
those  ||| S:20990 E:20996 ||| DT
seen  ||| S:20996 E:21001 ||| VBN
on  ||| S:21001 E:21004 ||| IN
spread  ||| S:21004 E:21011 ||| NN
HPB-ALL  ||| S:21011 E:21019 ||| JJ
cells  ||| S:21019 E:21033 ||| NNS
( ||| S:21033 E:21034 ||| -LRB-
figure  ||| S:21034 E:21041 ||| NN
5 ||| S:21041 E:21042 ||| CD
)  ||| S:21042 E:21044 ||| -RRB-
around  ||| S:21044 E:21051 ||| IN
the  ||| S:21051 E:21055 ||| DT
periphery  ||| S:21055 E:21065 ||| NN
of  ||| S:21065 E:21068 ||| IN
the  ||| S:21068 E:21072 ||| DT
cell  ||| S:21072 E:21077 ||| NN
body  ||| S:21077 E:21082 ||| NN
and  ||| S:21082 E:21094 ||| CC
extended  ||| S:21094 E:21103 ||| JJ
pseudopods ||| S:21103 E:21113 ||| NN
.  ||| S:21113 E:21115 ||| .
After  ||| S:21115 E:21121 ||| IN
C3  ||| S:21121 E:21124 ||| CD
electroporation ||| S:21124 E:21139 ||| NN
,  ||| S:21139 E:21141 ||| ,
HPB-ALL  ||| S:21141 E:21149 ||| NNP
were  ||| S:21149 E:21162 ||| VBD
allowed  ||| S:21162 E:21170 ||| VBN
to  ||| S:21170 E:21173 ||| TO
spread  ||| S:21173 E:21180 ||| VB
on  ||| S:21180 E:21183 ||| IN
VCAM-1  ||| S:21183 E:21190 ||| CD
for  ||| S:21190 E:21194 ||| IN
1  ||| S:21194 E:21196 ||| CD
hour ||| S:21196 E:21200 ||| NN
,  ||| S:21200 E:21202 ||| ,
and  ||| S:21202 E:21214 ||| CC
TRITC-phalloidin  ||| S:21214 E:21231 ||| JJ
staining  ||| S:21231 E:21240 ||| NN
demonstrated  ||| S:21240 E:21253 ||| VBD
the  ||| S:21253 E:21257 ||| DT
complete  ||| S:21257 E:21266 ||| JJ
absence  ||| S:21266 E:21282 ||| NN
of  ||| S:21282 E:21285 ||| IN
fine  ||| S:21285 E:21290 ||| JJ
filopodial  ||| S:21290 E:21301 ||| JJ
structures ||| S:21301 E:21311 ||| NNS
.  ||| S:21311 E:21313 ||| .
Given  ||| S:21313 E:21319 ||| VBN
the  ||| S:21319 E:21323 ||| DT
morphologic  ||| S:21323 E:21343 ||| JJ
similarity  ||| S:21343 E:21354 ||| NN
between  ||| S:21354 E:21362 ||| IN
neurite  ||| S:21362 E:21370 ||| JJ
outgrowth  ||| S:21370 E:21380 ||| NN
of  ||| S:21380 E:21383 ||| IN
N1E-115  ||| S:21383 E:21391 ||| CD
cells  ||| S:21391 E:21397 ||| NNS
and  ||| S:21397 E:21409 ||| CC
the  ||| S:21409 E:21413 ||| DT
aberrant  ||| S:21413 E:21422 ||| JJ
pseudopodial  ||| S:21422 E:21435 ||| JJ
extension  ||| S:21435 E:21445 ||| NN
of  ||| S:21445 E:21448 ||| IN
HPB-ALL  ||| S:21448 E:21456 ||| JJ
when  ||| S:21456 E:21461 ||| WRB
RhoA  ||| S:21461 E:21466 ||| NNP
is  ||| S:21466 E:21477 ||| VBZ
inhibited  ||| S:21477 E:21487 ||| VBN
with  ||| S:21487 E:21492 ||| IN
C3  ||| S:21492 E:21495 ||| CD
exoenzyme ||| S:21495 E:21504 ||| NN
,  ||| S:21504 E:21506 ||| ,
it  ||| S:21506 E:21509 ||| PRP
will  ||| S:21509 E:21514 ||| MD
be  ||| S:21514 E:21517 ||| VB
interesting  ||| S:21517 E:21529 ||| JJ
to  ||| S:21529 E:21540 ||| TO
determine  ||| S:21540 E:21550 ||| VB
if  ||| S:21550 E:21553 ||| IN
other  ||| S:21553 E:21559 ||| JJ
GTPases  ||| S:21559 E:21567 ||| JJ
such  ||| S:21567 E:21572 ||| JJ
as  ||| S:21572 E:21575 ||| IN
Rac  ||| S:21575 E:21579 ||| NNP
or  ||| S:21579 E:21582 ||| CC
Cdc42  ||| S:21582 E:21588 ||| NNP
are  ||| S:21588 E:21600 ||| VBP
activated  ||| S:21600 E:21610 ||| VBN
to  ||| S:21610 E:21613 ||| TO
promote  ||| S:21613 E:21621 ||| VB
this  ||| S:21621 E:21626 ||| DT
phenotype  ||| S:21626 E:21636 ||| NN
after  ||| S:21636 E:21642 ||| IN
C3  ||| S:21642 E:21645 ||| CD
treatment  ||| S:21645 E:21655 ||| NN
of  ||| S:21655 E:21666 ||| IN
HPB-ALL  ||| S:21666 E:21674 ||| JJ
cells ||| S:21674 E:21679 ||| NNS
.  ||| S:21679 E:21681 ||| .
The  ||| S:21681 E:21685 ||| DT
thick  ||| S:21685 E:21691 ||| JJ
actin  ||| S:21691 E:21697 ||| JJ
rich  ||| S:21697 E:21702 ||| JJ
stellate  ||| S:21702 E:21711 ||| JJ
projections  ||| S:21711 E:21731 ||| NNS
emanating  ||| S:21731 E:21741 ||| VBN
from  ||| S:21741 E:21746 ||| IN
the  ||| S:21746 E:21750 ||| DT
cell  ||| S:21750 E:21755 ||| NN
body  ||| S:21755 E:21760 ||| NN
of  ||| S:21760 E:21763 ||| IN
C3  ||| S:21763 E:21766 ||| CD
electroporated  ||| S:21766 E:21781 ||| JJ
HPB-ALL  ||| S:21781 E:21797 ||| NN
may  ||| S:21797 E:21801 ||| MD
be  ||| S:21801 E:21804 ||| VB
the  ||| S:21804 E:21808 ||| DT
result  ||| S:21808 E:21815 ||| NN
of  ||| S:21815 E:21818 ||| IN
condensation  ||| S:21818 E:21831 ||| NN
of  ||| S:21831 E:21834 ||| IN
filopodia ||| S:21834 E:21843 ||| NN
,  ||| S:21843 E:21845 ||| ,
where  ||| S:21845 E:21851 ||| WRB
Cdc42  ||| S:21851 E:21865 ||| NNP
may  ||| S:21865 E:21869 ||| MD
be  ||| S:21869 E:21872 ||| VB
induced  ||| S:21872 E:21880 ||| VBN
into  ||| S:21880 E:21885 ||| IN
a  ||| S:21885 E:21887 ||| DT
highly  ||| S:21887 E:21894 ||| RB
active  ||| S:21894 E:21901 ||| JJ
state ||| S:21901 E:21906 ||| NN
.  ||| S:21906 E:21908 ||| .
Actin  ||| S:21908 E:21914 ||| JJ
filament  ||| S:21914 E:21931 ||| JJ
elongation  ||| S:21931 E:21942 ||| NN
would  ||| S:21942 E:21948 ||| MD
continue  ||| S:21948 E:21957 ||| VB
and  ||| S:21957 E:21961 ||| CC
RhoA  ||| S:21961 E:21966 ||| JJ
dependent  ||| S:21966 E:21976 ||| JJ
retraction  ||| S:21976 E:21987 ||| NN
of  ||| S:21987 E:21998 ||| IN
filamentous  ||| S:21998 E:22010 ||| JJ
actin  ||| S:22010 E:22016 ||| NN
would  ||| S:22016 E:22022 ||| MD
be  ||| S:22022 E:22025 ||| VB
abrogated ||| S:22025 E:22034 ||| NNS
.  ||| S:22034 E:22036 ||| .
This  ||| S:22036 E:22041 ||| DT
could  ||| S:22041 E:22047 ||| MD
occur  ||| S:22047 E:22053 ||| VB
by  ||| S:22053 E:22064 ||| IN
the  ||| S:22064 E:22068 ||| DT
release  ||| S:22068 E:22076 ||| NN
of  ||| S:22076 E:22079 ||| IN
limited  ||| S:22079 E:22087 ||| JJ
effector  ||| S:22087 E:22096 ||| NNS
molecules  ||| S:22096 E:22106 ||| VBP
shared  ||| S:22106 E:22113 ||| VBN
between  ||| S:22113 E:22129 ||| IN
the  ||| S:22129 E:22133 ||| DT
two  ||| S:22133 E:22137 ||| CD
GTPases ||| S:22137 E:22144 ||| NN
,  ||| S:22144 E:22146 ||| ,
possibilities  ||| S:22146 E:22160 ||| NNS
that  ||| S:22160 E:22165 ||| WDT
are  ||| S:22165 E:22169 ||| VBP
currently  ||| S:22169 E:22179 ||| RB
under  ||| S:22179 E:22193 ||| IN
investigation ||| S:22193 E:22206 ||| NN
.  ||| S:22206 E:22216 ||| .
The  ||| S:22216 E:22220 ||| DT
immunolocalization  ||| S:22220 E:22239 ||| NN
of  ||| S:22239 E:22242 ||| IN
RhoA  ||| S:22242 E:22247 ||| JJ
in  ||| S:22247 E:22250 ||| IN
normal  ||| S:22250 E:22257 ||| JJ
and  ||| S:22257 E:22261 ||| CC
C3  ||| S:22261 E:22264 ||| CD
treated  ||| S:22264 E:22280 ||| CD
cells  ||| S:22280 E:22286 ||| NNS
did  ||| S:22286 E:22290 ||| VBD
not  ||| S:22290 E:22294 ||| RB
appear  ||| S:22294 E:22301 ||| VBP
drastically  ||| S:22301 E:22313 ||| RB
different  ||| S:22313 E:22323 ||| JJ
in  ||| S:22323 E:22326 ||| IN
that  ||| S:22326 E:22331 ||| DT
RhoA  ||| S:22331 E:22336 ||| NN
was  ||| S:22336 E:22348 ||| VBD
apparent  ||| S:22348 E:22357 ||| JJ
in  ||| S:22357 E:22360 ||| IN
both  ||| S:22360 E:22365 ||| DT
normal  ||| S:22365 E:22372 ||| JJ
and  ||| S:22372 E:22376 ||| CC
aberrant  ||| S:22376 E:22385 ||| JJ
pseudopodial  ||| S:22385 E:22406 ||| JJ
extensions ||| S:22406 E:22416 ||| NNS
.  ||| S:22416 E:22418 ||| .
The  ||| S:22418 E:22422 ||| DT
notable  ||| S:22422 E:22430 ||| JJ
exception  ||| S:22430 E:22440 ||| NN
was  ||| S:22440 E:22444 ||| VBD
that  ||| S:22444 E:22449 ||| DT
clusters  ||| S:22449 E:22458 ||| NN
of  ||| S:22458 E:22461 ||| IN
RhoA  ||| S:22461 E:22474 ||| NNP
appeared  ||| S:22474 E:22483 ||| VBD
less  ||| S:22483 E:22488 ||| JJR
diffuse  ||| S:22488 E:22496 ||| NN
in  ||| S:22496 E:22499 ||| IN
the  ||| S:22499 E:22503 ||| DT
altered  ||| S:22503 E:22511 ||| JJ
pseudopods  ||| S:22511 E:22522 ||| NN
of  ||| S:22522 E:22525 ||| IN
C3  ||| S:22525 E:22536 ||| CD
treated  ||| S:22536 E:22544 ||| CD
cells  ||| S:22544 E:22550 ||| NNS
( ||| S:22550 E:22551 ||| -LRB-
figure  ||| S:22551 E:22558 ||| NN
6 ||| S:22558 E:22559 ||| CD
) ||| S:22559 E:22560 ||| -RRB-
.  ||| S:22560 E:22562 ||| .
Although  ||| S:22562 E:22571 ||| IN
ADP-ribosylation  ||| S:22571 E:22588 ||| JJ
of  ||| S:22588 E:22591 ||| IN
Rho  ||| S:22591 E:22603 ||| NNP
does  ||| S:22603 E:22608 ||| VBZ
not  ||| S:22608 E:22612 ||| RB
significantly  ||| S:22612 E:22626 ||| RB
alter  ||| S:22626 E:22632 ||| VB
the  ||| S:22632 E:22636 ||| DT
subcellular  ||| S:22636 E:22648 ||| JJ
distribution  ||| S:22648 E:22669 ||| NN
of  ||| S:22669 E:22672 ||| IN
RhoA ||| S:22672 E:22676 ||| NNP
,  ||| S:22676 E:22678 ||| ,
Rho  ||| S:22678 E:22682 ||| NNP
activity  ||| S:22682 E:22691 ||| NN
is  ||| S:22691 E:22694 ||| VBZ
inhibited ||| S:22694 E:22703 ||| VBN
.  ||| S:22703 E:22705 ||| .
This  ||| S:22705 E:22710 ||| DT
is  ||| S:22710 E:22713 ||| VBZ
thought  ||| S:22713 E:22721 ||| VBN
to  ||| S:22721 E:22732 ||| TO
prevent  ||| S:22732 E:22740 ||| VB
activation  ||| S:22740 E:22751 ||| VBN
of  ||| S:22751 E:22754 ||| IN
downstream  ||| S:22754 E:22765 ||| JJ
Rho  ||| S:22765 E:22769 ||| NNP
targets  ||| S:22769 E:22777 ||| VBZ
required  ||| S:22777 E:22786 ||| VBN
for  ||| S:22786 E:22798 ||| IN
normal  ||| S:22798 E:22805 ||| JJ
integrin  ||| S:22805 E:22814 ||| JJ
dependent  ||| S:22814 E:22824 ||| JJ
morphological  ||| S:22824 E:22838 ||| JJ
changes ||| S:22838 E:22845 ||| NNS
.  ||| S:22845 E:22847 ||| .
A  ||| S:22847 E:22849 ||| DT
number  ||| S:22849 E:22864 ||| NN
of  ||| S:22864 E:22867 ||| IN
potential  ||| S:22867 E:22877 ||| JJ
downstream  ||| S:22877 E:22888 ||| JJ
Rho  ||| S:22888 E:22892 ||| JJ
effector  ||| S:22892 E:22901 ||| JJ
molecules  ||| S:22901 E:22911 ||| NNS
have  ||| S:22911 E:22916 ||| VBP
been  ||| S:22916 E:22929 ||| VBN
identified  ||| S:22929 E:22940 ||| VBN
recently ||| S:22940 E:22948 ||| RB
.  ||| S:22948 E:22950 ||| .
These  ||| S:22950 E:22956 ||| DT
include  ||| S:22956 E:22964 ||| VBP
p150  ||| S:22964 E:22969 ||| RB
RhoA-binding  ||| S:22969 E:22982 ||| JJ
kinase  ||| S:22982 E:22997 ||| JJ
α  ||| S:22997 E:22999 ||| NN
and  ||| S:22999 E:23003 ||| CC
β  ||| S:23003 E:23005 ||| NNS
( ||| S:23005 E:23006 ||| -LRB-
p150  ||| S:23006 E:23011 ||| NNP
ROKα  ||| S:23011 E:23016 ||| NNP
and  ||| S:23016 E:23020 ||| CC
β ||| S:23020 E:23021 ||| CD
)  ||| S:23021 E:23023 ||| -RRB-
[  ||| S:23023 E:23025 ||| -LRB-
40  ||| S:23025 E:23028 ||| CD
41  ||| S:23028 E:23031 ||| CD
]  ||| S:23031 E:23033 ||| -RRB-
,  ||| S:23033 E:23035 ||| ,
p160  ||| S:23035 E:23040 ||| FW
Rho-associated  ||| S:23040 E:23063 ||| FW
coiled-coil  ||| S:23063 E:23075 ||| FW
containing  ||| S:23075 E:23086 ||| FW
protein  ||| S:23086 E:23094 ||| FW
kinase  ||| S:23094 E:23101 ||| FW
( ||| S:23101 E:23102 ||| -LRB-
Rho-p160ROCK ||| S:23102 E:23114 ||| NNP
)  ||| S:23114 E:23116 ||| -RRB-
[  ||| S:23116 E:23118 ||| -LRB-
42  ||| S:23118 E:23121 ||| CD
]  ||| S:23121 E:23131 ||| -RRB-
,  ||| S:23131 E:23133 ||| ,
p164  ||| S:23133 E:23138 ||| FW
Rho  ||| S:23138 E:23142 ||| FW
kinase  ||| S:23142 E:23149 ||| FW
[  ||| S:23149 E:23151 ||| -LRB-
43  ||| S:23151 E:23154 ||| CD
]  ||| S:23154 E:23156 ||| -RRB-
,  ||| S:23156 E:23158 ||| ,
p120  ||| S:23158 E:23163 ||| FW
protein  ||| S:23163 E:23171 ||| FW
kinase  ||| S:23171 E:23178 ||| FW
N  ||| S:23178 E:23180 ||| NNP
( ||| S:23180 E:23181 ||| -LRB-
p120  ||| S:23181 E:23186 ||| NNP
PKN ||| S:23186 E:23189 ||| NNP
)  ||| S:23189 E:23199 ||| -RRB-
[  ||| S:23199 E:23201 ||| -LRB-
44  ||| S:23201 E:23204 ||| CD
45  ||| S:23204 E:23207 ||| CD
]  ||| S:23207 E:23209 ||| -RRB-
,  ||| S:23209 E:23211 ||| ,
and  ||| S:23211 E:23215 ||| CC
PKC-related  ||| S:23215 E:23227 ||| NNP
kinase-2  ||| S:23227 E:23236 ||| NNP
( ||| S:23236 E:23237 ||| -LRB-
PRK-2 ||| S:23237 E:23242 ||| NNP
)  ||| S:23242 E:23244 ||| -RRB-
[  ||| S:23244 E:23246 ||| -LRB-
46  ||| S:23246 E:23249 ||| CD
]  ||| S:23249 E:23251 ||| -RRB-
.  ||| S:23251 E:23253 ||| .
These  ||| S:23253 E:23267 ||| DT
kinases  ||| S:23267 E:23275 ||| NN
specifically  ||| S:23275 E:23288 ||| RB
bind  ||| S:23288 E:23293 ||| VBN
to  ||| S:23293 E:23296 ||| TO
the  ||| S:23296 E:23300 ||| DT
GTP  ||| S:23300 E:23304 ||| NNP
bound  ||| S:23304 E:23310 ||| JJ
form  ||| S:23310 E:23315 ||| NN
of  ||| S:23315 E:23318 ||| IN
Rho ||| S:23318 E:23321 ||| NNP
,  ||| S:23321 E:23331 ||| ,
except  ||| S:23331 E:23338 ||| IN
for  ||| S:23338 E:23342 ||| IN
PRK-2 ||| S:23342 E:23347 ||| NNP
,  ||| S:23347 E:23349 ||| ,
which  ||| S:23349 E:23355 ||| WDT
can  ||| S:23355 E:23359 ||| MD
bind  ||| S:23359 E:23364 ||| VB
both  ||| S:23364 E:23369 ||| DT
Rho  ||| S:23369 E:23373 ||| NNP
and  ||| S:23373 E:23377 ||| CC
Rac  ||| S:23377 E:23381 ||| NNP
GTPases ||| S:23381 E:23388 ||| NNP
.  ||| S:23388 E:23398 ||| .
Interestingly ||| S:23398 E:23411 ||| RB
,  ||| S:23411 E:23413 ||| ,
inhibition  ||| S:23413 E:23424 ||| VBG
of  ||| S:23424 E:23427 ||| IN
Rho-p160ROCK  ||| S:23427 E:23440 ||| NNP
has  ||| S:23440 E:23444 ||| VBZ
recently  ||| S:23444 E:23453 ||| RB
been  ||| S:23453 E:23466 ||| VBN
shown  ||| S:23466 E:23472 ||| VBN
to  ||| S:23472 E:23475 ||| TO
give  ||| S:23475 E:23480 ||| VB
similar  ||| S:23480 E:23488 ||| JJ
lymphocyte  ||| S:23488 E:23499 ||| JJ
morphology  ||| S:23499 E:23510 ||| NN
as  ||| S:23510 E:23513 ||| IN
inhibition  ||| S:23513 E:23532 ||| NN
of  ||| S:23532 E:23535 ||| IN
Rho  ||| S:23535 E:23539 ||| NNP
with  ||| S:23539 E:23544 ||| IN
C3  ||| S:23544 E:23547 ||| NNP
[  ||| S:23547 E:23549 ||| -LRB-
50  ||| S:23549 E:23552 ||| CD
]  ||| S:23552 E:23554 ||| -RRB-
.  ||| S:23554 E:23556 ||| .
Another  ||| S:23556 E:23564 ||| DT
interesting  ||| S:23564 E:23576 ||| JJ
candidate  ||| S:23576 E:23586 ||| NN
may  ||| S:23586 E:23598 ||| MD
be  ||| S:23598 E:23601 ||| VB
p120  ||| S:23601 E:23606 ||| NNP
PKN ||| S:23606 E:23609 ||| NNP
,  ||| S:23609 E:23611 ||| ,
as  ||| S:23611 E:23614 ||| IN
recent  ||| S:23614 E:23621 ||| JJ
studies  ||| S:23621 E:23629 ||| NNS
have  ||| S:23629 E:23634 ||| VBP
established  ||| S:23634 E:23646 ||| VBN
that  ||| S:23646 E:23651 ||| IN
PKN  ||| S:23651 E:23663 ||| NNP
phosphorylates  ||| S:23663 E:23678 ||| FW
cytoskeletal  ||| S:23678 E:23691 ||| FW
intermediate  ||| S:23691 E:23704 ||| FW
filaments  ||| S:23704 E:23714 ||| FW
[  ||| S:23714 E:23716 ||| -LRB-
47  ||| S:23716 E:23719 ||| CD
]  ||| S:23719 E:23729 ||| -RRB-
and  ||| S:23729 E:23733 ||| CC
is  ||| S:23733 E:23736 ||| VBZ
directly  ||| S:23736 E:23745 ||| RB
linked  ||| S:23745 E:23752 ||| VBN
to  ||| S:23752 E:23755 ||| TO
the  ||| S:23755 E:23759 ||| DT
cytoskeletal  ||| S:23759 E:23772 ||| JJ
network  ||| S:23772 E:23780 ||| NN
through  ||| S:23780 E:23796 ||| IN
associations  ||| S:23796 E:23809 ||| NNS
with  ||| S:23809 E:23814 ||| IN
α-actinin  ||| S:23814 E:23824 ||| NNP
[  ||| S:23824 E:23826 ||| -LRB-
48  ||| S:23826 E:23829 ||| CD
]  ||| S:23829 E:23831 ||| -RRB-
.  ||| S:23831 E:23833 ||| .
Also ||| S:23833 E:23837 ||| RB
,  ||| S:23837 E:23839 ||| ,
PKN  ||| S:23839 E:23843 ||| NNP
may  ||| S:23843 E:23847 ||| MD
be  ||| S:23847 E:23858 ||| VB
involved  ||| S:23858 E:23867 ||| VBN
in  ||| S:23867 E:23870 ||| IN
relating  ||| S:23870 E:23879 ||| VBG
cytoplasmic  ||| S:23879 E:23891 ||| JJ
signals  ||| S:23891 E:23899 ||| NNS
to  ||| S:23899 E:23902 ||| TO
the  ||| S:23902 E:23906 ||| DT
nucleus ||| S:23906 E:23913 ||| NN
,  ||| S:23913 E:23923 ||| ,
for  ||| S:23923 E:23927 ||| IN
in  ||| S:23927 E:23930 ||| IN
response  ||| S:23930 E:23939 ||| NN
to  ||| S:23939 E:23942 ||| TO
stress ||| S:23942 E:23948 ||| VB
,  ||| S:23948 E:23950 ||| ,
nuclear  ||| S:23950 E:23958 ||| JJ
translocation  ||| S:23958 E:23972 ||| NN
of  ||| S:23972 E:23975 ||| IN
PKN  ||| S:23975 E:23987 ||| NNP
occurs  ||| S:23987 E:23994 ||| VBZ
[  ||| S:23994 E:23996 ||| -LRB-
49  ||| S:23996 E:23999 ||| CD
]  ||| S:23999 E:24001 ||| -RRB-
.  ||| S:24001 E:24003 ||| .
This  ||| S:24003 E:24008 ||| DT
is  ||| S:24008 E:24011 ||| VBZ
particularly  ||| S:24011 E:24024 ||| RB
important  ||| S:24024 E:24034 ||| JJ
in  ||| S:24034 E:24037 ||| IN
light  ||| S:24037 E:24043 ||| NN
of  ||| S:24043 E:24054 ||| IN
previous  ||| S:24054 E:24063 ||| JJ
work  ||| S:24063 E:24068 ||| NN
demonstrating  ||| S:24068 E:24082 ||| VBG
that  ||| S:24082 E:24087 ||| DT
inactivation  ||| S:24087 E:24100 ||| NN
of  ||| S:24100 E:24103 ||| IN
Rho  ||| S:24103 E:24107 ||| NNP
in  ||| S:24107 E:24118 ||| IN
peripheral  ||| S:24118 E:24129 ||| JJ
blood  ||| S:24129 E:24135 ||| NN
T  ||| S:24135 E:24137 ||| NN
lymphocytes  ||| S:24137 E:24149 ||| FW
inhibits  ||| S:24149 E:24158 ||| FW
costimulatory  ||| S:24158 E:24180 ||| FW
signals  ||| S:24180 E:24188 ||| FW
up-regulating  ||| S:24188 E:24202 ||| FW
IL-2  ||| S:24202 E:24207 ||| FW
production  ||| S:24207 E:24218 ||| NN
[  ||| S:24218 E:24220 ||| -LRB-
25  ||| S:24220 E:24223 ||| CD
]  ||| S:24223 E:24225 ||| -RRB-
.  ||| S:24225 E:24227 ||| .
Future  ||| S:24227 E:24242 ||| JJ
experiments  ||| S:24242 E:24254 ||| NNS
will  ||| S:24254 E:24259 ||| MD
focus  ||| S:24259 E:24265 ||| VB
on  ||| S:24265 E:24268 ||| IN
determining  ||| S:24268 E:24280 ||| VBG
the  ||| S:24280 E:24284 ||| DT
relationship  ||| S:24284 E:24297 ||| NN
of  ||| S:24297 E:24308 ||| IN
Rho  ||| S:24308 E:24312 ||| NNP
GTPases  ||| S:24312 E:24320 ||| NNP
and  ||| S:24320 E:24324 ||| CC
the  ||| S:24324 E:24328 ||| DT
regulation  ||| S:24328 E:24339 ||| NN
of  ||| S:24339 E:24342 ||| IN
T  ||| S:24342 E:24344 ||| NN
cell  ||| S:24344 E:24349 ||| NN
morphology  ||| S:24349 E:24360 ||| NNS
[  ||| S:24360 E:24362 ||| -LRB-
25  ||| S:24362 E:24365 ||| CD
51  ||| S:24365 E:24376 ||| CD
52  ||| S:24376 E:24379 ||| CD
]  ||| S:24379 E:24381 ||| -RRB-
.  ||| S:24381 E:24405 ||| .
Conclusions  ||| S:24405 E:24425 ||| NNP
Inactivation  ||| S:24425 E:24438 ||| NNP
of  ||| S:24438 E:24441 ||| IN
Rho  ||| S:24441 E:24445 ||| NNP
results  ||| S:24445 E:24453 ||| NNS
in  ||| S:24453 E:24456 ||| IN
an  ||| S:24456 E:24459 ||| DT
active  ||| S:24459 E:24466 ||| JJ
elongation  ||| S:24466 E:24477 ||| NN
of  ||| S:24477 E:24488 ||| IN
actin  ||| S:24488 E:24494 ||| JJ
rich ||| S:24494 E:24498 ||| JJ
,  ||| S:24498 E:24500 ||| ,
finger-like  ||| S:24500 E:24512 ||| JJ
dendritic  ||| S:24512 E:24522 ||| NN
processes  ||| S:24522 E:24532 ||| VBZ
dependent  ||| S:24532 E:24542 ||| JJ
on  ||| S:24542 E:24545 ||| IN
β1  ||| S:24545 E:24556 ||| CD
integrin  ||| S:24556 E:24565 ||| CD
signaling ||| S:24565 E:24574 ||| NNS
.  ||| S:24574 E:24576 ||| .
Thus  ||| S:24576 E:24581 ||| RB
Rho  ||| S:24581 E:24585 ||| JJ
activity  ||| S:24585 E:24594 ||| NN
is  ||| S:24594 E:24597 ||| VBZ
required  ||| S:24597 E:24606 ||| VBN
for  ||| S:24606 E:24610 ||| IN
T  ||| S:24610 E:24620 ||| NN
lymphocyte  ||| S:24620 E:24631 ||| VBZ
spreading  ||| S:24631 E:24641 ||| VBG
morphologies ||| S:24641 E:24653 ||| NN
,  ||| S:24653 E:24655 ||| ,
and  ||| S:24655 E:24659 ||| CC
is  ||| S:24659 E:24662 ||| VBZ
required  ||| S:24662 E:24671 ||| VBN
for  ||| S:24671 E:24675 ||| IN
T  ||| S:24675 E:24685 ||| NN
lymphocyte  ||| S:24685 E:24696 ||| NN
motility ||| S:24696 E:24704 ||| NN
.  ||| S:24704 E:24706 ||| .
In  ||| S:24706 E:24709 ||| IN
static  ||| S:24709 E:24716 ||| JJ
cell  ||| S:24716 E:24721 ||| NN
adhesion  ||| S:24721 E:24730 ||| NN
assays ||| S:24730 E:24736 ||| NN
,  ||| S:24736 E:24746 ||| ,
however ||| S:24746 E:24753 ||| RB
,  ||| S:24753 E:24755 ||| ,
Rho  ||| S:24755 E:24759 ||| NNP
activity  ||| S:24759 E:24768 ||| NN
is  ||| S:24768 E:24771 ||| VBZ
not  ||| S:24771 E:24775 ||| RB
required  ||| S:24775 E:24784 ||| VBN
to  ||| S:24784 E:24787 ||| TO
maintain  ||| S:24787 E:24804 ||| VB
constitutively  ||| S:24804 E:24819 ||| JJ
high  ||| S:24819 E:24824 ||| JJ
levels  ||| S:24824 E:24831 ||| NNS
of  ||| S:24831 E:24834 ||| IN
adhesion  ||| S:24834 E:24843 ||| VBG
to  ||| S:24843 E:24846 ||| TO
fibronectin ||| S:24846 E:24857 ||| VB
.  ||| S:24857 E:24867 ||| .
Further  ||| S:24867 E:24875 ||| JJ
study  ||| S:24875 E:24881 ||| NN
of  ||| S:24881 E:24884 ||| IN
Rho  ||| S:24884 E:24888 ||| NNP
and  ||| S:24888 E:24892 ||| CC
it ||| S:24892 E:24894 ||| PRP
's  ||| S:24894 E:24897 ||| VBZ
related  ||| S:24897 E:24905 ||| VBN
GTPases  ||| S:24905 E:24913 ||| JJ
and  ||| S:24913 E:24925 ||| CC
downstream  ||| S:24925 E:24936 ||| JJ
effector  ||| S:24936 E:24945 ||| JJ
molecules ||| S:24945 E:24954 ||| NNS
,  ||| S:24954 E:24956 ||| ,
will  ||| S:24956 E:24961 ||| MD
be  ||| S:24961 E:24964 ||| VB
important  ||| S:24964 E:24974 ||| JJ
in  ||| S:24974 E:24985 ||| IN
elucidating  ||| S:24985 E:24997 ||| JJ
mechanisms  ||| S:24997 E:25008 ||| NNS
regulating  ||| S:25008 E:25019 ||| VBG
the  ||| S:25019 E:25023 ||| DT
lymphocyte  ||| S:25023 E:25042 ||| JJ
cytoskeleton  ||| S:25042 E:25055 ||| NN
and  ||| S:25055 E:25059 ||| CC
thus  ||| S:25059 E:25064 ||| RB
T  ||| S:25064 E:25066 ||| NN
cell  ||| S:25066 E:25071 ||| NN
function ||| S:25071 E:25079 ||| NN
.  ||| S:25079 E:25103 ||| .
Materials  ||| S:25103 E:25113 ||| NNS
and  ||| S:25113 E:25117 ||| CC
Methods  ||| S:25117 E:25144 ||| NNP
Reagents  ||| S:25144 E:25163 ||| NNP
Poly-L-lysine  ||| S:25163 E:25177 ||| NNP
was  ||| S:25177 E:25181 ||| VBD
purchased  ||| S:25181 E:25191 ||| VBN
from  ||| S:25191 E:25196 ||| IN
Sigma  ||| S:25196 E:25202 ||| NNP
Chemical  ||| S:25202 E:25211 ||| NNP
Co ||| S:25211 E:25213 ||| NNP
.  ||| S:25213 E:25225 ||| .
( ||| S:25225 E:25226 ||| -LRB-
St.  ||| S:25226 E:25230 ||| NNP
Louis ||| S:25230 E:25235 ||| NNP
,  ||| S:25235 E:25237 ||| ,
MO ||| S:25237 E:25239 ||| NNP
) ||| S:25239 E:25240 ||| -RRB-
.  ||| S:25240 E:25242 ||| .
Fn  ||| S:25242 E:25245 ||| NNP
was  ||| S:25245 E:25249 ||| VBD
affinity  ||| S:25249 E:25258 ||| JJ
purified  ||| S:25258 E:25267 ||| NN
from  ||| S:25267 E:25272 ||| IN
200  ||| S:25272 E:25276 ||| CD
ml  ||| S:25276 E:25279 ||| NN
of  ||| S:25279 E:25292 ||| IN
human  ||| S:25292 E:25298 ||| JJ
plasma  ||| S:25298 E:25305 ||| NNS
( ||| S:25305 E:25306 ||| -LRB-
Gulf  ||| S:25306 E:25311 ||| NNP
Coast  ||| S:25311 E:25317 ||| NNP
Regional  ||| S:25317 E:25326 ||| NNP
Blood  ||| S:25326 E:25332 ||| NNP
Center ||| S:25332 E:25338 ||| NNP
,  ||| S:25338 E:25340 ||| ,
Houston ||| S:25340 E:25347 ||| NNP
,  ||| S:25347 E:25359 ||| ,
TX ||| S:25359 E:25361 ||| NNP
) ||| S:25361 E:25362 ||| -RRB-
.  ||| S:25362 E:25364 ||| .
Briefly ||| S:25364 E:25371 ||| RB
,  ||| S:25371 E:25373 ||| ,
gelatin-conjugated  ||| S:25373 E:25392 ||| JJ
sepharose  ||| S:25392 E:25402 ||| JJ
bead  ||| S:25402 E:25407 ||| JJ
columns  ||| S:25407 E:25425 ||| NNS
were  ||| S:25425 E:25430 ||| VBD
pre-washed  ||| S:25430 E:25441 ||| JJ
with  ||| S:25441 E:25446 ||| IN
PBS  ||| S:25446 E:25450 ||| NNP
containing  ||| S:25450 E:25461 ||| VBG
2  ||| S:25461 E:25463 ||| CD
mM  ||| S:25463 E:25466 ||| JJ
EDTA  ||| S:25466 E:25471 ||| NNP
and  ||| S:25471 E:25475 ||| CC
0.1  ||| S:25475 E:25479 ||| CD
mM  ||| S:25479 E:25492 ||| JJ
PMSF ||| S:25492 E:25496 ||| NNP
.  ||| S:25496 E:25498 ||| .
After  ||| S:25498 E:25504 ||| IN
washing ||| S:25504 E:25511 ||| NN
,  ||| S:25511 E:25513 ||| ,
plasma  ||| S:25513 E:25520 ||| VBZ
containing  ||| S:25520 E:25531 ||| VBG
2  ||| S:25531 E:25533 ||| CD
mM  ||| S:25533 E:25536 ||| JJ
EDTA  ||| S:25536 E:25541 ||| NNP
and  ||| S:25541 E:25545 ||| CC
0.1  ||| S:25545 E:25559 ||| CD
mM  ||| S:25559 E:25562 ||| JJ
PMSF  ||| S:25562 E:25567 ||| NNP
was  ||| S:25567 E:25571 ||| VBD
passed  ||| S:25571 E:25578 ||| VBN
over  ||| S:25578 E:25583 ||| IN
the  ||| S:25583 E:25587 ||| DT
column  ||| S:25587 E:25594 ||| NN
twice ||| S:25594 E:25599 ||| RB
,  ||| S:25599 E:25601 ||| ,
then  ||| S:25601 E:25606 ||| RB
washed  ||| S:25606 E:25623 ||| VBN
with  ||| S:25623 E:25628 ||| IN
at  ||| S:25628 E:25631 ||| IN
least  ||| S:25631 E:25637 ||| JJS
4  ||| S:25637 E:25639 ||| CD
volumes  ||| S:25639 E:25647 ||| NNS
of  ||| S:25647 E:25650 ||| IN
PBS ||| S:25650 E:25653 ||| NNP
/ ||| S:25653 E:25654 ||| NNP
EDTA ||| S:25654 E:25658 ||| NNP
/ ||| S:25658 E:25659 ||| NNP
PMSF ||| S:25659 E:25663 ||| NNP
.  ||| S:25663 E:25665 ||| .
Elution  ||| S:25665 E:25673 ||| NNP
of  ||| S:25673 E:25676 ||| IN
FN  ||| S:25676 E:25689 ||| NNP
from  ||| S:25689 E:25694 ||| IN
the  ||| S:25694 E:25698 ||| DT
columns  ||| S:25698 E:25706 ||| NNS
was  ||| S:25706 E:25710 ||| VBD
performed  ||| S:25710 E:25720 ||| VBN
with  ||| S:25720 E:25725 ||| IN
4  ||| S:25725 E:25727 ||| CD
M  ||| S:25727 E:25729 ||| NNP
urea  ||| S:25729 E:25734 ||| NN
in  ||| S:25734 E:25737 ||| IN
0.15  ||| S:25737 E:25742 ||| NNP
M  ||| S:25742 E:25754 ||| NNP
NaCl ||| S:25754 E:25758 ||| NNP
,  ||| S:25758 E:25760 ||| ,
2  ||| S:25760 E:25762 ||| CD
mM  ||| S:25762 E:25765 ||| JJ
EDTA ||| S:25765 E:25769 ||| NNP
,  ||| S:25769 E:25771 ||| ,
0.1  ||| S:25771 E:25775 ||| CD
mM  ||| S:25775 E:25778 ||| JJ
PMSF ||| S:25778 E:25782 ||| NNP
,  ||| S:25782 E:25784 ||| ,
20  ||| S:25784 E:25787 ||| CD
mM  ||| S:25787 E:25790 ||| JJ
Tris-HCl ||| S:25790 E:25798 ||| NN
,  ||| S:25798 E:25800 ||| ,
pH  ||| S:25800 E:25803 ||| NNP
8.0 ||| S:25803 E:25806 ||| NNP
.  ||| S:25806 E:25818 ||| .
Collected  ||| S:25818 E:25828 ||| JJ
fractions  ||| S:25828 E:25838 ||| NNS
were  ||| S:25838 E:25843 ||| VBD
dialyzed  ||| S:25843 E:25852 ||| VBN
in  ||| S:25852 E:25855 ||| IN
PBS ||| S:25855 E:25858 ||| NNP
.  ||| S:25858 E:25860 ||| .
All  ||| S:25860 E:25864 ||| DT
procedures  ||| S:25864 E:25885 ||| NNS
were  ||| S:25885 E:25890 ||| VBD
carried  ||| S:25890 E:25898 ||| VBN
out  ||| S:25898 E:25902 ||| RP
at  ||| S:25902 E:25905 ||| IN
RT ||| S:25905 E:25907 ||| NNP
.  ||| S:25907 E:25909 ||| .
Fn  ||| S:25909 E:25912 ||| JJ
purity  ||| S:25912 E:25919 ||| NN
was  ||| S:25919 E:25923 ||| VBD
determined  ||| S:25923 E:25934 ||| VBN
by  ||| S:25934 E:25947 ||| IN
SDS-PAGE ||| S:25947 E:25955 ||| JJ
.  ||| S:25955 E:25957 ||| .
VCAM-1  ||| S:25957 E:25964 ||| NNP
was  ||| S:25964 E:25968 ||| VBD
provided  ||| S:25968 E:25977 ||| VBN
by  ||| S:25977 E:25980 ||| IN
Dr.  ||| S:25980 E:25984 ||| NNP
S.  ||| S:25984 E:25987 ||| NNP
Fong  ||| S:25987 E:25992 ||| NNP
( ||| S:25992 E:25993 ||| -LRB-
Genentech ||| S:25993 E:26002 ||| NNP
,  ||| S:26002 E:26014 ||| ,
San  ||| S:26014 E:26018 ||| NNP
Francisco ||| S:26018 E:26027 ||| NNP
,  ||| S:26027 E:26029 ||| ,
CA ||| S:26029 E:26031 ||| NNP
) ||| S:26031 E:26032 ||| -RRB-
.  ||| S:26032 E:26034 ||| .
C3  ||| S:26034 E:26037 ||| NNP
exoenzyme  ||| S:26037 E:26047 ||| NN
was  ||| S:26047 E:26051 ||| VBD
purified  ||| S:26051 E:26060 ||| VBN
as  ||| S:26060 E:26073 ||| IN
previously  ||| S:26073 E:26084 ||| RB
described  ||| S:26084 E:26094 ||| VBN
[  ||| S:26094 E:26096 ||| -LRB-
25  ||| S:26096 E:26099 ||| CD
]  ||| S:26099 E:26101 ||| -RRB-
.  ||| S:26101 E:26103 ||| .
Anti-β1  ||| S:26103 E:26111 ||| FW
integrin  ||| S:26111 E:26120 ||| FW
mAb  ||| S:26120 E:26124 ||| FW
33B6  ||| S:26124 E:26139 ||| FW
and  ||| S:26139 E:26143 ||| FW
anti  ||| S:26143 E:26148 ||| FW
α4β1  ||| S:26148 E:26153 ||| FW
integrin  ||| S:26153 E:26162 ||| FW
mAb  ||| S:26162 E:26166 ||| FW
19H8  ||| S:26166 E:26171 ||| NNP
were  ||| S:26171 E:26176 ||| VBD
generated  ||| S:26176 E:26186 ||| VBN
in  ||| S:26186 E:26189 ||| IN
this  ||| S:26189 E:26204 ||| DT
laboratory  ||| S:26204 E:26215 ||| NN
and  ||| S:26215 E:26219 ||| CC
have  ||| S:26219 E:26224 ||| VBP
been  ||| S:26224 E:26229 ||| VBN
previously  ||| S:26229 E:26240 ||| RB
described  ||| S:26240 E:26250 ||| VBN
[  ||| S:26250 E:26252 ||| -LRB-
27  ||| S:26252 E:26255 ||| CD
28  ||| S:26255 E:26258 ||| CD
]  ||| S:26258 E:26260 ||| -RRB-
.  ||| S:26260 E:26272 ||| .
Rabbit  ||| S:26272 E:26279 ||| FW
polyclonal  ||| S:26279 E:26290 ||| FW
anti-Cdc42 ||| S:26290 E:26300 ||| FW
,  ||| S:26300 E:26302 ||| ,
-Rac1 ||| S:26302 E:26307 ||| NNP
,  ||| S:26307 E:26309 ||| ,
-Rac2 ||| S:26309 E:26314 ||| NNP
,  ||| S:26314 E:26316 ||| ,
-RhoA ||| S:26316 E:26321 ||| NNP
,  ||| S:26321 E:26323 ||| ,
and  ||| S:26323 E:26337 ||| CC
mouse  ||| S:26337 E:26343 ||| JJ
monoclonal  ||| S:26343 E:26354 ||| JJ
anti-Ras ||| S:26354 E:26362 ||| NN
,  ||| S:26362 E:26364 ||| ,
were  ||| S:26364 E:26369 ||| VBD
purchased  ||| S:26369 E:26379 ||| VBN
from  ||| S:26379 E:26384 ||| IN
Santa  ||| S:26384 E:26390 ||| NNP
Cruz  ||| S:26390 E:26405 ||| NNP
Biotechnology  ||| S:26405 E:26419 ||| NNP
( ||| S:26419 E:26420 ||| -LRB-
Santa  ||| S:26420 E:26426 ||| NNP
Cruz ||| S:26426 E:26430 ||| NNP
,  ||| S:26430 E:26432 ||| ,
CA ||| S:26432 E:26434 ||| NNP
) ||| S:26434 E:26435 ||| -RRB-
.  ||| S:26435 E:26465 ||| .
Cells  ||| S:26465 E:26481 ||| NNS
The  ||| S:26481 E:26485 ||| DT
T  ||| S:26485 E:26487 ||| NN
cell  ||| S:26487 E:26492 ||| NN
lines  ||| S:26492 E:26498 ||| NNS
HPB-ALL  ||| S:26498 E:26506 ||| JJ
and  ||| S:26506 E:26510 ||| CC
CEM  ||| S:26510 E:26514 ||| NNP
were  ||| S:26514 E:26519 ||| VBD
maintained  ||| S:26519 E:26530 ||| VBN
in  ||| S:26530 E:26543 ||| IN
complete  ||| S:26543 E:26552 ||| JJ
media  ||| S:26552 E:26558 ||| NNS
( ||| S:26558 E:26559 ||| -LRB-
RPMI-1640  ||| S:26559 E:26569 ||| NNP
supplemented  ||| S:26569 E:26582 ||| NN
with  ||| S:26582 E:26587 ||| IN
10 ||| S:26587 E:26589 ||| CD
%  ||| S:26589 E:26591 ||| NN
FBS ||| S:26591 E:26594 ||| NNP
;  ||| S:26594 E:26596 ||| :
10  ||| S:26596 E:26609 ||| CD
U ||| S:26609 E:26610 ||| NNP
/ ||| S:26610 E:26611 ||| NNP
ml  ||| S:26611 E:26614 ||| NN
of  ||| S:26614 E:26617 ||| IN
both  ||| S:26617 E:26622 ||| DT
penicillin  ||| S:26622 E:26633 ||| NN
and  ||| S:26633 E:26637 ||| CC
streptomycin ||| S:26637 E:26649 ||| NNS
;  ||| S:26649 E:26651 ||| :
and  ||| S:26651 E:26655 ||| CC
1  ||| S:26655 E:26657 ||| CD
mM  ||| S:26657 E:26670 ||| JJ
L-Glutamine ||| S:26670 E:26681 ||| NN
,  ||| S:26681 E:26683 ||| ,
all  ||| S:26683 E:26687 ||| DT
from  ||| S:26687 E:26692 ||| IN
Life  ||| S:26692 E:26697 ||| NNP
Technologies ||| S:26697 E:26709 ||| NNPS
,  ||| S:26709 E:26711 ||| ,
Grand  ||| S:26711 E:26717 ||| NNP
Island ||| S:26717 E:26723 ||| NNP
,  ||| S:26723 E:26735 ||| ,
NY ||| S:26735 E:26737 ||| NNP
) ||| S:26737 E:26738 ||| -RRB-
.  ||| S:26738 E:26740 ||| .
Freshly  ||| S:26740 E:26748 ||| RB
isolated  ||| S:26748 E:26757 ||| VBN
peripheral  ||| S:26757 E:26768 ||| JJ
blood  ||| S:26768 E:26774 ||| NN
T  ||| S:26774 E:26776 ||| NN
cells  ||| S:26776 E:26782 ||| NNS
were  ||| S:26782 E:26797 ||| VBD
purified  ||| S:26797 E:26806 ||| JJ
and  ||| S:26806 E:26810 ||| CC
activated  ||| S:26810 E:26820 ||| VBN
by  ||| S:26820 E:26823 ||| IN
cross-linking  ||| S:26823 E:26837 ||| NNP
CD28  ||| S:26837 E:26842 ||| NNP
and  ||| S:26842 E:26846 ||| CC
CD3  ||| S:26846 E:26850 ||| CD
as  ||| S:26850 E:26863 ||| IN
previously  ||| S:26863 E:26874 ||| RB
described  ||| S:26874 E:26884 ||| VBN
[  ||| S:26884 E:26886 ||| -LRB-
29  ||| S:26886 E:26889 ||| CD
]  ||| S:26889 E:26891 ||| -RRB-
.  ||| S:26891 E:26921 ||| .
Time  ||| S:26921 E:26926 ||| NNP
Lapse  ||| S:26926 E:26932 ||| NNP
and  ||| S:26932 E:26936 ||| CC
Fluorescence  ||| S:26936 E:26949 ||| NNP
Microscopy  ||| S:26949 E:26970 ||| NNP
HPB-ALL  ||| S:26970 E:26978 ||| JJ
cells  ||| S:26978 E:26984 ||| NNS
were  ||| S:26984 E:26989 ||| VBD
plated  ||| S:26989 E:26996 ||| VBN
on  ||| S:26996 E:26999 ||| IN
VCAM-1  ||| S:26999 E:27006 ||| CD
in  ||| S:27006 E:27009 ||| IN
the  ||| S:27009 E:27013 ||| DT
temperature  ||| S:27013 E:27035 ||| NN
controlled  ||| S:27035 E:27046 ||| VBN
environment  ||| S:27046 E:27058 ||| NN
of  ||| S:27058 E:27061 ||| IN
an  ||| S:27061 E:27064 ||| DT
inverted  ||| S:27064 E:27073 ||| JJ
Nikon  ||| S:27073 E:27079 ||| NNP
( ||| S:27079 E:27080 ||| -LRB-
Melville ||| S:27080 E:27088 ||| NNP
,  ||| S:27088 E:27100 ||| ,
NY ||| S:27100 E:27102 ||| NNP
)  ||| S:27102 E:27104 ||| -RRB-
Diaphot-TMD  ||| S:27104 E:27116 ||| JJ
microscope  ||| S:27116 E:27127 ||| NN
for  ||| S:27127 E:27131 ||| IN
1  ||| S:27131 E:27133 ||| CD
hour ||| S:27133 E:27137 ||| NN
.  ||| S:27137 E:27139 ||| .
During  ||| S:27139 E:27146 ||| IN
this  ||| S:27146 E:27151 ||| DT
time ||| S:27151 E:27155 ||| NN
,  ||| S:27155 E:27167 ||| ,
images  ||| S:27167 E:27174 ||| NNS
were  ||| S:27174 E:27179 ||| VBD
obtained  ||| S:27179 E:27188 ||| VBN
through  ||| S:27188 E:27196 ||| IN
an  ||| S:27196 E:27199 ||| DT
Optronics  ||| S:27199 E:27209 ||| NNP
( ||| S:27209 E:27210 ||| -LRB-
Galeto ||| S:27210 E:27216 ||| NNP
,  ||| S:27216 E:27218 ||| ,
CA ||| S:27218 E:27220 ||| NNP
)  ||| S:27220 E:27232 ||| -RRB-
VI-470  ||| S:27232 E:27239 ||| NNP
CCD  ||| S:27239 E:27243 ||| NNP
camera  ||| S:27243 E:27250 ||| NN
and  ||| S:27250 E:27254 ||| CC
recorded  ||| S:27254 E:27263 ||| VBN
by  ||| S:27263 E:27266 ||| IN
time-lapse  ||| S:27266 E:27287 ||| JJ
cinematography  ||| S:27287 E:27302 ||| NN
on  ||| S:27302 E:27305 ||| IN
a  ||| S:27305 E:27307 ||| DT
Panasonic  ||| S:27307 E:27317 ||| NNP
( ||| S:27317 E:27318 ||| -LRB-
Secaucus ||| S:27318 E:27326 ||| NNP
,  ||| S:27326 E:27328 ||| ,
NJ ||| S:27328 E:27330 ||| NNP
)  ||| S:27330 E:27332 ||| -RRB-
sVHS  ||| S:27332 E:27337 ||| JJ
AG-6730  ||| S:27337 E:27355 ||| CD
time-lapse  ||| S:27355 E:27366 ||| JJ
videocassette  ||| S:27366 E:27380 ||| NN
recorder ||| S:27380 E:27388 ||| NN
.  ||| S:27388 E:27390 ||| .
Recordings  ||| S:27390 E:27401 ||| NNS
were  ||| S:27401 E:27406 ||| VBD
played  ||| S:27406 E:27423 ||| VBN
back  ||| S:27423 E:27428 ||| RP
and  ||| S:27428 E:27432 ||| CC
digitized  ||| S:27432 E:27442 ||| NN
on  ||| S:27442 E:27445 ||| IN
a  ||| S:27445 E:27447 ||| DT
Macintosh  ||| S:27447 E:27457 ||| NNP
IIVX  ||| S:27457 E:27462 ||| NNP
computer  ||| S:27462 E:27471 ||| NN
equipped  ||| S:27471 E:27490 ||| VBN
with  ||| S:27490 E:27495 ||| IN
a  ||| S:27495 E:27497 ||| DT
Data  ||| S:27497 E:27502 ||| NNP
Translation  ||| S:27502 E:27514 ||| NNP
( ||| S:27514 E:27515 ||| -LRB-
Marlboro ||| S:27515 E:27523 ||| NNP
,  ||| S:27523 E:27525 ||| ,
MA ||| S:27525 E:27527 ||| NNP
)  ||| S:27527 E:27529 ||| -RRB-
Frame  ||| S:27529 E:27535 ||| NNP
Grabber  ||| S:27535 E:27543 ||| NNP
card  ||| S:27543 E:27558 ||| NN
using  ||| S:27558 E:27564 ||| VBG
NIH  ||| S:27564 E:27568 ||| NNP
IMAGE  ||| S:27568 E:27574 ||| NNP
software  ||| S:27574 E:27583 ||| NN
( ||| S:27583 E:27584 ||| -LRB-
available  ||| S:27584 E:27594 ||| JJ
from  ||| S:27594 E:27609 ||| IN
ftp ||| S:27609 E:27612 ||| NNS
: ||| S:27612 E:27613 ||| :
/ ||| S:27613 E:27614 ||| FW
/ ||| S:27614 E:27615 ||| FW
codon.nih.gov ||| S:27615 E:27628 ||| FW
/ ||| S:27628 E:27629 ||| FW
pub ||| S:27629 E:27632 ||| FW
/ ||| S:27632 E:27633 ||| FW
nih-image ||| S:27633 E:27642 ||| FW
/ ||| S:27642 E:27643 ||| FW
nih-image161_fat.hqx ||| S:27643 E:27663 ||| FW
) ||| S:27663 E:27664 ||| -RRB-
.  ||| S:27664 E:27676 ||| .
For  ||| S:27676 E:27680 ||| IN
fluorescence  ||| S:27680 E:27693 ||| JJ
microscopy ||| S:27693 E:27703 ||| NN
,  ||| S:27703 E:27705 ||| ,
glass  ||| S:27705 E:27711 ||| NN
coverslips  ||| S:27711 E:27722 ||| NNS
were  ||| S:27722 E:27737 ||| VBD
coated  ||| S:27737 E:27744 ||| VBN
with  ||| S:27744 E:27749 ||| IN
Fn  ||| S:27749 E:27752 ||| NNP
( ||| S:27752 E:27753 ||| -LRB-
10  ||| S:27753 E:27756 ||| CD
μg ||| S:27756 E:27758 ||| CD
/ ||| S:27758 E:27759 ||| CD
ml ||| S:27759 E:27761 ||| CD
) ||| S:27761 E:27762 ||| -RRB-
,  ||| S:27762 E:27764 ||| ,
VCAM-1  ||| S:27764 E:27771 ||| NNP
( ||| S:27771 E:27772 ||| -LRB-
5  ||| S:27772 E:27774 ||| CD
μg ||| S:27774 E:27776 ||| CD
/ ||| S:27776 E:27777 ||| CD
ml ||| S:27777 E:27779 ||| CD
)  ||| S:27779 E:27781 ||| -RRB-
or  ||| S:27781 E:27784 ||| CC
mAb  ||| S:27784 E:27788 ||| NNP
19H8  ||| S:27788 E:27803 ||| NNP
( ||| S:27803 E:27804 ||| -LRB-
0.5  ||| S:27804 E:27808 ||| CD
μg ||| S:27808 E:27810 ||| CD
/ ||| S:27810 E:27811 ||| CD
ml ||| S:27811 E:27813 ||| CD
)  ||| S:27813 E:27815 ||| -RRB-
for  ||| S:27815 E:27819 ||| IN
at  ||| S:27819 E:27822 ||| IN
least  ||| S:27822 E:27828 ||| JJS
2  ||| S:27828 E:27830 ||| CD
hours  ||| S:27830 E:27836 ||| NNS
at  ||| S:27836 E:27839 ||| IN
37°C  ||| S:27839 E:27844 ||| CD
in  ||| S:27844 E:27847 ||| IN
50  ||| S:27847 E:27850 ||| CD
mM  ||| S:27850 E:27853 ||| JJ
Tris  ||| S:27853 E:27868 ||| NNP
( ||| S:27868 E:27869 ||| -LRB-
pH  ||| S:27869 E:27872 ||| NNP
9.5 ||| S:27872 E:27875 ||| CD
) ||| S:27875 E:27876 ||| -RRB-
.  ||| S:27876 E:27878 ||| .
Coverslips  ||| S:27878 E:27889 ||| NNP
were  ||| S:27889 E:27894 ||| VBD
blocked  ||| S:27894 E:27902 ||| VBN
with  ||| S:27902 E:27907 ||| IN
BSA  ||| S:27907 E:27911 ||| NNP
( ||| S:27911 E:27912 ||| -LRB-
1 ||| S:27912 E:27913 ||| CD
%  ||| S:27913 E:27915 ||| NN
w ||| S:27915 E:27916 ||| VBD
/ ||| S:27916 E:27917 ||| CD
v  ||| S:27917 E:27919 ||| NN
in  ||| S:27919 E:27932 ||| IN
PBS ||| S:27932 E:27935 ||| NNP
)  ||| S:27935 E:27937 ||| -RRB-
for  ||| S:27937 E:27941 ||| IN
30  ||| S:27941 E:27944 ||| CD
min  ||| S:27944 E:27948 ||| NN
at  ||| S:27948 E:27951 ||| IN
room  ||| S:27951 E:27956 ||| NN
temperature  ||| S:27956 E:27968 ||| NN
then  ||| S:27968 E:27973 ||| RB
washed  ||| S:27973 E:27980 ||| VBN
with  ||| S:27980 E:27985 ||| IN
PBS ||| S:27985 E:27988 ||| NNP
.  ||| S:27988 E:28000 ||| .
HPB-ALL  ||| S:28000 E:28008 ||| JJ
cells  ||| S:28008 E:28014 ||| NNS
were  ||| S:28014 E:28019 ||| VBD
then  ||| S:28019 E:28024 ||| RB
plated  ||| S:28024 E:28031 ||| VBN
onto  ||| S:28031 E:28036 ||| IN
the  ||| S:28036 E:28040 ||| DT
coverslips  ||| S:28040 E:28051 ||| NN
and  ||| S:28051 E:28065 ||| CC
incubated  ||| S:28065 E:28075 ||| NN
for  ||| S:28075 E:28079 ||| IN
1  ||| S:28079 E:28081 ||| CD
hour  ||| S:28081 E:28086 ||| NN
at  ||| S:28086 E:28089 ||| IN
37°C  ||| S:28089 E:28094 ||| CD
in  ||| S:28094 E:28097 ||| IN
complete  ||| S:28097 E:28106 ||| JJ
media ||| S:28106 E:28111 ||| NNS
.  ||| S:28111 E:28113 ||| .
The  ||| S:28113 E:28117 ||| DT
cells  ||| S:28117 E:28133 ||| NNS
were  ||| S:28133 E:28138 ||| VBD
then  ||| S:28138 E:28143 ||| RB
washed  ||| S:28143 E:28150 ||| VBN
on  ||| S:28150 E:28153 ||| IN
the  ||| S:28153 E:28157 ||| DT
coverslips ||| S:28157 E:28167 ||| NN
,  ||| S:28167 E:28169 ||| ,
and  ||| S:28169 E:28173 ||| CC
fixed  ||| S:28173 E:28179 ||| VBN
with  ||| S:28179 E:28184 ||| IN
2 ||| S:28184 E:28185 ||| CD
%  ||| S:28185 E:28197 ||| NN
paraformaldehyde  ||| S:28197 E:28214 ||| NN
for  ||| S:28214 E:28218 ||| IN
at  ||| S:28218 E:28221 ||| IN
least  ||| S:28221 E:28227 ||| JJS
30  ||| S:28227 E:28230 ||| CD
min  ||| S:28230 E:28234 ||| NN
at  ||| S:28234 E:28237 ||| IN
4°C ||| S:28237 E:28240 ||| CD
.  ||| S:28240 E:28242 ||| .
A  ||| S:28242 E:28244 ||| DT
solution  ||| S:28244 E:28263 ||| NN
of  ||| S:28263 E:28266 ||| IN
0.1 ||| S:28266 E:28269 ||| CD
%  ||| S:28269 E:28271 ||| NN
TritonX-100  ||| S:28271 E:28283 ||| NN
was  ||| S:28283 E:28287 ||| VBD
then  ||| S:28287 E:28292 ||| RB
used  ||| S:28292 E:28297 ||| VBN
to  ||| S:28297 E:28300 ||| TO
permeabilize  ||| S:28300 E:28313 ||| VB
the  ||| S:28313 E:28327 ||| DT
cells  ||| S:28327 E:28333 ||| NNS
by  ||| S:28333 E:28336 ||| IN
treatment  ||| S:28336 E:28346 ||| NN
for  ||| S:28346 E:28350 ||| IN
10  ||| S:28350 E:28353 ||| CD
min  ||| S:28353 E:28357 ||| NN
at  ||| S:28357 E:28360 ||| IN
4°C ||| S:28360 E:28363 ||| CD
.  ||| S:28363 E:28365 ||| .
After  ||| S:28365 E:28381 ||| IN
permeabilization ||| S:28381 E:28397 ||| NN
,  ||| S:28397 E:28399 ||| ,
coverslips  ||| S:28399 E:28410 ||| NN
were  ||| S:28410 E:28415 ||| VBD
again  ||| S:28415 E:28421 ||| RB
blocked  ||| S:28421 E:28429 ||| VBN
with  ||| S:28429 E:28434 ||| IN
1 ||| S:28434 E:28435 ||| CD
%  ||| S:28435 E:28447 ||| NN
BSA ||| S:28447 E:28450 ||| NNP
.  ||| S:28450 E:28452 ||| .
After  ||| S:28452 E:28458 ||| IN
washing  ||| S:28458 E:28466 ||| VBG
in  ||| S:28466 E:28469 ||| IN
PBS ||| S:28469 E:28472 ||| NNP
,  ||| S:28472 E:28474 ||| ,
80  ||| S:28474 E:28477 ||| CD
μM  ||| S:28477 E:28480 ||| JJ
phalloidin-TRITC  ||| S:28480 E:28497 ||| JJ
or  ||| S:28497 E:28500 ||| CC
1  ||| S:28500 E:28512 ||| CD
μg ||| S:28512 E:28514 ||| CD
/ ||| S:28514 E:28515 ||| CD
ml  ||| S:28515 E:28518 ||| CD
anti-RhoA  ||| S:28518 E:28528 ||| JJ
antibody  ||| S:28528 E:28537 ||| NN
was  ||| S:28537 E:28541 ||| VBD
incubated  ||| S:28541 E:28551 ||| VBN
for  ||| S:28551 E:28555 ||| IN
30  ||| S:28555 E:28558 ||| CD
min  ||| S:28558 E:28562 ||| NN
at  ||| S:28562 E:28565 ||| IN
4°C ||| S:28565 E:28568 ||| CD
.  ||| S:28568 E:28580 ||| .
Cells  ||| S:28580 E:28586 ||| NNS
were  ||| S:28586 E:28591 ||| VBD
visualized  ||| S:28591 E:28602 ||| VBN
on  ||| S:28602 E:28605 ||| IN
a  ||| S:28605 E:28607 ||| DT
Nikon  ||| S:28607 E:28613 ||| NNP
DIAPHOT-TMD  ||| S:28613 E:28625 ||| JJ
inverted  ||| S:28625 E:28644 ||| JJ
microscope  ||| S:28644 E:28655 ||| NN
and  ||| S:28655 E:28659 ||| CC
images  ||| S:28659 E:28666 ||| NNS
were  ||| S:28666 E:28671 ||| VBD
digitized  ||| S:28671 E:28681 ||| VBN
as  ||| S:28681 E:28684 ||| RB
described  ||| S:28684 E:28704 ||| VBN
above ||| S:28704 E:28709 ||| IN
.  ||| S:28709 E:28739 ||| .
Western  ||| S:28739 E:28747 ||| NNP
Blotting  ||| S:28747 E:28766 ||| NNP
All  ||| S:28766 E:28770 ||| DT
western  ||| S:28770 E:28778 ||| JJ
blotting  ||| S:28778 E:28787 ||| JJ
steps  ||| S:28787 E:28793 ||| NNS
were  ||| S:28793 E:28798 ||| VBD
carried  ||| S:28798 E:28806 ||| VBN
out  ||| S:28806 E:28810 ||| RP
at  ||| S:28810 E:28813 ||| IN
4°C  ||| S:28813 E:28817 ||| CD
for  ||| S:28817 E:28831 ||| IN
at  ||| S:28831 E:28834 ||| IN
least  ||| S:28834 E:28840 ||| JJS
2  ||| S:28840 E:28842 ||| CD
hours ||| S:28842 E:28847 ||| NNS
.  ||| S:28847 E:28849 ||| .
Cell  ||| S:28849 E:28854 ||| NN
lysates  ||| S:28854 E:28862 ||| NN
from  ||| S:28862 E:28867 ||| IN
approximately  ||| S:28867 E:28881 ||| RB
2  ||| S:28881 E:28883 ||| CD
×  ||| S:28883 E:28885 ||| CD
10  ||| S:28885 E:28898 ||| CD
6cell  ||| S:28898 E:28904 ||| CD
equivalents  ||| S:28904 E:28916 ||| NNS
were  ||| S:28916 E:28921 ||| VBD
subjected  ||| S:28921 E:28931 ||| VBN
to  ||| S:28931 E:28934 ||| TO
12.5 ||| S:28934 E:28938 ||| CD
%  ||| S:28938 E:28940 ||| NN
SDS-PAGE ||| S:28940 E:28948 ||| NN
,  ||| S:28948 E:28960 ||| ,
transferred  ||| S:28960 E:28972 ||| VBN
onto  ||| S:28972 E:28977 ||| IN
PVDF  ||| S:28977 E:28982 ||| NNP
membranes  ||| S:28982 E:28992 ||| NNS
( ||| S:28992 E:28993 ||| -LRB-
Bio-rad ||| S:28993 E:29000 ||| NNP
,  ||| S:29000 E:29002 ||| ,
Richmond ||| S:29002 E:29010 ||| NNP
,  ||| S:29010 E:29012 ||| ,
CA ||| S:29012 E:29014 ||| NNP
) ||| S:29014 E:29015 ||| -RRB-
,  ||| S:29015 E:29027 ||| ,
then  ||| S:29027 E:29032 ||| RB
blocked  ||| S:29032 E:29040 ||| VBN
with  ||| S:29040 E:29045 ||| IN
5 ||| S:29045 E:29046 ||| CD
%  ||| S:29046 E:29048 ||| NN
BSA  ||| S:29048 E:29052 ||| NNP
and  ||| S:29052 E:29056 ||| CC
5 ||| S:29056 E:29057 ||| CD
%  ||| S:29057 E:29059 ||| NN
non-fat  ||| S:29059 E:29067 ||| JJ
milk ||| S:29067 E:29071 ||| NN
.  ||| S:29071 E:29073 ||| .
Membranes  ||| S:29073 E:29093 ||| NNP
were  ||| S:29093 E:29098 ||| VBD
extensively  ||| S:29098 E:29110 ||| RB
washed ||| S:29110 E:29116 ||| VBN
,  ||| S:29116 E:29118 ||| ,
then  ||| S:29118 E:29123 ||| RB
incubated  ||| S:29123 E:29133 ||| VBN
with  ||| S:29133 E:29138 ||| IN
the  ||| S:29138 E:29142 ||| DT
primary  ||| S:29142 E:29160 ||| JJ
( ||| S:29160 E:29161 ||| -LRB-
0.5  ||| S:29161 E:29165 ||| CD
μg ||| S:29165 E:29167 ||| CD
/ ||| S:29167 E:29168 ||| CD
ml ||| S:29168 E:29170 ||| CD
)  ||| S:29170 E:29172 ||| -RRB-
polyclonal  ||| S:29172 E:29183 ||| JJ
anti-RhoA ||| S:29183 E:29192 ||| NN
.  ||| S:29192 E:29194 ||| .
After  ||| S:29194 E:29200 ||| IN
washing ||| S:29200 E:29207 ||| NN
,  ||| S:29207 E:29219 ||| ,
membranes  ||| S:29219 E:29229 ||| NN
were  ||| S:29229 E:29234 ||| VBD
incubated  ||| S:29234 E:29244 ||| VBN
with  ||| S:29244 E:29249 ||| IN
Goat  ||| S:29249 E:29254 ||| NNP
anti-rabbit  ||| S:29254 E:29266 ||| JJ
polyclonal  ||| S:29266 E:29287 ||| JJ
antibody  ||| S:29287 E:29296 ||| NN
conjugated  ||| S:29296 E:29307 ||| NN
to  ||| S:29307 E:29310 ||| TO
HRP  ||| S:29310 E:29314 ||| NNP
( ||| S:29314 E:29315 ||| -LRB-
Cappel ||| S:29315 E:29321 ||| NNP
,  ||| S:29321 E:29323 ||| ,
Durham ||| S:29323 E:29329 ||| NNP
,  ||| S:29329 E:29331 ||| ,
NC ||| S:29331 E:29333 ||| NNP
) ||| S:29333 E:29334 ||| -RRB-
.  ||| S:29334 E:29346 ||| .
Chemiluminescence  ||| S:29346 E:29364 ||| NNP
was  ||| S:29364 E:29368 ||| VBD
performed  ||| S:29368 E:29378 ||| VBN
as  ||| S:29378 E:29381 ||| RB
described  ||| S:29381 E:29391 ||| VBN
by  ||| S:29391 E:29394 ||| IN
the  ||| S:29394 E:29408 ||| DT
manufacturer  ||| S:29408 E:29421 ||| NN
( ||| S:29421 E:29422 ||| -LRB-
Pierce ||| S:29422 E:29428 ||| NNP
,  ||| S:29428 E:29430 ||| ,
Rockford ||| S:29430 E:29438 ||| NNP
,  ||| S:29438 E:29440 ||| ,
IL ||| S:29440 E:29442 ||| NNP
) ||| S:29442 E:29443 ||| -RRB-
.  ||| S:29443 E:29473 ||| .
Cell  ||| S:29473 E:29478 ||| NNP
Adhesion  ||| S:29478 E:29487 ||| NNP
Assays  ||| S:29487 E:29504 ||| NNP
Adhesion  ||| S:29504 E:29513 ||| NNP
assays  ||| S:29513 E:29520 ||| NN
were  ||| S:29520 E:29525 ||| VBD
performed  ||| S:29525 E:29535 ||| VBN
in  ||| S:29535 E:29538 ||| IN
modified  ||| S:29538 E:29547 ||| FW
Tyrodes  ||| S:29547 E:29565 ||| FW
buffer  ||| S:29565 E:29572 ||| FW
[  ||| S:29572 E:29574 ||| -LRB-
30  ||| S:29574 E:29577 ||| CD
]  ||| S:29577 E:29579 ||| -RRB-
composed  ||| S:29579 E:29588 ||| VBN
of  ||| S:29588 E:29591 ||| IN
12  ||| S:29591 E:29594 ||| CD
mM  ||| S:29594 E:29597 ||| JJ
NaHCO  ||| S:29597 E:29614 ||| JJ
3  ||| S:29614 E:29616 ||| CD
( ||| S:29616 E:29617 ||| -LRB-
pH  ||| S:29617 E:29620 ||| NNP
7.4 ||| S:29620 E:29623 ||| CD
) ||| S:29623 E:29624 ||| -RRB-
,  ||| S:29624 E:29626 ||| ,
150  ||| S:29626 E:29630 ||| CD
mM  ||| S:29630 E:29633 ||| JJ
NaCl ||| S:29633 E:29637 ||| NN
,  ||| S:29637 E:29639 ||| ,
2.5  ||| S:29639 E:29643 ||| CD
mM  ||| S:29643 E:29646 ||| JJ
KCl ||| S:29646 E:29649 ||| NN
,  ||| S:29649 E:29651 ||| ,
2  ||| S:29651 E:29663 ||| CD
mM  ||| S:29663 E:29666 ||| JJ
MgCl  ||| S:29666 E:29682 ||| JJ
2  ||| S:29682 E:29684 ||| CD
,  ||| S:29684 E:29686 ||| ,
1  ||| S:29686 E:29688 ||| CD
mg ||| S:29688 E:29690 ||| CD
/ ||| S:29690 E:29691 ||| CD
ml  ||| S:29691 E:29694 ||| JJ
BSA ||| S:29694 E:29697 ||| NNP
,  ||| S:29697 E:29699 ||| ,
and  ||| S:29699 E:29703 ||| CC
1  ||| S:29703 E:29705 ||| CD
mg ||| S:29705 E:29707 ||| CD
/ ||| S:29707 E:29708 ||| CD
ml  ||| S:29708 E:29711 ||| JJ
glucose ||| S:29711 E:29718 ||| NN
.  ||| S:29718 E:29730 ||| .
Plates  ||| S:29730 E:29737 ||| NNP
were  ||| S:29737 E:29742 ||| VBD
pre-coated  ||| S:29742 E:29753 ||| JJ
with  ||| S:29753 E:29758 ||| IN
Fn  ||| S:29758 E:29761 ||| NNP
( ||| S:29761 E:29762 ||| -LRB-
10  ||| S:29762 E:29765 ||| CD
μg ||| S:29765 E:29767 ||| CD
/ ||| S:29767 E:29768 ||| CD
ml ||| S:29768 E:29770 ||| CD
)  ||| S:29770 E:29772 ||| -RRB-
for  ||| S:29772 E:29776 ||| IN
at  ||| S:29776 E:29779 ||| IN
least  ||| S:29779 E:29785 ||| JJS
2  ||| S:29785 E:29797 ||| CD
hours  ||| S:29797 E:29803 ||| NNS
at  ||| S:29803 E:29806 ||| IN
RT  ||| S:29806 E:29809 ||| NNP
in  ||| S:29809 E:29812 ||| IN
0.1  ||| S:29812 E:29816 ||| CD
M  ||| S:29816 E:29818 ||| NNP
NaHCO  ||| S:29818 E:29835 ||| NNP
3  ||| S:29835 E:29837 ||| CD
.  ||| S:29837 E:29839 ||| .
BSA  ||| S:29839 E:29843 ||| NNP
( ||| S:29843 E:29844 ||| -LRB-
2 ||| S:29844 E:29845 ||| CD
%  ||| S:29845 E:29847 ||| NN
w ||| S:29847 E:29848 ||| FW
/ ||| S:29848 E:29849 ||| FW
v ||| S:29849 E:29850 ||| FW
)  ||| S:29850 E:29852 ||| -RRB-
was  ||| S:29852 E:29856 ||| VBD
then  ||| S:29856 E:29861 ||| RB
added  ||| S:29861 E:29867 ||| VBD
to  ||| S:29867 E:29880 ||| TO
block  ||| S:29880 E:29886 ||| VB
unbound  ||| S:29886 E:29894 ||| JJ
sites ||| S:29894 E:29899 ||| NNS
.  ||| S:29899 E:29901 ||| .
Cells  ||| S:29901 E:29907 ||| NNS
were  ||| S:29907 E:29912 ||| VBD
resuspended  ||| S:29912 E:29924 ||| VBN
in  ||| S:29924 E:29927 ||| IN
modified  ||| S:29927 E:29946 ||| JJ
Tyrodes  ||| S:29946 E:29954 ||| JJ
buffer ||| S:29954 E:29960 ||| NN
.  ||| S:29960 E:29962 ||| .
After  ||| S:29962 E:29968 ||| IN
the  ||| S:29968 E:29972 ||| DT
cells  ||| S:29972 E:29978 ||| NNS
were  ||| S:29978 E:29983 ||| VBD
added  ||| S:29983 E:29989 ||| VBN
to  ||| S:29989 E:29992 ||| TO
the  ||| S:29992 E:29996 ||| DT
washed  ||| S:29996 E:30013 ||| JJ
plates  ||| S:30013 E:30020 ||| NN
in  ||| S:30020 E:30023 ||| IN
100  ||| S:30023 E:30027 ||| CD
μl  ||| S:30027 E:30030 ||| NN
of  ||| S:30030 E:30033 ||| IN
modified  ||| S:30033 E:30042 ||| JJ
tyrodes  ||| S:30042 E:30050 ||| NNS
( ||| S:30050 E:30051 ||| -LRB-
1  ||| S:30051 E:30053 ||| CD
×  ||| S:30053 E:30055 ||| CD
10  ||| S:30055 E:30058 ||| CD
5cells ||| S:30058 E:30064 ||| CD
) ||| S:30064 E:30065 ||| -RRB-
,  ||| S:30065 E:30077 ||| ,
plates  ||| S:30077 E:30084 ||| NN
were  ||| S:30084 E:30089 ||| VBD
spun  ||| S:30089 E:30094 ||| VBN
at  ||| S:30094 E:30097 ||| IN
300  ||| S:30097 E:30101 ||| CD
rpm  ||| S:30101 E:30105 ||| NN
for  ||| S:30105 E:30109 ||| IN
5  ||| S:30109 E:30111 ||| CD
min ||| S:30111 E:30114 ||| NN
,  ||| S:30114 E:30116 ||| ,
then  ||| S:30116 E:30121 ||| RB
incubated  ||| S:30121 E:30131 ||| VBN
for  ||| S:30131 E:30145 ||| IN
45  ||| S:30145 E:30148 ||| CD
min  ||| S:30148 E:30152 ||| NN
at  ||| S:30152 E:30155 ||| IN
37°C  ||| S:30155 E:30160 ||| NNP
and  ||| S:30160 E:30164 ||| CC
5 ||| S:30164 E:30165 ||| CD
%  ||| S:30165 E:30167 ||| NN
CO  ||| S:30167 E:30181 ||| NNP
2  ||| S:30181 E:30183 ||| CD
.  ||| S:30183 E:30185 ||| .
Two  ||| S:30185 E:30189 ||| CD
images  ||| S:30189 E:30196 ||| NNS
were  ||| S:30196 E:30201 ||| VBD
digitized  ||| S:30201 E:30211 ||| NNS
( ||| S:30211 E:30212 ||| -LRB-
see  ||| S:30212 E:30226 ||| VB
above ||| S:30226 E:30231 ||| IN
)  ||| S:30231 E:30233 ||| -RRB-
from  ||| S:30233 E:30238 ||| IN
each  ||| S:30238 E:30243 ||| DT
well  ||| S:30243 E:30248 ||| RB
before  ||| S:30248 E:30255 ||| IN
washing ||| S:30255 E:30262 ||| NN
,  ||| S:30262 E:30264 ||| ,
then  ||| S:30264 E:30269 ||| RB
plates  ||| S:30269 E:30276 ||| RB
were  ||| S:30276 E:30291 ||| VBD
carefully  ||| S:30291 E:30301 ||| RB
washed  ||| S:30301 E:30308 ||| VBD
4  ||| S:30308 E:30310 ||| CD
×  ||| S:30310 E:30312 ||| CD
with  ||| S:30312 E:30317 ||| IN
pre-warmed  ||| S:30317 E:30328 ||| NNP
( ||| S:30328 E:30329 ||| -LRB-
37°C ||| S:30329 E:30333 ||| NNP
)  ||| S:30333 E:30335 ||| -RRB-
modified  ||| S:30335 E:30354 ||| VBN
Tyrodes  ||| S:30354 E:30362 ||| JJ
buffer ||| S:30362 E:30368 ||| NN
.  ||| S:30368 E:30370 ||| .
After  ||| S:30370 E:30376 ||| IN
washing ||| S:30376 E:30383 ||| NN
,  ||| S:30383 E:30385 ||| ,
images  ||| S:30385 E:30392 ||| NNS
from  ||| S:30392 E:30397 ||| IN
the  ||| S:30397 E:30401 ||| DT
same  ||| S:30401 E:30416 ||| JJ
position  ||| S:30416 E:30425 ||| NN
were  ||| S:30425 E:30430 ||| VBD
digitized ||| S:30430 E:30439 ||| VBN
.  ||| S:30439 E:30441 ||| .
Cell  ||| S:30441 E:30446 ||| NN
numbers  ||| S:30446 E:30454 ||| NNS
were  ||| S:30454 E:30459 ||| VBD
quantitated  ||| S:30459 E:30481 ||| VBN
using  ||| S:30481 E:30487 ||| VBG
NIH  ||| S:30487 E:30491 ||| NNP
Image  ||| S:30491 E:30497 ||| NNP
software ||| S:30497 E:30505 ||| NN
,  ||| S:30505 E:30507 ||| ,
and  ||| S:30507 E:30511 ||| CC
adhesion  ||| S:30511 E:30520 ||| JJ
assays  ||| S:30520 E:30527 ||| NNS
are  ||| S:30527 E:30531 ||| VBP
graphed  ||| S:30531 E:30549 ||| VBN
as  ||| S:30549 E:30552 ||| IN
the  ||| S:30552 E:30556 ||| DT
percentage  ||| S:30556 E:30567 ||| NN
of  ||| S:30567 E:30570 ||| IN
input  ||| S:30570 E:30576 ||| NN
cells  ||| S:30576 E:30582 ||| NNS
remaining  ||| S:30582 E:30592 ||| VBG
after  ||| S:30592 E:30608 ||| IN
washing ||| S:30608 E:30615 ||| NN
.  ||| S:30615 E:30645 ||| .
Electroporation  ||| S:30645 E:30661 ||| NNP
of  ||| S:30661 E:30664 ||| IN
C3  ||| S:30664 E:30667 ||| CD
into  ||| S:30667 E:30672 ||| IN
HPB-ALL  ||| S:30672 E:30680 ||| JJ
cells  ||| S:30680 E:30696 ||| NNS
HPB-ALL  ||| S:30696 E:30704 ||| JJ
cells  ||| S:30704 E:30710 ||| NNS
were  ||| S:30710 E:30715 ||| VBD
washed  ||| S:30715 E:30722 ||| VBN
in  ||| S:30722 E:30725 ||| IN
RPMI-1640  ||| S:30725 E:30735 ||| NNP
and  ||| S:30735 E:30739 ||| CC
resuspended  ||| S:30739 E:30761 ||| NN
between  ||| S:30761 E:30769 ||| IN
1-2  ||| S:30769 E:30773 ||| CD
×  ||| S:30773 E:30775 ||| CD
10  ||| S:30775 E:30778 ||| CD
6cells  ||| S:30778 E:30785 ||| CD
per  ||| S:30785 E:30789 ||| IN
100  ||| S:30789 E:30793 ||| CD
μl  ||| S:30793 E:30796 ||| CD
RPMI-1640 ||| S:30796 E:30805 ||| CD
.  ||| S:30805 E:30807 ||| .
Control  ||| S:30807 E:30825 ||| NN
cells  ||| S:30825 E:30831 ||| NNS
were  ||| S:30831 E:30836 ||| VBD
electroporated  ||| S:30836 E:30851 ||| VBN
with  ||| S:30851 E:30856 ||| IN
the  ||| S:30856 E:30860 ||| DT
indicated  ||| S:30860 E:30870 ||| JJ
control  ||| S:30870 E:30888 ||| NN
buffers ||| S:30888 E:30895 ||| NN
.  ||| S:30895 E:30897 ||| .
Cell  ||| S:30897 E:30902 ||| NN
samples  ||| S:30902 E:30910 ||| NNS
were  ||| S:30910 E:30915 ||| VBD
placed  ||| S:30915 E:30922 ||| VBN
into  ||| S:30922 E:30927 ||| IN
pre-chilled  ||| S:30927 E:30939 ||| NNP
( ||| S:30939 E:30940 ||| -LRB-
4°C ||| S:30940 E:30943 ||| NNP
)  ||| S:30943 E:30955 ||| -RRB-
4  ||| S:30955 E:30957 ||| CD
mm  ||| S:30957 E:30960 ||| NNS
or  ||| S:30960 E:30963 ||| CC
1  ||| S:30963 E:30965 ||| CD
mm  ||| S:30965 E:30968 ||| FW
electroporation  ||| S:30968 E:30984 ||| FW
cuvettes  ||| S:30984 E:30993 ||| FW
( ||| S:30993 E:30994 ||| -LRB-
BTX  ||| S:30994 E:30998 ||| NNP
Inc. ||| S:30998 E:31002 ||| NNP
,  ||| S:31002 E:31004 ||| ,
San  ||| S:31004 E:31018 ||| NNP
Diego ||| S:31018 E:31023 ||| NNP
,  ||| S:31023 E:31025 ||| ,
CA ||| S:31025 E:31027 ||| NNP
)  ||| S:31027 E:31029 ||| -RRB-
and  ||| S:31029 E:31033 ||| CC
electroporated  ||| S:31033 E:31048 ||| NN
under  ||| S:31048 E:31054 ||| IN
the  ||| S:31054 E:31058 ||| DT
following  ||| S:31058 E:31078 ||| JJ
conditions ||| S:31078 E:31088 ||| NNS
:  ||| S:31088 E:31090 ||| :
500  ||| S:31090 E:31094 ||| CD
V ||| S:31094 E:31095 ||| NNP
/ ||| S:31095 E:31096 ||| NNP
capacitance  ||| S:31096 E:31108 ||| NN
and  ||| S:31108 E:31112 ||| CC
resistance ||| S:31112 E:31122 ||| NN
,  ||| S:31122 E:31124 ||| ,
1250  ||| S:31124 E:31129 ||| CD
μF  ||| S:31129 E:31142 ||| JJ
capacitance  ||| S:31142 E:31154 ||| JJ
timing ||| S:31154 E:31160 ||| NN
,  ||| S:31160 E:31162 ||| ,
720  ||| S:31162 E:31166 ||| CD
ohms  ||| S:31166 E:31171 ||| JJ
resistance ||| S:31171 E:31181 ||| NN
,  ||| S:31181 E:31183 ||| ,
and  ||| S:31183 E:31187 ||| CC
270  ||| S:31187 E:31191 ||| CD
V  ||| S:31191 E:31193 ||| NNP
for  ||| S:31193 E:31197 ||| IN
4  ||| S:31197 E:31209 ||| CD
mm  ||| S:31209 E:31212 ||| JJ
gap  ||| S:31212 E:31216 ||| NN
cuvettes  ||| S:31216 E:31225 ||| NNS
or  ||| S:31225 E:31228 ||| CC
68  ||| S:31228 E:31231 ||| CD
V  ||| S:31231 E:31233 ||| NNP
for  ||| S:31233 E:31237 ||| IN
1  ||| S:31237 E:31239 ||| CD
mm  ||| S:31239 E:31242 ||| JJ
gap  ||| S:31242 E:31246 ||| NN
cuvettes  ||| S:31246 E:31255 ||| NNS
( ||| S:31255 E:31256 ||| -LRB-
field  ||| S:31256 E:31272 ||| NN
strength  ||| S:31272 E:31281 ||| NN
of  ||| S:31281 E:31284 ||| IN
~700  ||| S:31284 E:31289 ||| NNP
Vcm  ||| S:31289 E:31293 ||| NNP
-1 ||| S:31293 E:31295 ||| NNP
) ||| S:31295 E:31296 ||| -RRB-
.  ||| S:31296 E:31298 ||| .
Both  ||| S:31298 E:31303 ||| DT
antibodies  ||| S:31303 E:31314 ||| NNS
and  ||| S:31314 E:31318 ||| CC
C3  ||| S:31318 E:31321 ||| NNP
were  ||| S:31321 E:31336 ||| VBD
electroporated  ||| S:31336 E:31351 ||| VBN
at  ||| S:31351 E:31354 ||| IN
a  ||| S:31354 E:31356 ||| DT
final  ||| S:31356 E:31362 ||| JJ
concentration  ||| S:31362 E:31376 ||| NN
of  ||| S:31376 E:31379 ||| IN
25  ||| S:31379 E:31382 ||| CD
μg ||| S:31382 E:31384 ||| CD
/ ||| S:31384 E:31385 ||| CD
ml ||| S:31385 E:31387 ||| NN
,  ||| S:31387 E:31399 ||| ,
incubated  ||| S:31399 E:31409 ||| VBG
on  ||| S:31409 E:31412 ||| IN
ice  ||| S:31412 E:31416 ||| NN
for  ||| S:31416 E:31420 ||| IN
5  ||| S:31420 E:31422 ||| CD
min ||| S:31422 E:31425 ||| NN
,  ||| S:31425 E:31427 ||| ,
then  ||| S:31427 E:31432 ||| RB
washed  ||| S:31432 E:31439 ||| VBN
with  ||| S:31439 E:31444 ||| IN
complete  ||| S:31444 E:31463 ||| JJ
media  ||| S:31463 E:31469 ||| NNS
at  ||| S:31469 E:31472 ||| IN
room  ||| S:31472 E:31477 ||| NN
temperature  ||| S:31477 E:31489 ||| NN
and  ||| S:31489 E:31493 ||| CC
used  ||| S:31493 E:31498 ||| VBN
for  ||| S:31498 E:31502 ||| IN
assays ||| S:31502 E:31508 ||| NN
.  ||| S:31508 E:31510 ||| .
Control  ||| S:31510 E:31528 ||| NN
buffer  ||| S:31528 E:31535 ||| NN
for  ||| S:31535 E:31539 ||| IN
electroporation  ||| S:31539 E:31555 ||| NN
of  ||| S:31555 E:31558 ||| IN
C3  ||| S:31558 E:31561 ||| NNP
consisted  ||| S:31561 E:31571 ||| VBD
of  ||| S:31571 E:31574 ||| IN
the  ||| S:31574 E:31578 ||| DT
buffers  ||| S:31578 E:31596 ||| NN
used  ||| S:31596 E:31601 ||| VBN
in  ||| S:31601 E:31604 ||| IN
the  ||| S:31604 E:31608 ||| DT
purification  ||| S:31608 E:31621 ||| NN
of  ||| S:31621 E:31624 ||| IN
C3 ||| S:31624 E:31626 ||| NNP
,  ||| S:31626 E:31628 ||| ,
including  ||| S:31628 E:31638 ||| VBG
the  ||| S:31638 E:31642 ||| DT
appropriate  ||| S:31642 E:31664 ||| JJ
concentration  ||| S:31664 E:31678 ||| NN
of  ||| S:31678 E:31681 ||| IN
bovine  ||| S:31681 E:31688 ||| JJ
α-thrombin  ||| S:31688 E:31699 ||| NN
[  ||| S:31699 E:31701 ||| -LRB-
25  ||| S:31701 E:31704 ||| CD
]  ||| S:31704 E:31706 ||| -RRB-
.  ||| S:31706 E:31708 ||| .
All  ||| S:31708 E:31722 ||| DT
electroporation  ||| S:31722 E:31738 ||| NN
of  ||| S:31738 E:31741 ||| IN
proteins  ||| S:31741 E:31750 ||| NNS
were  ||| S:31750 E:31755 ||| VBD
carried  ||| S:31755 E:31763 ||| VBN
out  ||| S:31763 E:31767 ||| RP
on  ||| S:31767 E:31770 ||| IN
an  ||| S:31770 E:31783 ||| DT
Electro  ||| S:31783 E:31791 ||| NNP
Cell  ||| S:31791 E:31796 ||| NNP
Manipulator  ||| S:31796 E:31808 ||| NNP
600  ||| S:31808 E:31812 ||| CD
( ||| S:31812 E:31813 ||| -LRB-
BTX  ||| S:31813 E:31817 ||| NNP
Inc. ||| S:31817 E:31821 ||| NNP
) ||| S:31821 E:31822 ||| -RRB-
.  ||| S:31822 E:31824 ||| .
This  ||| S:31824 E:31829 ||| DT
procedure  ||| S:31829 E:31849 ||| NN
had  ||| S:31849 E:31853 ||| VBD
previously  ||| S:31853 E:31864 ||| RB
been  ||| S:31864 E:31869 ||| VBN
optimized  ||| S:31869 E:31879 ||| VBN
for  ||| S:31879 E:31883 ||| IN
intracellular  ||| S:31883 E:31907 ||| JJ
incorporation  ||| S:31907 E:31921 ||| NN
of  ||| S:31921 E:31924 ||| IN
macromolecules  ||| S:31924 E:31939 ||| NN
by  ||| S:31939 E:31942 ||| IN
electroporation  ||| S:31942 E:31958 ||| NN
of  ||| S:31958 E:31971 ||| IN
goat  ||| S:31971 E:31976 ||| FW
anti-mouse  ||| S:31976 E:31987 ||| FW
FITC  ||| S:31987 E:31992 ||| FW
conjugated  ||| S:31992 E:32003 ||| FW
antibodies ||| S:32003 E:32013 ||| FW
.  ||| S:32013 E:32025 ||| .
Electroporation  ||| S:32025 E:32041 ||| JJ
efficiency  ||| S:32041 E:32052 ||| NN
during  ||| S:32052 E:32059 ||| IN
the  ||| S:32059 E:32063 ||| DT
optimization  ||| S:32063 E:32086 ||| JJ
procedure  ||| S:32086 E:32096 ||| NN
was  ||| S:32096 E:32100 ||| VBD
monitored  ||| S:32100 E:32110 ||| VBN
by  ||| S:32110 E:32113 ||| IN
FACS  ||| S:32113 E:32118 ||| NNP
analysis  ||| S:32118 E:32127 ||| NN
and  ||| S:32127 E:32131 ||| CC
fluorescence  ||| S:32131 E:32154 ||| JJ
imaging  ||| S:32154 E:32162 ||| NN
( ||| S:32162 E:32163 ||| -LRB-
data  ||| S:32163 E:32168 ||| NNS
not  ||| S:32168 E:32172 ||| RB
shown ||| S:32172 E:32177 ||| VBN
) ||| S:32177 E:32178 ||| -RRB-
.  ||| S:32178 E:32208 ||| .
C3  ||| S:32208 E:32211 ||| NNP
Ribosylation  ||| S:32211 E:32234 ||| NNP
Purified  ||| S:32234 E:32243 ||| NNP
C3  ||| S:32243 E:32246 ||| NNP
or  ||| S:32246 E:32249 ||| CC
BSA  ||| S:32249 E:32253 ||| NNP
control  ||| S:32253 E:32261 ||| NN
were  ||| S:32261 E:32266 ||| VBD
electroporated  ||| S:32266 E:32281 ||| VBN
at  ||| S:32281 E:32284 ||| IN
a  ||| S:32284 E:32296 ||| DT
concentration  ||| S:32296 E:32310 ||| NN
of  ||| S:32310 E:32313 ||| IN
25  ||| S:32313 E:32316 ||| CD
μg ||| S:32316 E:32318 ||| CD
/ ||| S:32318 E:32319 ||| CD
ml ||| S:32319 E:32321 ||| NNS
.  ||| S:32321 E:32323 ||| .
After  ||| S:32323 E:32329 ||| IN
electroporation ||| S:32329 E:32344 ||| NN
,  ||| S:32344 E:32346 ||| ,
cells  ||| S:32346 E:32362 ||| NNS
were  ||| S:32362 E:32367 ||| VBD
transferred  ||| S:32367 E:32379 ||| VBN
into  ||| S:32379 E:32384 ||| IN
1.5  ||| S:32384 E:32388 ||| CD
ml  ||| S:32388 E:32391 ||| CD
eppendorf  ||| S:32391 E:32401 ||| CD
tubes  ||| S:32401 E:32407 ||| NNS
and  ||| S:32407 E:32421 ||| CC
incubated  ||| S:32421 E:32431 ||| NN
for  ||| S:32431 E:32435 ||| IN
1  ||| S:32435 E:32437 ||| CD
hr  ||| S:32437 E:32440 ||| NN
at  ||| S:32440 E:32443 ||| IN
37°C  ||| S:32443 E:32448 ||| CD
to  ||| S:32448 E:32451 ||| TO
allow  ||| S:32451 E:32457 ||| VB
ribosylation ||| S:32457 E:32469 ||| NNS
.  ||| S:32469 E:32471 ||| .
Cells  ||| S:32471 E:32487 ||| NNS
were  ||| S:32487 E:32492 ||| VBD
then  ||| S:32492 E:32497 ||| RB
washed  ||| S:32497 E:32504 ||| VBN
extensively  ||| S:32504 E:32516 ||| RB
in  ||| S:32516 E:32519 ||| IN
1 ||| S:32519 E:32520 ||| CD
%  ||| S:32520 E:32522 ||| NN
BSA ||| S:32522 E:32525 ||| NNP
/ ||| S:32525 E:32526 ||| NNP
PBS  ||| S:32526 E:32530 ||| NNP
to  ||| S:32530 E:32533 ||| TO
remove  ||| S:32533 E:32540 ||| VB
any  ||| S:32540 E:32554 ||| DT
C3  ||| S:32554 E:32557 ||| NN
not  ||| S:32557 E:32561 ||| RB
incorporated  ||| S:32561 E:32574 ||| VBN
into  ||| S:32574 E:32579 ||| IN
the  ||| S:32579 E:32583 ||| DT
cells ||| S:32583 E:32588 ||| NNS
.  ||| S:32588 E:32590 ||| .
Next ||| S:32590 E:32594 ||| JJ
,  ||| S:32594 E:32596 ||| ,
the  ||| S:32596 E:32600 ||| DT
cells  ||| S:32600 E:32606 ||| NNS
were  ||| S:32606 E:32621 ||| VBD
resuspended  ||| S:32621 E:32633 ||| VBN
at  ||| S:32633 E:32636 ||| IN
3  ||| S:32636 E:32638 ||| CD
×  ||| S:32638 E:32640 ||| CD
10  ||| S:32640 E:32643 ||| CD
6cells ||| S:32643 E:32649 ||| CD
/ ||| S:32649 E:32650 ||| CD
ml  ||| S:32650 E:32653 ||| NN
in  ||| S:32653 E:32656 ||| IN
ice  ||| S:32656 E:32660 ||| NN
cold  ||| S:32660 E:32665 ||| JJ
sonication  ||| S:32665 E:32686 ||| JJ
buffer  ||| S:32686 E:32693 ||| NN
( ||| S:32693 E:32694 ||| -LRB-
250  ||| S:32694 E:32698 ||| CD
mM  ||| S:32698 E:32701 ||| JJ
sucrose ||| S:32701 E:32708 ||| NN
;  ||| S:32708 E:32710 ||| :
10  ||| S:32710 E:32713 ||| CD
mM  ||| S:32713 E:32716 ||| JJ
HEPES ||| S:32716 E:32721 ||| NNP
,  ||| S:32721 E:32723 ||| ,
pH  ||| S:32723 E:32726 ||| JJ
7.4 ||| S:32726 E:32729 ||| CD
;  ||| S:32729 E:32731 ||| :
1  ||| S:32731 E:32733 ||| CD
mM  ||| S:32733 E:32736 ||| JJ
EDTA ||| S:32736 E:32740 ||| NNP
;  ||| S:32740 E:32742 ||| :
5  ||| S:32742 E:32754 ||| CD
mM  ||| S:32754 E:32757 ||| JJ
MgCl  ||| S:32757 E:32773 ||| JJ
2  ||| S:32773 E:32775 ||| CD
;  ||| S:32775 E:32777 ||| :
1  ||| S:32777 E:32779 ||| CD
mM  ||| S:32779 E:32782 ||| JJ
DTT ||| S:32782 E:32785 ||| NNP
;  ||| S:32785 E:32787 ||| :
0.1  ||| S:32787 E:32791 ||| CD
mM  ||| S:32791 E:32794 ||| JJ
GTP ||| S:32794 E:32797 ||| NNP
;  ||| S:32797 E:32799 ||| :
1  ||| S:32799 E:32801 ||| CD
μg ||| S:32801 E:32803 ||| CD
/ ||| S:32803 E:32804 ||| CD
ml  ||| S:32804 E:32817 ||| JJ
leupeptin ||| S:32817 E:32826 ||| NN
,  ||| S:32826 E:32828 ||| ,
1  ||| S:32828 E:32830 ||| CD
μg ||| S:32830 E:32832 ||| FW
/ ||| S:32832 E:32833 ||| FW
ml  ||| S:32833 E:32836 ||| FW
pepstatin  ||| S:32836 E:32846 ||| FW
A ||| S:32846 E:32847 ||| NNP
,  ||| S:32847 E:32849 ||| ,
and  ||| S:32849 E:32853 ||| CC
1  ||| S:32853 E:32855 ||| CD
μg ||| S:32855 E:32857 ||| CD
/ ||| S:32857 E:32858 ||| CD
ml  ||| S:32858 E:32861 ||| CD
aprotinin ||| S:32861 E:32870 ||| NNS
;  ||| S:32870 E:32872 ||| :
1  ||| S:32872 E:32884 ||| CD
mM  ||| S:32884 E:32887 ||| JJ
PMSF ||| S:32887 E:32891 ||| NNP
)  ||| S:32891 E:32893 ||| -RRB-
and  ||| S:32893 E:32897 ||| CC
sonicated  ||| S:32897 E:32907 ||| NN
for  ||| S:32907 E:32911 ||| IN
10  ||| S:32911 E:32914 ||| CD
seconds ||| S:32914 E:32921 ||| NNS
.  ||| S:32921 E:32923 ||| .
After  ||| S:32923 E:32929 ||| IN
sonication  ||| S:32929 E:32950 ||| NN
with  ||| S:32950 E:32955 ||| IN
a  ||| S:32955 E:32957 ||| DT
Sonic  ||| S:32957 E:32963 ||| NNP
Dismembrator  ||| S:32963 E:32976 ||| NNP
Model  ||| S:32976 E:32982 ||| NNP
300  ||| S:32982 E:32986 ||| CD
with  ||| S:32986 E:32991 ||| IN
microtip  ||| S:32991 E:33010 ||| NNS
( ||| S:33010 E:33011 ||| -LRB-
Fisher ||| S:33011 E:33017 ||| NNP
) ||| S:33017 E:33018 ||| -RRB-
,  ||| S:33018 E:33020 ||| ,
100  ||| S:33020 E:33024 ||| CD
μl  ||| S:33024 E:33027 ||| NN
of  ||| S:33027 E:33030 ||| IN
the  ||| S:33030 E:33034 ||| DT
mixture  ||| S:33034 E:33042 ||| NN
was  ||| S:33042 E:33046 ||| VBD
added  ||| S:33046 E:33052 ||| VBN
to  ||| S:33052 E:33055 ||| TO
50  ||| S:33055 E:33058 ||| CD
μl  ||| S:33058 E:33061 ||| NN
of  ||| S:33061 E:33064 ||| IN
3  ||| S:33064 E:33066 ||| CD
×  ||| S:33066 E:33078 ||| CD
reaction  ||| S:33078 E:33087 ||| NN
buffer  ||| S:33087 E:33094 ||| NN
containing  ||| S:33094 E:33105 ||| VBG
150  ||| S:33105 E:33109 ||| CD
mM  ||| S:33109 E:33112 ||| JJ
Tris-HCl ||| S:33112 E:33120 ||| NN
,  ||| S:33120 E:33122 ||| ,
pH  ||| S:33122 E:33125 ||| NNP
8.0 ||| S:33125 E:33128 ||| NNP
;  ||| S:33128 E:33130 ||| :
30  ||| S:33130 E:33133 ||| CD
mM  ||| S:33133 E:33146 ||| JJ
thymidine ||| S:33146 E:33155 ||| NN
;  ||| S:33155 E:33157 ||| :
3  ||| S:33157 E:33159 ||| CD
mM  ||| S:33159 E:33162 ||| JJ
DTT ||| S:33162 E:33165 ||| NNP
;  ||| S:33165 E:33167 ||| :
5  ||| S:33167 E:33169 ||| CD
mM  ||| S:33169 E:33172 ||| JJ
MgCl  ||| S:33172 E:33188 ||| JJ
2  ||| S:33188 E:33190 ||| CD
,  ||| S:33190 E:33192 ||| ,
0.3  ||| S:33192 E:33196 ||| CD
mM  ||| S:33196 E:33199 ||| JJ
GTP ||| S:33199 E:33202 ||| NNP
.  ||| S:33202 E:33204 ||| .
To  ||| S:33204 E:33207 ||| TO
this  ||| S:33207 E:33212 ||| DT
mixture ||| S:33212 E:33219 ||| NN
,  ||| S:33219 E:33221 ||| ,
1.0  ||| S:33221 E:33235 ||| CD
μg  ||| S:33235 E:33238 ||| CD
purified  ||| S:33238 E:33247 ||| CD
C3  ||| S:33247 E:33250 ||| CD
and  ||| S:33250 E:33254 ||| CC
2  ||| S:33254 E:33256 ||| CD
μCi  ||| S:33256 E:33260 ||| NNS
[  ||| S:33260 E:33262 ||| -LRB-
32P ||| S:33262 E:33265 ||| NNP
] ||| S:33265 E:33266 ||| -RRB-
-NAD  ||| S:33266 E:33271 ||| NNP
( ||| S:33271 E:33272 ||| -LRB-
NEN-Dupont ||| S:33272 E:33282 ||| NNP
,  ||| S:33282 E:33284 ||| ,
Boston ||| S:33284 E:33290 ||| NNP
,  ||| S:33290 E:33302 ||| ,
MA ||| S:33302 E:33304 ||| NNP
)  ||| S:33304 E:33306 ||| -RRB-
were  ||| S:33306 E:33311 ||| VBD
added ||| S:33311 E:33316 ||| VBN
.  ||| S:33316 E:33318 ||| .
After  ||| S:33318 E:33324 ||| IN
incubation  ||| S:33324 E:33335 ||| NN
for  ||| S:33335 E:33339 ||| IN
1  ||| S:33339 E:33341 ||| CD
hr  ||| S:33341 E:33344 ||| NN
at  ||| S:33344 E:33347 ||| IN
37°C ||| S:33347 E:33351 ||| NNP
,  ||| S:33351 E:33353 ||| ,
SDS  ||| S:33353 E:33367 ||| NNP
was  ||| S:33367 E:33371 ||| VBD
added  ||| S:33371 E:33377 ||| VBN
to  ||| S:33377 E:33380 ||| TO
2 ||| S:33380 E:33381 ||| CD
%  ||| S:33381 E:33383 ||| NN
final  ||| S:33383 E:33389 ||| JJ
w ||| S:33389 E:33390 ||| NN
/ ||| S:33390 E:33391 ||| CD
v  ||| S:33391 E:33393 ||| NNS
and  ||| S:33393 E:33397 ||| CC
this  ||| S:33397 E:33402 ||| DT
mixture  ||| S:33402 E:33410 ||| NN
was  ||| S:33410 E:33414 ||| VBD
immersed  ||| S:33414 E:33433 ||| VBN
in  ||| S:33433 E:33436 ||| IN
a  ||| S:33436 E:33438 ||| DT
boiling  ||| S:33438 E:33446 ||| JJ
water  ||| S:33446 E:33452 ||| NN
bath  ||| S:33452 E:33457 ||| NN
for  ||| S:33457 E:33461 ||| IN
10  ||| S:33461 E:33464 ||| CD
min ||| S:33464 E:33467 ||| NNS
.  ||| S:33467 E:33469 ||| .
Eight  ||| S:33469 E:33475 ||| CD
volumes  ||| S:33475 E:33483 ||| NNS
of  ||| S:33483 E:33486 ||| IN
ice  ||| S:33486 E:33500 ||| NN
cold  ||| S:33500 E:33505 ||| JJ
ethanol  ||| S:33505 E:33513 ||| NN
was  ||| S:33513 E:33517 ||| VBD
then  ||| S:33517 E:33522 ||| RB
added ||| S:33522 E:33527 ||| VBD
,  ||| S:33527 E:33529 ||| ,
and  ||| S:33529 E:33533 ||| CC
these  ||| S:33533 E:33539 ||| DT
samples  ||| S:33539 E:33547 ||| NNS
were  ||| S:33547 E:33552 ||| VBD
kept  ||| S:33552 E:33567 ||| VBN
at  ||| S:33567 E:33570 ||| IN
-20°C  ||| S:33570 E:33576 ||| CD
for  ||| S:33576 E:33580 ||| IN
at  ||| S:33580 E:33583 ||| IN
least  ||| S:33583 E:33589 ||| JJS
1  ||| S:33589 E:33591 ||| CD
hr ||| S:33591 E:33593 ||| NNS
.  ||| S:33593 E:33595 ||| .
Precipitated  ||| S:33595 E:33608 ||| JJ
proteins  ||| S:33608 E:33617 ||| NNS
were  ||| S:33617 E:33632 ||| VBD
pelleted ||| S:33632 E:33640 ||| CD
,  ||| S:33640 E:33642 ||| ,
and  ||| S:33642 E:33646 ||| CC
dissolved  ||| S:33646 E:33656 ||| VBN
in  ||| S:33656 E:33659 ||| IN
SDS-PAGE  ||| S:33659 E:33668 ||| JJ
sample  ||| S:33668 E:33675 ||| NN
buffer  ||| S:33675 E:33682 ||| NN
by  ||| S:33682 E:33695 ||| IN
boiling  ||| S:33695 E:33703 ||| VBG
for  ||| S:33703 E:33707 ||| IN
10  ||| S:33707 E:33710 ||| CD
min ||| S:33710 E:33713 ||| NNS
.  ||| S:33713 E:33715 ||| .
Samples  ||| S:33715 E:33723 ||| NNS
were  ||| S:33723 E:33728 ||| VBD
then  ||| S:33728 E:33733 ||| RB
subjected  ||| S:33733 E:33743 ||| VBN
to  ||| S:33743 E:33746 ||| TO
12.5 ||| S:33746 E:33750 ||| CD
%  ||| S:33750 E:33762 ||| NN
SDS-PAGE  ||| S:33762 E:33771 ||| NN
and  ||| S:33771 E:33775 ||| CC
analyzed  ||| S:33775 E:33784 ||| VBD
by  ||| S:33784 E:33787 ||| IN
autoradiography ||| S:33787 E:33802 ||| NN
.  ||| S:33802 E:33835 ||| .
Authors ||| S:33835 E:33842 ||| NNP
'  ||| S:33842 E:33844 ||| POS
Contributions  ||| S:33844 E:33866 ||| NNP
DGW  ||| S:33866 E:33870 ||| NNP
drafted  ||| S:33870 E:33878 ||| VBD
the  ||| S:33878 E:33882 ||| DT
manuscript ||| S:33882 E:33892 ||| NN
,  ||| S:33892 E:33894 ||| ,
performed  ||| S:33894 E:33904 ||| VBD
ADP-ribosylation  ||| S:33904 E:33929 ||| JJ
experiments ||| S:33929 E:33940 ||| NNS
,  ||| S:33940 E:33942 ||| ,
adhesion  ||| S:33942 E:33951 ||| NN
and  ||| S:33951 E:33955 ||| CC
spreading  ||| S:33955 E:33965 ||| VBG
assays ||| S:33965 E:33971 ||| NN
,  ||| S:33971 E:33973 ||| ,
and  ||| S:33973 E:33985 ||| CC
immunofluorescence ||| S:33985 E:34003 ||| NN
.  ||| S:34003 E:34005 ||| .
DKW  ||| S:34005 E:34009 ||| NNP
and  ||| S:34009 E:34013 ||| CC
TU  ||| S:34013 E:34016 ||| NNP
expressed  ||| S:34016 E:34026 ||| VBD
and  ||| S:34026 E:34030 ||| CC
purified  ||| S:34030 E:34039 ||| CD
C3  ||| S:34039 E:34050 ||| CD
exoenzyme ||| S:34050 E:34059 ||| NNS
.  ||| S:34059 E:34061 ||| .
TKT  ||| S:34061 E:34065 ||| NNP
performed  ||| S:34065 E:34075 ||| VBD
initial  ||| S:34075 E:34083 ||| JJ
spreading  ||| S:34083 E:34093 ||| VBG
experiments  ||| S:34093 E:34105 ||| NNS
and  ||| S:34105 E:34117 ||| CC
video  ||| S:34117 E:34123 ||| JJ
time  ||| S:34123 E:34128 ||| NN
lapse  ||| S:34128 E:34134 ||| NN
microscopy ||| S:34134 E:34144 ||| NN
.  ||| S:34144 E:34146 ||| .
YM  ||| S:34146 E:34149 ||| NNP
performed  ||| S:34149 E:34159 ||| VBD
experiments  ||| S:34159 E:34171 ||| NNS
on  ||| S:34171 E:34182 ||| IN
activated  ||| S:34182 E:34192 ||| JJ
human  ||| S:34192 E:34198 ||| JJ
T  ||| S:34198 E:34200 ||| NN
cells ||| S:34200 E:34205 ||| NNS
.  ||| S:34205 E:34207 ||| .
EGC  ||| S:34207 E:34211 ||| NNP
helped  ||| S:34211 E:34218 ||| VBD
generate  ||| S:34218 E:34227 ||| VB
the  ||| S:34227 E:34231 ||| DT
methods  ||| S:34231 E:34239 ||| NNS
to  ||| S:34239 E:34250 ||| TO
electroporate  ||| S:34250 E:34264 ||| VB
suspension  ||| S:34264 E:34275 ||| NN
cells  ||| S:34275 E:34281 ||| NNS
with  ||| S:34281 E:34286 ||| IN
C3  ||| S:34286 E:34289 ||| CD
exotoxin ||| S:34289 E:34297 ||| NNS
.  ||| S:34297 E:34299 ||| .
BFA  ||| S:34299 E:34311 ||| NNP
quantitated  ||| S:34311 E:34323 ||| VBD
the  ||| S:34323 E:34327 ||| DT
time-resolved  ||| S:34327 E:34341 ||| JJ
morphological  ||| S:34341 E:34355 ||| JJ
alterations ||| S:34355 E:34366 ||| NN
.  ||| S:34366 E:34376 ||| .
BWM  ||| S:34376 E:34380 ||| NNP
aided  ||| S:34380 E:34386 ||| VBD
in  ||| S:34386 E:34389 ||| IN
the  ||| S:34389 E:34393 ||| DT
conception ||| S:34393 E:34403 ||| NN
,  ||| S:34403 E:34405 ||| ,
design ||| S:34405 E:34411 ||| NN
,  ||| S:34411 E:34413 ||| ,
and  ||| S:34413 E:34417 ||| CC
implementation  ||| S:34417 E:34432 ||| NN
of  ||| S:34432 E:34443 ||| IN
the  ||| S:34443 E:34447 ||| DT
experiments ||| S:34447 E:34458 ||| NNS
,  ||| S:34458 E:34460 ||| ,
and  ||| S:34460 E:34464 ||| CC
edited  ||| S:34464 E:34471 ||| VBG
the  ||| S:34471 E:34475 ||| DT
manuscript ||| S:34475 E:34485 ||| NN
.  ||| S:34485 E:34502 ||| .
